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Summary
Alcohol has long been known as a risk factor for disease. The 1990
Global Burden of Disease (GBD) study (Murray and Lopez 1996a,
1996b) identiﬁed alcohol as one of the major global risk factors, account-
ing for 1.5% of global deaths, 2.1% of years of healthy life lost owing
to premature mortality, 6.0% of years of life lost owing to disability and
3.5% of disability-adjusted life years (DALYs).
Based on the epidemiological literature, and modelling the relation-
ship between alcohol exposure and disease, two dimensions of alcohol
consumption were deﬁned as exposure variables:
• average volume of alcohol consumption; and
• pattern of drinking.
Average volume of consumption was estimated using both existing
estimates of country-speciﬁc adult per capita consumption (based on pro-
duction and sales data) and self-reported alcohol consumption from
general population surveys. Country-speciﬁc patterns of drinking were
deﬁned using indicators of high-volume drinking occasions and types 
of drinking situation (e.g. drinking with meals). These indicators were
drawn from key informant surveys and general population surveys,
where available. Optimal scaling procedures were used to determine
whether drinking patterns formed a single dimension and the relative
impact of the underlying indicators on the pattern value.
The relationship between exposure and various disease categories 
was estimated by the following methods. Estimates of the relationship
between categories of average volume of alcohol consumed and chronic
disease were based on disease-speciﬁc meta-analyses. Estimates of the
relationship between average volume of alcohol consumption and acute
disease were based on alcohol-attributable fractions (AAFs) published in
the literature. To estimate the impact of patterns of drinking on the risk
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of ischaemic heart disease (IHD) and injuries, multilevel modelling with
random intercept and random slope was used.
Effects of alcohol on someone other than the drinker were either
included in the AAFs of the literature (e.g. alcohol-related injury) or were
modelled indirectly (e.g. in the case of the effect of alcohol on the
newborn).
Both average volume of alcohol consumption and patterns of drink-
ing varied markedly across subregions.1 Average volume of drinking was
highest in EUR-A, EUR-C and AMR-A, and lowest in EMR-B, EMR-D
and SEAR-D. Patterns were most detrimental in EUR-C, EUR-B, AMR-
D and AFR-E. Patterns were least detrimental in EUR-A and WPR-A.
Existing research indicates causal relationships between average
volume of consumption and more than 60 International Statistical 
Classiﬁcation of Diseases and Related Health Problems (ICD) codes,
including both chronic diseases (malignant neoplasms, neuro-psychiatric
conditions, cardiovascular diseases, gastrointestinal conditions) and
injuries (intentional and unintentional). Although most of these rela-
tionships involve a detrimental impact of alcohol, there are beneﬁcial
relationships between alcohol and IHD, cerebrovascular disease and type
II diabetes for certain combinations of average volume of consumption
and patterns of drinking. Patterns of drinking were also associated with
the level of injury burden from alcohol, although no pattern of drinking
had beneﬁcial effects on injury.
The present analysis found that alcohol-related burden of disease is
considerable: 3.2% of global mortality and 4.0% of the global burden
of disease measured in DALYs. In terms of alcohol-related mortality,
almost half of the global burden is related to acute causes, i.e. uninten-
tional and intentional injuries, particularly unintentional injuries. The
next most important category comprises malignant neoplasms with 20%
of the overall alcohol-related mortality burden, followed by cardio-
vascular diseases (15% of all alcohol-attributable deaths) and other 
noncommunicable diseases, primarily liver cirrhosis (13%). However,
although the overall proportion of cardiovascular deaths attributable to
alcohol reﬂects a net result of 15%, this ﬁgure does not give a clear
picture of the underlying structure of the relationship between alcohol
consumption and cardiovascular disease. In particular, although alcohol
was estimated to cause a total of almost 600000 cardiovascular deaths
in the year 2000, exceeding even the alcohol-related deaths of uninten-
tional injuries, this ﬁgure was partly “offset” by the beneﬁcial effects of
alcohol on IHD and stroke. Across all diseases, more males than females
die from the effects of alcohol, with a ratio of about 10 :1.
In terms of DALYs, 4.0% of the overall global disease burden was
attributable to alcohol. The biggest differential effect of alcohol on 
mortality vs morbidity was for neuro-psychiatric diseases. Neuro-
psychiatric diseases are often disabling, but not fatal, and this is reﬂected
in the markedly higher proportion of overall disease burden caused by
960 Comparative Quantification of Health Risks
this category compared to alcohol-attributable mortality (38% of
alcohol-attributable DALYs vs 6% of alcohol-attributable deaths). As
with alcohol-related mortality, males have more than ﬁve times the
alcohol-related disease burden in terms of DALYs than females.
Alcohol-attributable disease burden is expected to further increase in
the future. This is due partly to increases in consumption in developing
and emerging economies in south-east Asia and partly to shifting pat-
terns of morbidity and mortality, in particular the increased signiﬁcance
of chronic diseases and injuries related to alcohol. This trend, however,
could be reversed quickly, as much of the disease burden of alcohol is
almost immediately preventable (40% of the overall alcohol-attributable
burden is from acute conditions). While a total ban on alcohol is not
realistic, there are other alcohol policy measures that could be imple-
mented to reduce the resulting disease burden.
1. Introduction
1.1 Deﬁnition of alcohol as a risk factor
The relationship between alcohol consumption and health and social
outcomes2 is complex and multidimensional. Figure 12.1 gives an
overview.
Alcohol consumption is linked to long-term biological and social 
consequences through three intermediate outcomes: intoxication, 
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Figure 12.1 Model of alcohol consumption, intermediate outcomes and
long-term consequences
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dependence and direct biochemical effects. Examples of such biochemi-
cal effects are the promotion of blood clot dissolution and direct toxic
effects on acinar cells triggering pancreatic damage.3 Figure 12.1 shows
only the main causal pathways. Intoxication may, for example, lead to
chronic social consequences (e.g. when a drunken driver kills somebody
and thereafter loses his or her job and social standing). Most of the con-
sequences of intoxication are nonetheless covered by acute health and
social consequences.
• Direct biochemical effects of alcohol consumption may inﬂuence
chronic disease, either beneﬁcially or in a harmful way. Beneﬁcial
effects include the inﬂuence of moderate drinking on IHD by reduc-
ing plaque deposits in arteries, protecting against blood clot forma-
tion and promoting blood clot dissolution (Zakhari 1997). Examples
of harmful effects include increasing the risk of high blood pressure,
direct toxic effects on acinar cells triggering pancreatic damage (Apte
et al. 1997) and hormonal disturbances (Emanuele and Emanuele
1997). The term “direct toxic and beneﬁcial effects” is used to sum-
marize all the biochemical effects of alcohol on body functions other
than intoxication and dependence.
• Intoxication is a powerful mediator, mainly for acute outcomes such
as accidents, intentional injuries or deaths, domestic conﬂict and 
violence, although episodes of intoxication can also be implicated 
in chronic health and social problems. The effects of alcohol on the
central nervous system mainly determine the subjective feeling of
intoxication. These effects are felt and can be measured even at con-
sumption levels that are light to moderate (Eckardt et al. 1998).
• Alcohol dependence is a disorder in itself, but is also a powerful 
mechanism sustaining alcohol consumption and mediating its impact
on both chronic and acute physiological and social consequences
(Drummond 1990).
Biological mechanisms have historically been the most important 
criteria in establishing the causal link between alcohol consumption 
and health outcomes (English et al. 1995; Hill 1965; Rothman and
Greenland 1998a).
Total consumption or average volume of consumption has been the
usual measure of exposure linking alcohol to disease (Bruun et al. 1975).
Average volume was linked to more than 60 disease conditions in a series
of recent meta-analyses (English et al. 1995; Gutjahr et al. 2001; Ridolfo
and Stevenson 2001; Single et al. 1999a).
As shown in Figure 12.1, average volume of consumption as a risk
factor works mainly through biochemical effects or through dependence
to produce long-term consequences. Although average volume is some-
what correlated with intoxication, this correlation is not of sufﬁcient
strength to adequately predict acute effects of alcohol related to injury
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and death. Such effects are much better predicted by patterns of drink-
ing (Rehm et al. 1996). For example, the same overall average volume
of alcohol can be consumed in small quantities regularly with meals (e.g.
two drinks a day with meals) or in large quantities on few occasions (e.g.
two bottles of wine on a single occasion every Friday). Data on the inﬂu-
ence of patterns of drinking are less available than data on overall con-
sumption, but evidence is accumulating that patterns of drinking affect
the link between alcohol and disease (Bondy 1996; Puddey et al. 1999;
Rehm et al. 1996, 2003) and between alcohol and mortality (Rehm 
et al. 2001d). In other words, the impact of an average volume of con-
sumption on mortality or morbidity is partly moderated by the way
alcohol is consumed by the individual, which in turn is inﬂuenced by the
social context (Room and Mäkelä 2000). It should be noted that pat-
terns of drinking have been linked not only to acute health outcomes
such as injuries (Greenﬁeld 2001; Rossow et al. 2001) but also to chronic
diseases such as IHD and especially sudden cardiac death (Britton and
McKee 2000; Chadwick and Goode 1998; Puddey et al. 1999; Trevisan
et al. 2001a, 2001b).
1.2 Choice of exposure variable
To determine the impact of alcohol on burden of disease, both average
volume of consumption and pattern of drinking have to be considered
and included in the analysis. Unfortunately, average volume of con-
sumption and pattern of drinking are not independent at the level of the
individual drinker, because average volume is often determined by heavy
drinking occasions (Rehm and Gmel 2000a). Consider someone who
drinks eight drinks per day. This person has by deﬁnition both a high
average volume of consumption and many heavy drinking occasions. On
the aggregate level, however, the two dimensions can be statistically inde-
pendent, as described below in section 2.3.
Average volume of drinking is a relatively simple concept, at least on
a theoretical level. It is more difﬁcult to conceptualize patterns of drink-
ing on a worldwide scale. For the comparative risk assessment (CRA)
project (see also WHO 2002), aspects of drinking patterns likely to con-
tribute to consequences were identiﬁed as a ﬁrst step in this process (see
also Rehm et al. 2001a, 2001b). Table 12.1 provides an overview of the
results of this exercise.
1.3 Choice of theoretical minimum
Because the relationship between alcohol and disease or injury stems
from two potentially interrelated dimensions—average volume of
alcohol consumption and drinking pattern—the theoretical minimum or
other counterfactual scenarios that provide a reference for hypothetical
risk reduction should take both dimensions into account. One obvious
and important counterfactual would be total abstinence from alcohol. If
all effects of alcohol on health were negative, this would obviously be
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the ideal theoretical minimum. However, it has been shown that alcohol,
if consumed in a regular pattern of light to moderate doses, has protec-
tive effects against IHD and potentially other ischaemic diseases (Ashley
et al. 2000; Puddey et al. 1999).
The cardioprotective effect has the most relevance to countries with
established market economies, which tend to have the longest life
expectancy and the highest proportion of deaths from ischaemic disease
(Murray and Lopez 1996a). In addition, the pattern of light regular
drinking associated with this protective effect, when it occurs, is found
mainly in these countries. Drinking to intoxication, heavy drinking occa-
sions and other more detrimental drinking patterns, on the other hand,
are often the prevalent drinking style outside established market
economies4 (see Table 12.3 for an overview of country-by-country drink-
ing patterns). Economic development and patterns of drinking are cor-
related to a higher degree than volume of alcohol consumption and
economic development (Pearson correlation of 0.6 between patterns and
per capita gross national product [GNP] on the 2001 data set of the CRA
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Table 12.1 Patterns of drinking relevant to CRA
Pattern indicators Link to disease
Proportion of the adult population The same adult consumption per capita will have more
who abstain from alcohol detrimental effects in countries where drinking is 
concentrated among fewer people. This variable was 
later dropped from the pattern analyses, as it has been 
incorporated into the average drinking categories
Heavy drinking occasionsa The fewer occasions on which a given amount of 
High usual quantity of alcohol alcohol is consumed, the more detrimental the 
per occasion consequences (Puddey et al. 1999; Room et al. 2002;
Proportion of drinkers who drink Walsh and Rehm 1996). Heavy drinking occasions lead 
daily or nearly daily to an increase in injuries. Also, heavy drinking occasions
Proportion of drinking occasions have been shown to lead to detrimental cardiovascular 
when drinkers get drunk outcomes
Festive drinking common—at 
ﬁestas or community celebrations
Drinking with meals—how  Drinking with meals has been shown in epidemiological
common to drink with meals and biological research to be less detrimental than 
drinking at other times (Gentry 2000; Ramchandani 
et al. 2001; Trevisan et al. 2001a)
Drinking in public places—how Drinking in public often requires transportation, and 
common to drink in public places thus has been linked to trafﬁc accidents and injuries 
(Fahrenkrug and Rehm 1994)
Drinking linked to violence Alcohol-related violence is an important cause of 
injuries. This variable confounds exposure and a potential 
consequence and was thus dropped in subsequent analyses
a This is often termed “binge drinking”. However, the deﬁnition of binge drinking varies widely (e.g. from
heavy festive drinking with intoxication lasting more than one day to having ﬁve or more drinks on one
occasion). It was therefore decided not to use the term in this work.
with 89 countries, where the correlation between average volume of con-
sumption and GNP is 0.2; see Rehm et al. 2001a, 2001b). Unfortunately,
insufﬁcient research has been carried out to identify the causal determi-
nants of this relationship.
It is proposed to establish the following counterfactual scenarios for
measuring the effects of alcohol consumption:
• total abstinence, which would mean an increase in the disease burden
of some cardiovascular categories for established market economies
and countries with a general pattern of light to moderate drinking;
• as a sensitivity analysis, the current status in patterns of drinking with
different scenarios for volume of drinking;
• as a sensitivity analysis, the current status in average consumption
with different values for patterns of drinking; and
• changing both average volume of consumption and drinking patterns
towards light, regular drinking.
The overall attributable burden of disease should be calculated using
abstainers as the comparison group, as this provides the global theoret-
ical minimum. Owing to the large contribution of neuropsychological
disease and injuries, neither of which beneﬁts from alcohol consumption,
it is also likely that at the population level in every subregion except
AMR-A, EUR-A and WPR-A abstinence results in the lowest population
risk. The cardioprotective effect will be included in established market
economies with light to moderate drinking patterns by using relative
risks smaller than 1, thus subtracting “prevented burden” from the
burden of disease for these countries.
2. Estimating risk factor levels
2.1 Measuring average volume of alcohol consumption
and patterns of drinking
To quantify the effects of alcohol on population health, it is necessary
to measure the two key exposure variables, average volume of alcohol
consumption and patterns of drinking, at the population level around
the world.
AVERAGE VOLUME OF ALCOHOL CONSUMPTION
There have been a number of attempts to gather country-level data on
average volume of alcohol consumption, most recently by the World
Health Organization (WHO) in the Global status report on alcohol
(1999). Most attempts have tried to arrive at an aggregate ﬁgure per
country, i.e. per capita consumption or adult per capita consumption (i.e.
per capita consumption for all inhabitants aged >15 years). For several
reasons, however, this aggregate ﬁgure is insufﬁcient for health impact
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assessment. First, as a global ﬁgure, this approach does not allow dis-
aggregation into different groups (e.g. as deﬁned by sex and age), which
is needed for valid estimates of burden of disease. Second, per capita con-
sumption estimates are usually based on production ﬁgures or sales data,
and thus do not include consumption of home-made or illegally imported
alcohol (see discussion of unrecorded consumption in Giesbrecht et al.
2000; Leifman 2001; Summer 2000).
On the positive side, the production and trade or sales data required
to calculate per capita consumption have traditionally been collected by
various sources (including the alcoholic beverage industry and interna-
tional agencies such as the Food and Agriculture Organization of the
United Nations [FAO]) and are available for most countries of the world.
FAO collects production and trade data for different alcoholic beverages,
mainly from ministries of agriculture and customs departments. For
some countries, estimates include data on alcoholic beverages outside 
the usual beer, wine and spirits categories (e.g. palm wine and sorghum
beer) but they do not systematically include home production or illicit
production.
To use per capita consumption data for detailed risk analysis, we com-
bined this source with survey data from various countries. Survey data
are especially important in determining the proportion of abstainers in
a country, as well as in dividing the overall volume into drinking cate-
gories by sex and age groups. In addition, some surveys can be used to
estimate unrecorded consumption (e.g. Kühlhorn et al. 1999; and the
current WHO-supported efforts in Brazil, China, India and Nigeria).5
Although survey data are essential for reﬁning per capita estimates,
they also have problems that preclude them from being used as the single
source of data. In particular, survey data from many established market
economies considerably underestimate total volume (Midanik 1988;
Midanik and Harford 1994; Rehm 1998a; de Vries et al. 1999).6 In addi-
tion, survey data are less available than per capita consumption data on
an international level (Rehm and Gmel 2000b; WHO 1999). Neverthe-
less, by combining both kinds of information one may arrive at disag-
gregated estimates. In this combination, the per capita estimates based
on production and sales (combined with data on unrecorded consump-
tion where available) are taken as the overall value. Surveys are then
used to estimate the distribution of this overall volume among various
groups, as deﬁned by abstinence and different levels of drinking, and by
sex and age.
PATTERNS OF DRINKING
Existing general population surveys cover some of the patterns of drink-
ing listed in Table 12.1, but rarely would one ﬁnd all features in one rep-
resentative survey in a particular country. Moreover, not all surveys on
drinking patterns are recent. Therefore, to develop drinking pattern esti-
mates for the 14 subregions used in the CRA, key informant question-
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naire studies were undertaken in early 2000 (Rehm et al. 2001b; for the
key informant questionnaire see Appendix 1 in European Addiction
Research 2001) and repeated in 2001, using a slightly modiﬁed ques-
tionnaire.7 In 2000, 61 questionnaires were sent out, 52 of which were
returned, and in 2001 another 155 were sent out, 40 of which were
returned. Table 12.2 lists, by subregion, the countries for which key
informant surveys were received. Together with survey data, the
responses from the survey on patterns provided sufﬁcient data for a ﬁrst
estimate of patterns of drinking for all subregions.
SUMMARY OF DATA SOURCES USED
The following country level measures of alcohol consumption were used
in the analysis:
• adult per capita consumption based on sales data or production and
trade data;
• unrecorded consumption based on various estimates;
• survey data on abstinence, average volume consumed in different
sex and age groups, and patterns of drinking; and
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Table 12.2 Countries with returned key informant questionnaires
Total no. of
countries in
Subregion Countries that returned questionnaires in at least one phase subregion
AFR-D Burkina Faso, Nigeria, Seychelles 26
AFR-E Congo, Namibia, South Africa, Zambia 20
AMR-A Canada, USA 3
AMR-B Argentina, Brazil, Costa Rica, Mexico, Trinidad and Tobago 26
AMR-D Peru 6
EMR-B None 13
EMR-D None 9
EUR-A Austria, Belgium, Czech Republic, Denmark, Finland, 26
France, Germany, Greece, Iceland, Ireland, Israel,
Italy, Malta, Netherlands, Norway, Portugal, Slovenia,
Spain, Sweden, Switzerland, United Kingdom
EUR-B Armenia, Bulgaria, Poland, Slovakia, The former Yugoslav  16
Republic of Macedonia
EUR-C Belarus, Estonia, Hungary, Latvia, Lithuania, Russian Federation 9
SEAR-B Sri Lanka, Thailand 3
SEAR-D India 7
WPR-A Australia, Japan, New Zealand, Singapore 5
WPR-B China, Fiji, Malaysia, Micronesia, Palau, Papua New Guinea, 22
Philippines, Republic of Korea, Solomon Islands
Total 191
• key informant information on various aspects of patterns of 
drinking.
Data for all years after 1998 were considered. Data were checked for
consistency across time and for internal consistency (e.g. survey vs per
capita estimates of average volume of consumption).
2.2 Data sources for average volume of 
alcohol consumption
Data on adult per capita and unrecorded consumption were taken from
the Global status report on alcohol (WHO 1999) and from the WHO
Global Alcohol Database, created by the Marin Institute for the Pre-
vention of Alcohol and Other Drug Problems and currently maintained
by the Swiss Institute for the Prevention of Alcohol Problems. Surveys
were also collected from this database, but additional surveys were
accessed based on individual contacts (including several experts from
each subregion) and by announcing this project on a speciﬁc WHO list-
serve and at the Annual Alcohol Epidemiology Symposia of the Kettil
Bruun Society for Social and Epidemiological Research on Alcohol. Data
on drinking patterns were collected from researchers and health ofﬁcials
known to WHO who had the knowledge to serve as key informants for
their countries or regions. Key informant information was collected by
surveys in early 2000 and in mid 2001.
Categorical levels for average volume of alcohol per day in relating
consumption to chronic disease were selected to be consistent with pre-
vious meta-analyses (English et al. 1995; Gutjahr et al. 2001; Ridolfo
and Stevenson 2001; Single et al. 1999a; for a discussion of the back-
ground to these categories see English et al. 1995; Holman et al. 1996)
and were deﬁned as follows:
• abstainer: a person not having had a drink containing alcohol within
the last year;
• average volume drinking category I: for females 0–19.99g pure
alcohol daily; for males 0–39.99g pure alcohol daily;
• average volume drinking category II: for females 20–39.99g pure
alcohol daily; for males 40–59.99g pure alcohol daily; and
• average volume drinking category III: for females 40g or more pure
alcohol daily; for males 60g or more pure alcohol daily.8
This categorization of average drinking, rather than using a continu-
ous measure of consumption, makes it possible to derive different shapes
of risk curve (linear, J-shape, threshold, etc.) while, at the same time,
allowing inclusion of data from studies in which only categorical infor-
mation on levels of alcohol consumption were collected. Using per capita
consumption data derived from production and trade or sales data plus
unrecorded consumption as the ﬁrst estimate of overall alcohol con-
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sumption, the following strategy was adopted to generate age- and sex-
speciﬁc prevalence rates.
• For each subregion, the average adult per capita consumption, includ-
ing unrecorded consumption for the population aged ≥15 years, was
estimated as a population-weighted average of country-speciﬁc per
capita consumption data. All entries per country after 1998 were
taken and averaged to obtain a stable estimate for 2000. The weights
were derived from the average population aged ≥15 years in each
country for the years after 1998, on the basis of United Nations pop-
ulation data. Country-speciﬁc adult per capita data were estimated for
132 countries (see Table 12.3). Per capita consumption was known
and adult per capita consumption could be calculated for more than
90% of the world’s population. Survey information on abstinence was
available for 69 countries, in particular from almost all countries with
population larger than 100 million resulting in more than 80% of the
world population with available survey data. This means that more
than 50% of the countries for which data were available on per capita
consumption also had survey data available.
• Country-speciﬁc survey data of the ratio of male to female consump-
tion were used to allocate proportionally the overall adult per capita
consumption to adult male and adult female per capita consumption.
• Based on surveys, the age-speciﬁc prevalence of drinking was calcu-
lated on the assumption that the average per capita consumption and
the proportions of male and female abstainers were correct. 
2.3 Data sources for patterns of drinking
Initial estimates of drinking patterns across a range of countries were
based on two surveys of key informants selected by WHO staff, con-
ducted in early 2000 and mid 2001. The surveys covered relevant drink-
ing characteristics within different countries or regions. In most cases,
respondents had access to national or regional survey data, although
these data had not always been published in the international literature.
In addition, the informants provided a conﬁdence rating for their
responses (i.e. whether based on surveys or just best guesses). This infor-
mation was used for decisions about inclusion of data when conﬂicting
information existed. As listed in Table 12.1, the survey considered ﬁve
main areas of drinking patterns that might be expected to affect the
impact of volume of drinking: proportion of abstainers, heavy drinking
occasions, drinking with meals, drinking in public places and drinking
linked to violence (later dropped from analyses because of its interfer-
ence with outcome measures).
The key informant ratings were analysed using optimal scaling analy-
sis (Bijleveld et al. 1998, chapter 2). This analysis is similar to factor
analysis, but permits the simultaneous inclusion of ordinal and categor-
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ical data. As with factor analysis, this statistical technique allows the
analyst to determine the number of underlying dimensions and the rela-
tion of items to each dimension. In the analysis of patterns of drinking,
one global dimension was identiﬁed and labelled as detrimental impact
(for details see Rehm et al. 2001b).
The results of the optimal scaling analysis were very similar to a score
derived simply by summing the ratings of the key informant survey
(Pearson correlation: 0.93). To further simplify the pattern values into
robust general categories based on these scale values, the countries were
placed in four categories and assigned values from 1 to 4. By the time
the ﬁnal pattern values were constructed, additional survey data were
available as well as the second wave of key informant data, allowing
reﬁnement and corrections of estimates. Also, the proportion of abstain-
ers was no longer included as one of the parameters of pattern weights,
because rates of abstinence were taken into account separately as one of
the average volume of consumption categories. The underlying variables
and the scoring pattern can be found in Appendix A.
To apply pattern values to estimate the burden of disease attributable
to alcohol, countries with missing data on drinking pattern values were
assigned the same category as that of neighbouring countries, taking into
consideration geographical and cultural proximity. The pattern values
for more than 130 countries worldwide can be seen in Table 12.3.9
Patterns of drinking thus deﬁned were found to be unrelated to
volume: the overall Pearson correlation between pattern values and per
capita consumption for the countries included is –0.126 and the more
appropriate Spearman correlation is –0.072. Both correlations do not
achieve statistical signiﬁcance; that is, they are not signiﬁcantly different
from zero (both correlations based on 132 countries with data on both
variables). This suggests that drinking pattern may provide important
unique information about the risks of drinking alcohol beyond that 
captured by per capita consumption.
Although this procedure allowed us to derive drinking pattern values
from a combination of empirical data and expert judgement, these pat-
terns still needed to be validated empirically to demonstrate that they
were, in fact, related to outcomes. In other words, pattern values serve
as a description of one aspect of exposure that is theoretically postulated
to be related to harm, but such a relation still has to be empirically estab-
lished. In addition, the degree of inﬂuence of patterns on harm (i.e. how
much weight to assign to drinking pattern in calculating the burden of
disease attributable to alcohol) had to be estimated. Moreover, the
weight to be assigned to drinking pattern may vary by type of outcome,
sex and age. A later section of this chapter describes how these weights
were developed.
970 Comparative Quantification of Health Risks
2.4 Methods for obtaining estimates where more than one
data source exists
For estimating overall consumption, clear hierarchies were used for 
integrating per capita data into the WHO Global Alcohol Database and
subsequently into this work.
• Scientiﬁcally derived and well documented local estimates (e.g. from
the National Drug Research Institute in Australia, see Catalano et al.
2001) were given ﬁrst priority.
• Production/sales data were used, such as the annual data on per capita
consumption published by the alcohol industry (e.g. Productschap
voor Gedistilleerde Dranken 1999, 2000).
• FAO production and trade data were used where other data were not
available.
If more than one data point existed for the time after 1998 (e.g. per
capita estimates for 1998 and 1999), data points were averaged. With
respect to survey data, if more than one representative survey with more
than 2000 persons existed, the most recent survey estimates were used.
Survey data were always given priority over key informant estimates in
estimating pattern values.
2.5 Methods for obtaining estimates where no data 
source exists
Most regions had sufﬁcient data for estimating prevalence of average
volume of drinking, based on per capita consumption (including
unrecorded consumption) plus the sex-speciﬁc ratio of abstinence derived
from surveys. Survey data on abstinence were available for 69 countries
(52.3% of all 132 countries included), and were additionally estimated
for 39 countries (29.5% of all the countries). Estimation was based on
abstinence rates in adjoining countries. Survey data on abstinence were
available for many of the countries with large populations: Brazil, China,
India, Mexico, Nigeria, the Russian Federation, South Africa, the United
States of America and the major (western) European countries. These
surveys were taken as indicators for the respective subregions. Regional
numbers are to a large degree inﬂuenced by a limited number of highly
populated countries. Thus, it is important to get the numbers for these
countries correct by investing limited resources in estimating alcohol con-
sumption for these countries, rather than attempting to improve the data
for all countries in the world.10
Data were scarcer with respect to patterns of drinking. Only 44 coun-
tries (33.3% of 132 countries) had sufﬁcient information on patterns to
compute a pattern score. For another 88 countries (66.6%), data on pat-
terns had to be estimated. Clearly, it is a priority for future estimates that
more data on drinking patterns be collected for use in these analyses (see
Jürgen Rehm et al. 971
also Rehm and Gmel 2000b). As with per capita consumption, ratings
on drinking patterns for countries for which no data were available were
based on social and cultural factors (Muslim vs non-Muslim country,
type of drinking culture, etc.) and on drinking patterns in surrounding
countries.
2.6 Description of databases, including 
methodological qualities
A description of the WHO Global Alcohol Database can be found in the
Global status report on alcohol (WHO 1999). The Swiss Institute for
the Prevention of Alcohol Problems constantly updates and expands the
Database, which includes both adult per capita and survey data. In addi-
tion, many surveys were directly sent to the ﬁrst author of this work,
especially from countries that also supplied key informant information.
Additional surveys from developing countries can be found in a WHO
collection (WHO 2001). The data in the WHO Database are selected
and scrutinized according to set criteria. The data from established
market economies are usually based on more reliable sales data and
better-quality surveys than those from developing countries.
2.7 Characteristics of excluded studies/databases
Studies were excluded only if better survey information was available for
the same country. Better survey information was deﬁned in terms of how
recently the survey had been conducted, the availability of a probability
sample of at least 2000 respondents, or other quality criteria (e.g. a rep-
resentative survey based on probabilistic sampling of the whole country
vs a non-representative survey or regional survey; better alcohol mea-
sures, such as quantity–frequency measure vs frequency-only measure;
or larger survey at the same time).
2.8 Estimates of country data and exposure dimensions by
subregion, age and sex
Table 12.3 provides country-speciﬁc information on alcohol consump-
tion, drinking patterns, percentage abstainers and validity ratings for
estimates. Also shown are the relevant subregion and the population
aged ≥15 years in 2000.
Table 12.4 gives estimates of the proportion of population in each of
the four categories of average alcohol consumption described above by
subregion, sex and age. The CRA required two age groups for people
aged >70 years: 70–79 years and ≥80 years. With a lack of evidence to
differentiate between these two age categories, both were assumed to
have the same prevalence and risk relations.
These ﬁgures assume no alcohol consumption leading to harm for
young people under the age of 15 years. This is certainly not true for
young people in established market economies, where drinking starts
early and where alcohol-related harm can be found (though not with a
972 Comparative Quantification of Health Risks
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high prevalence) before the age of 15 years (Hibell et al. 2000). However,
as data for this age group are scarce and as the prevalence rates for drink-
ing and harm are low, the conservative approach of estimating no
alcohol-related harm for this age group was adopted. The decision to
model alcohol-related harm at zero for people’s own drinking does not
mean that there will be no alcohol-related harm estimated in this age
group altogether. Rather, owing to the nature of effects, we must deviate
from the standard epidemiological model and include effects of drinking
on other externalities. To give just one example of this type of harm, a
drunken driver may kill innocent bystanders or passengers driving in his
car who are younger than 15 years, and this would be a fatality caused
by alcohol.
The following distribution data were based on survey-based informa-
tion on abstainers for 69 countries. For distributional information on
drinkers, the following sources were considered:
• AFR-D, Nigeria (Mustonen et al. 2001 and newer survey data
reported in the key informant questionnaire from I. Obot/O. Gureje);
• AFR-E, South Africa (Department of Health 1998, South African
Demographic and Health Survey);
• AMR-A, Canada and the United States (surveys provided by E. Adlaf
for Canada and T. Greenﬁeld for the United States);
• AMR-B, Brazil (São Paulo) (Galduróz et al. 2000) and Mexico
(surveys provided by the Mexican Institute of Psychiatry); see also
WHO (2001) for country reports on Costa Rica and Mexico, and
Jutkowitz and Hongsook (1994); 
• AMR-D (survey data for Peru and Jutkowitz and Hongsook 1994);
• EMR-B and EMR-D (only per capita information and general distri-
bution information as approximately log-normal11 with some data on
abstinence); 
• EUR-A (based on the average of many country surveys); 
• EUR-B, Poland (based on survey information provided by key 
informants); 
• EUR-C, the Russian Federation (published national and regional
survey data from Bobak et al. 1999; Malyutina et al. 2001); 
• SEAR-B, Sri Lanka and Thailand (survey estimates provided by key
informants); 
• SEAR-D, India (regional survey data provided by key informants); 
• WPR-A, Australia and New Zealand (survey data, see English 
et al. 1995; Ridolfo and Stevenson for Australia and http://www.
aphru.ac.nz/projects/Larger for New Zealand); and
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• WPR-B, China (Wei et al. 1999 and additional information by the
ﬁrst author).
The numbers in Table 12.4 are given as a proportion of the age–sex-
speciﬁc population. Thus, for females aged 15–29 years in WPR-B,
67.4% are estimated to abstain, 32.6% are estimated to drink the equiv-
alent of between 0g and 20g pure alcohol per day, 0.1% are estimated
to drink between 20g and 40g, and less than 0.05% are estimated to
drink more than 40g. In the oldest age group, 89.8% of females are esti-
mated to abstain, 10.2% to drink the equivalent of up to 20g pure
alcohol per day, and less than 0.05% to drink more.
Currently, pattern values assigned to each country and then computed
as a population-weighted average for each subregion are not speciﬁc by
sex and age (see Table 12.5). This may change in the future when survey
data on patterns become more available.
2.9 Quantitative and qualitative sources of uncertainty
UNCERTAINTY ANALYSIS
As described, alcohol consumption as a risk factor has two dimensions:
average volume and patterns. It is thus proposed to base the uncertainty
analysis on the weighted average of the available information for both
dimensions for each subregion. Uncertainty analysis is undertaken to give
an indication on uncertainty, based on different characteristics such as
the source or variability of the estimated data. It will also be used to cal-
culate the conﬁdence intervals (CIs) of the alcohol-related burden. Clas-
sically, CIs for prevalence are determined by sample size, assuming that
the underlying individual data are representative of the subregion. For
some subregions, however, we do not have probabilistic samples. As
alcohol consumption is a social activity and can vary markedly from one
country to another within a region, one cannot automatically assume
that the countries without surveys would have the same alcohol distrib-
ution as the countries with surveys. Thus, the procedure based on sample
size cannot be used here. Moreover, prevalence was derived from both
aggregate- (per capita consumption) and individual-level data in a tri-
angulation of information, for which there is no statistical theory for
readily deriving CIs.
The algorithms speciﬁed below were developed after extensive dis-
cussions with experts in the ﬁeld. They are intended to reﬂect the quan-
tity and quality of the underlying data sources. Aggregate-level data exist
for all countries. To estimate average volume of alcohol consumption,
we propose to base uncertainty analysis on the amount of survey infor-
mation available in a subregion. The procedure allowed the estimation
of lower or upper limits, even if no survey information existed. In  Pak-
istan, for example, per capita alcohol consumption set clear upper
boundaries for the highest drinking categories, since some values would
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Table 12.4 Estimated proportions of population in average volume of
consumption categories by sex, age and subregion, in 2000a
Average volume 
Age group (years)of consumption 
Subregion Sex categoryb 15–29 30–44 45–59 60–69 70–79 ≥80
AFR-D Male Abstinence 0.510 0.462 0.514 0.565 0.616 0.616
D I 0.420 0.447 0.396 0.354 0.323 0.323
D II 0.063 0.073 0.072 0.063 0.044 0.044
D III 0.007 0.018 0.018 0.018 0.016 0.016
Female Abstinence 0.746 0.697 0.697 0.746 0.796 0.796
D I 0.234 0.267 0.265 0.237 0.191 0.191
D II 0.019 0.030 0.029 0.010 0.010 0.010
D III 0.001 0.007 0.010 0.007 0.003 0.003
AFR-E Male Abstinence 0.432 0.375 0.428 0.482 0.536 0.536
D I 0.431 0.430 0.403 0.368 0.354 0.354
D II 0.125 0.161 0.135 0.116 0.082 0.082
D III 0.012 0.034 0.034 0.033 0.029 0.029
Female Abstinence 0.715 0.664 0.664 0.715 0.766 0.766
D I 0.243 0.277 0.271 0.237 0.203 0.203
D II 0.036 0.046 0.046 0.036 0.025 0.025
D III 0.006 0.012 0.018 0.012 0.006 0.006
AMR-A Male Abstinence 0.240 0.221 0.268 0.374 0.431 0.431
D I 0.522 0.583 0.577 0.525 0.498 0.498
D II 0.164 0.146 0.105 0.095 0.064 0.064
D III 0.074 0.050 0.050 0.006 0.006 0.006
Female Abstinence 0.360 0.331 0.409 0.584 0.633 0.633
D I 0.563 0.620 0.548 0.382 0.337 0.337
D II 0.050 0.033 0.027 0.025 0.023 0.023
D III 0.027 0.016 0.016 0.008 0.007 0.007
AMR-B Male Abstinence 0.220 0.203 0.172 0.199 0.358 0.358
D I 0.671 0.674 0.711 0.714 0.605 0.605
D II 0.035 0.045 0.045 0.031 0.025 0.025
D III 0.074 0.078 0.072 0.056 0.012 0.012
Female Abstinence 0.463 0.444 0.444 0.488 0.538 0.538
D I 0.464 0.475 0.486 0.450 0.429 0.429
D II 0.028 0.028 0.026 0.030 0.020 0.020
D III 0.046 0.053 0.044 0.032 0.013 0.013
AMR-D Male Abstinence 0.298 0.264 0.304 0.398 0.498 0.498
D I 0.677 0.712 0.672 0.585 0.494 0.494
D II 0.017 0.016 0.016 0.013 0.008 0.008
D III 0.008 0.008 0.008 0.004 0.001 0.001
Female Abstinence 0.431 0.393 0.487 0.548 0.628 0.628
D I 0.536 0.572 0.483 0.428 0.356 0.356
D II 0.024 0.025 0.021 0.019 0.012 0.012
D III 0.009 0.009 0.008 0.005 0.004 0.004
EMR-B Male Abstinence 0.789 0.838 0.838 0.887 0.976 0.976
D I 0.191 0.149 0.149 0.107 0.024 0.024
D II 0.013 0.010 0.010 0.004 0.000 0.000
D III 0.006 0.003 0.003 0.001 0.000 0.000
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Table 12.4 Estimated proportions of population in average volume of
consumption categories by sex, age and subregion, in 2000a
(continued)
Average volume 
Age group (years)of consumption 
Subregion Sex categoryb 15–29 30–44 45–59 60–69 70–79 ≥80
Female Abstinence 0.937 0.968 0.968 0.998 1.000 1.000
D I 0.052 0.027 0.027 0.002 0.000 0.000
D II 0.008 0.005 0.005 0.000 0.000 0.000
D III 0.003 0.000 0.000 0.000 0.000 0.000
EMR-D Male Abstinence 0.898 0.898 0.898 0.947 0.987 0.987
D I 0.101 0.102 0.102 0.052 0.013 0.013
D II 0.001 0.000 0.000 0.000 0.000 0.000
D III 0.000 0.000 0.000 0.000 0.000 0.000
Female Abstinence 0.975 0.990 0.990 1.000 1.000 1.000
D I 0.024 0.010 0.010 0.000 0.000 0.000
D II 0.001 0.000 0.000 0.000 0.000 0.000
D III 0.001 0.000 0.000 0.000 0.000 0.000
EUR-A Male Abstinence 0.074 0.074 0.093 0.139 0.186 0.186
D I 0.748 0.721 0.701 0.723 0.717 0.717
D II 0.087 0.102 0.096 0.069 0.042 0.042
D III 0.091 0.102 0.110 0.069 0.055 0.055
Female Abstinence 0.138 0.138 0.173 0.259 0.346 0.346
D I 0.698 0.726 0.662 0.635 0.571 0.571
D II 0.123 0.103 0.124 0.085 0.065 0.065
D III 0.041 0.033 0.041 0.021 0.017 0.017
EUR-B Male Abstinence 0.237 0.284 0.284 0.331 0.379 0.379
D I 0.653 0.606 0.625 0.598 0.582 0.582
D II 0.054 0.054 0.049 0.038 0.016 0.016
D III 0.056 0.056 0.042 0.033 0.024 0.024
Female Abstinence 0.410 0.461 0.512 0.614 0.614 0.614
D I 0.507 0.449 0.414 0.328 0.339 0.339
D II 0.068 0.069 0.053 0.047 0.037 0.037
D III 0.016 0.021 0.021 0.010 0.010 0.010
EUR-C Male Abstinence 0.088 0.088 0.110 0.164 0.219 0.219
D I 0.602 0.662 0.584 0.629 0.669 0.669
D II 0.188 0.159 0.185 0.132 0.067 0.067
D III 0.123 0.091 0.121 0.075 0.045 0.045
Female Abstinence 0.140 0.140 0.175 0.263 0.351 0.351
D I 0.719 0.743 0.683 0.645 0.588 0.588
D II 0.115 0.096 0.116 0.079 0.051 0.051
D III 0.026 0.020 0.026 0.013 0.011 0.011
SEAR-B Male Abstinence 0.631 0.561 0.701 0.841 0.981 0.981
D I 0.359 0.410 0.295 0.156 0.018 0.018
D II 0.007 0.024 0.003 0.002 0.000 0.000
D III 0.002 0.006 0.001 0.001 0.000 0.000
Female Abstinence 0.885 0.914 0.914 0.943 0.953 0.953
D I 0.103 0.078 0.078 0.052 0.047 0.047
D II 0.009 0.008 0.008 0.005 0.000 0.000
D III 0.002 0.000 0.000 0.000 0.000 0.000
continued
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Table 12.4 Estimated proportions of population in average volume of
consumption categories by sex, age and subregion, in 2000a
(continued)
Average volume 
Age group (years)of consumption 
Subregion Sex categoryb 15–29 30–44 45–59 60–69 70–79 ≥80
SEAR-D Male Abstinence 0.717 0.637 0.796 0.956 1.000 1.000
D I 0.276 0.338 0.201 0.044 0.000 0.000
D II 0.006 0.020 0.002 0.001 0.000 0.000
D III 0.002 0.005 0.001 0.000 0.000 0.000
Female Abstinence 0.937 0.968 0.968 0.998 1.000 1.000
D I 0.051 0.028 0.028 0.002 0.000 0.000
D II 0.007 0.004 0.004 0.000 0.000 0.000
D III 0.005 0.000 0.000 0.000 0.000 0.000
WPR-A Male Abstinence 0.095 0.095 0.119 0.179 0.238 0.238
D I 0.834 0.849 0.812 0.776 0.730 0.730
D II 0.033 0.028 0.032 0.023 0.013 0.013
D III 0.037 0.028 0.037 0.023 0.018 0.018
Female Abstinence 0.163 0.163 0.204 0.306 0.408 0.408
D I 0.806 0.812 0.766 0.675 0.578 0.578
D II 0.023 0.019 0.023 0.015 0.011 0.011
D III 0.008 0.006 0.008 0.004 0.003 0.003
WPR-B Male Abstinence 0.153 0.153 0.153 0.204 0.256 0.256
D I 0.769 0.761 0.761 0.719 0.684 0.684
D II 0.055 0.053 0.053 0.051 0.040 0.040
D III 0.022 0.032 0.032 0.026 0.020 0.020
Female Abstinence 0.674 0.674 0.674 0.786 0.898 0.898
D I 0.326 0.326 0.326 0.214 0.102 0.102
D II 0.001 0.000 0.000 0.000 0.000 0.000
D III 0.000 0.000 0.000 0.000 0.000 0.000
a Prevalences are rounded to full percentages. Thus, a value of zero does not necessarily indicate that
there are no people in a certain category, but may indicate a prevalence of less than 0.005 or 0.5%.
b Drinking categories are deﬁned as follows:
Risk factor: alcohol—ﬁrst dimension: average volume of consumption.
Units: grams of pure alcohol per day.
Deﬁnitions of categories of risk factor levels
Level 1: Abstinence abstainer
Level 2: D I drinking category I: women >0–<20 g; men >0–<40 g
Level 3: D II drinking category II: women 20–<40 g; men 40–<60 g
Level 4: D III drinking category III: women >40 g; men >60 g
not be physically possible within the overall volume consumed in this
country.
In operationalizing these principles, the validity of the abstainer cat-
egory was selected (for values in individual countries see Table 12.3).
This variable was aggregated using the population aged ≥15 years as a
weight. The resulting values were treated in the uncertainty analysis as
follows:
For aggregated validity values of 0 Base prevalence estimate on full 
range from 0 to twice the point
estimate (i.e. point estimate plus
100% of the point estimate).
For aggregated validity values >0  Point estimate ±50% of
and <0.5 point estimate of prevalence.
For aggregated validity values ≥0.5 Point estimate ±25% of 
and <0.75 point estimate of prevalence.
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Table 12.5 Patterns of drinking by subregion
Subregion Pattern valuea Validity of pattern value
AFR-D 2.48 0.52
AFR-E 3.09 0.24
AMR-A 2.00 0.97
AMR-B 3.14 0.77
AMR-D 3.10 0.38
EMR-B 2.01 0.00
EMR-D 2.35 0.00
EUR-A 1.34 0.92
EUR-B 2.93 0.31
EUR-C 3.62 0.75
SEAR-B 2.50 0.22
SEAR-D 2.95 0.93
WPR-A 1.16 0.98
WPR-B 2.15 0.93
a Pattern values were deﬁned as follows:
Risk factor: alcohol—second dimension: patterns of drinking.
Units: range between 1 and 4; originally derived from optimal scaling and then based on addition of
values of each pattern component (see Appendix A for details); subregional averages are population-
weighted country averages.
Deﬁnitions of categories of risk factor levels
Level 1: based on score of initial pattern components, with values in the lowest quartile reﬂecting least
detrimental patterns of drinking such as least heavy drinking occasions, drinking with meals, no ﬁesta
drinking and least drinking in public places.
Level 2: based on score of initial pattern components, with values in the second lowest quartile.
Level 3: based on score of initial pattern components, with values in the second highest quartile.
Level 4: based on score of initial pattern components, with values in the highest quartile reﬂecting
detrimental patterns such as many heavy drinking occasions, drinking outside meals, high level of ﬁesta
drinking and drinking in public places.
For aggregated validity values ≥0.75 Point estimate ±10% of point 
estimate of prevalence.
This applies to both sexes, as most surveys include both males and
females. Further corrections were made based on per capita consumption
for subregions where certain distributions were not plausible because the
known per capita consumption could not be derived with less than a
certain proportion of abstainers (for EMR-B: maximum CI for abstain-
ers ±15%, minimum: ±1%; for EMR-D: maximum ±10%, minimum:
±1%; for SEAR-B: maximum ±10%, minimum: ±1%; for SEAR-D and
WPR-B: minimum: ±0.2%). The results can be seen in Table 12.6.
Similarly, for constructing CIs around patterns of drinking (see Table
12.7), the validity of the underlying pattern values was used. Again, using
the weighted average on the validity ratings of the pattern value (see
Table 12.3 for the underlying country data), the following uncertainty
ranges were proposed:
For validity of pattern value of 0 Uncertainty analysis on full range
of pattern values (i.e. using 
pattern values 1 and 4 as bounds).
For validity of pattern value Point estimate ± 1.
ranging from >0 and <0.5 
For validity of pattern value Point estimate ± 0.5.
ranging from ≥0.5 and <0.75
For validity of pattern value Point estimate ± 0.25.
ranging from ≥0.75
The validity of pattern value ranged from 0 (e.g. only expert judge-
ments for pattern in EMR-B and EMR-D with no underlying data) to
values above 0.95 for several subregions (theoretically 1 if all the pattern
values of constituent countries were derived from survey estimates).
The suggested procedure clearly reﬂects our range of knowledge. For
example, we have no knowledge about patterns in EMR-B and EMR-D,
where the uncertainty estimates consequently varied between 1 (best pos-
sible pattern) and 4 (most detrimental pattern), whereas we have good
data for many other subregions (e.g. all the A mortality strata sub-
regions), where the uncertainty estimates vary by only ± 0.25 (e.g. EUR-
A, between 1.09 and 1.59).
OVERALL EVALUATION OF QUALITY FOR EXPOSURE DATA
Data on production and trade or sales required for estimating adult per
capita consumption have been collected systematically for decades in
most countries. In this sense, alcohol as a risk factor for global health is
privileged compared to some other risk factors, where exposure data are
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Table 12.6 Estimated uncertainty range (±%) around point estimate for
prevalence of average volume of consumption categories
Average volume 
Age group (years)of consumption 
Subregion Sex category 15–29 30–44 45–59 60–69 70–79 ≥80
AFR-D Male Abstinence 5.10 4.62 5.14 5.65 6.16 6.16
D I 4.20 4.47 3.96 3.54 3.23 3.23
D II 0.63 0.73 0.72 0.63 0.44 0.44
D III 0.07 0.18 0.18 0.18 0.16 0.16
Female Abstinence 7.46 6.97 6.97 7.46 7.96 7.96
D I 2.34 2.67 2.65 2.37 1.91 1.91
D II 0.19 0.30 0.29 0.10 0.10 0.10
D III 0.01 0.07 0.10 0.07 0.03 0.03
AFR-E Male Abstinence 10.80 9.37 10.71 12.05 13.39 13.39
D I 10.77 10.75 10.08 9.21 8.84 8.84
D II 3.12 4.03 3.36 2.91 2.05 2.05
D III 0.31 0.85 0.84 0.83 0.72 0.72
Female Abstinence 17.88 16.61 16.61 17.88 19.16 19.16
D I 6.07 6.93 6.78 5.92 5.07 5.07
D II 0.90 1.16 1.16 0.90 0.63 0.63
D III 0.15 0.30 0.45 0.30 0.15 0.15
AMR-A Male Abstinence 2.40 2.21 2.68 3.74 4.31 4.31
D I 5.22 5.83 5.77 5.25 4.98 4.98
D II 1.64 1.46 1.05 0.95 0.64 0.64
D III 0.74 0.50 0.50 0.06 0.06 0.06
Female Abstinence 3.60 3.31 4.09 5.84 6.33 6.33
D I 5.63 6.20 5.48 3.82 3.37 3.37
D II 0.50 0.33 0.27 0.25 0.23 0.23
D III 0.27 0.16 0.16 0.08 0.07 0.07
AMR-B Male Abstinence 2.20 2.03 1.72 1.99 3.58 3.58
D I 6.71 6.74 7.11 7.14 6.05 6.05
D II 0.35 0.45 0.45 0.31 0.25 0.25
D III 0.74 0.78 0.72 0.56 0.12 0.12
Female Abstinence 4.63 4.44 4.44 4.88 5.38 5.38
D I 4.64 4.75 4.86 4.50 4.29 4.29
D II 0.28 0.28 0.26 0.30 0.20 0.20
D III 0.46 0.53 0.44 0.32 0.13 0.13
AMR-D Male Abstinence 7.46 6.60 7.60 9.96 12.45 12.45
D I 16.93 17.80 16.80 14.62 12.34 12.34
D II 0.41 0.39 0.39 0.31 0.19 0.19
D III 0.20 0.20 0.20 0.10 0.02 0.02
Female Abstinence 10.79 9.83 12.17 13.70 15.70 15.70
D I 13.40 14.31 12.09 10.70 8.90 8.90
D II 0.60 0.63 0.53 0.48 0.31 0.31
D III 0.22 0.23 0.21 0.12 0.09 0.09
EMR-B Male Abstinence 15.00 15.00 15.00 15.00 15.00 15.00
D I 19.55 15.25 15.25 11.00 2.65 2.65
D II 1.21 1.00 1.00 1.00 1.00 1.00
D III 1.00 1.00 1.00 1.00 1.00 1.00
continued
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Table 12.6 Estimated uncertainty range (±%) around point estimate for
prevalence of average volume of consumption categories
(continued)
Average volume 
Age group (years)of consumption 
Subregion Sex category 15–29 30–44 45–59 60–69 70–79 ≥80
Female Abstinence 15.00 15.00 15.00 15.00 15.00 15.00
D I 5.40 2.87 2.87 1.00 1.00 1.00
D II 1.00 1.00 1.00 1.00 1.00 1.00
D III 1.00 1.00 1.00 1.00 1.00 1.00
EMR-D Male Abstinence 10.00 10.00 10.00 10.00 10.00 10.00
D I 5.07 5.09 5.09 2.61 1.00 1.00
D II 1.00 1.00 1.00 1.00 1.00 1.00
D III 1.00 1.00 1.00 1.00 1.00 1.00
Female Abstinence 10.00 10.00 10.00 10.00 10.00 10.00
D I 1.18 1.00 1.00 1.00 1.00 1.00
D II 1.00 1.00 1.00 1.00 1.00 1.00
D III 1.00 1.00 1.00 1.00 1.00 1.00
EUR-A Male Abstinence 0.74 0.74 0.93 1.39 1.86 1.86
D I 7.48 7.21 7.01 7.23 7.17 7.17
D II 0.87 1.02 0.96 0.69 0.42 0.42
D III 0.91 1.02 1.10 0.69 0.55 0.55
Female Abstinence 1.38 1.38 1.73 2.59 3.46 3.46
D I 6.98 7.26 6.62 6.35 5.71 5.71
D II 1.23 1.03 1.24 0.85 0.65 0.65
D III 0.41 0.33 0.41 0.21 0.17 0.17
EUR-B Male Abstinence 5.92 7.10 7.10 8.28 9.47 9.47
D I 16.34 15.14 15.63 14.94 14.55 14.55
D II 1.35 1.36 1.23 0.96 0.39 0.39
D III 1.39 1.40 1.05 0.82 0.59 0.59
Female Abstinence 10.24 11.52 12.80 15.36 15.36 15.36
D I 12.66 11.22 10.35 8.20 8.47 8.47
D II 1.70 1.73 1.32 1.18 0.91 0.91
D III 0.39 0.53 0.53 0.26 0.26 0.26
EUR-C Male Abstinence 2.19 2.19 2.74 4.11 5.48 5.48
D I 15.05 16.55 14.60 15.72 16.72 16.72
D II 4.69 3.98 4.63 3.29 1.68 1.68
D III 3.07 2.27 3.03 1.88 1.12 1.12
Female Abstinence 3.51 3.51 4.39 6.58 8.77 8.77
D I 17.97 18.58 17.07 16.12 14.69 14.69
D II 2.88 2.40 2.90 1.97 1.27 1.27
D III 0.64 0.51 0.64 0.33 0.27 0.27
SEAR-B Male Abstinence 10.00 10.00 10.00 10.00 10.00 10.00
D I 17.96 20.48 14.73 7.80 1.00 1.00
D II 0.37 1.18 1.00 1.00 1.00 1.00
D III 1.00 1.00 1.00 1.00 1.00 1.00
Female Abstinence 10.00 10.00 10.00 10.00 10.00 10.00
D I 5.16 3.88 3.88 2.62 2.36 2.36
D II 0.46 0.41 0.41 1.00 1.00 1.00
D III 1.00 1.00 1.00 1.00 1.00 1.00
SEAR-D Male Abstinence 7.17 6.37 7.96 9.56 10.00 10.00
D I 2.76 3.38 2.01 0.44 0.20 0.20
D II 0.20 0.20 0.20 0.20 0.20 0.20
D III 0.20 0.20 0.20 0.20 0.20 0.20
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Table 12.6 Estimated uncertainty range (±%) around point estimate for
prevalence of average volume of consumption categories
(continued)
Average volume 
Age group (years)of consumption 
Subregion Sex category 15–29 30–44 45–59 60–69 70–79 ≥80
Female Abstinence 9.37 9.68 9.68 9.98 10.00 10.00
D I 0.51 0.28 0.28 0.20 0.20 0.20
D II 0.20 0.20 0.20 0.20 0.20 0.20
D III 0.20 0.20 0.20 0.20 0.20 0.20
WPR-A Male Abstinence 0.95 0.95 1.19 1.79 2.38 2.38
D I 8.34 8.49 8.12 7.76 7.30 7.30
D II 0.33 0.28 0.32 0.23 0.13 0.13
D III 0.37 0.28 0.37 0.23 0.18 0.18
Female Abstinence 1.63 1.63 2.04 3.06 4.08 4.08
D I 8.06 8.12 7.66 6.75 5.78 5.78
D II 0.23 0.19 0.23 0.15 0.11 0.11
D III 0.08 0.06 0.08 0.04 0.03 0.03
WPR-B Male Abstinence 1.53 1.53 1.53 2.04 2.56 2.56
D I 7.69 7.61 7.61 7.19 6.84 6.84
D II 0.55 0.53 0.53 0.51 0.40 0.40
D III 0.22 0.32 0.32 0.26 0.20 0.20
Female Abstinence 6.74 6.74 6.74 7.86 8.98 8.98
D I 3.26 3.26 3.26 2.14 1.02 1.02
D II 0.20 0.20 0.20 0.20 0.20 0.20
D III 0.20 0.20 0.20 0.20 0.20 0.20
Table 12.7 Uncertainty analysis for patterns of drinking, by subregion
Validity of Lower boundary Upper boundary
Subregion Pattern value pattern value for uncertainty for uncertainty
AFR-D 2.48 0.52 1.98 2.98
AFR-E 3.09 0.24 2.09 4.00
AMR-A 2.00 0.97 1.75 2.25
AMR-B 3.14 0.77 2.89 3.39
AMR-D 3.10 0.38 2.10 4.00
EMR-B 2.01 0.00 1.00 4.00
EMR-D 2.35 0.00 1.00 4.00
EUR-A 1.34 0.92 1.09 1.59
EUR-B 2.93 0.31 1.93 3.93
EUR-C 3.62 0.75 3.37 3.87
SEAR-B 2.50 0.22 1.50 3.50
SEAR-D 2.95 0.93 2.70 3.20
WPR-A 1.16 0.98 1.00 1.66
WPR-B 2.15 0.93 1.90 2.40
available only in established market economies, if at all. Unfortunately,
adult per capita consumption ﬁgures per se, as described above, cannot
be used as exposure data for global burden of disease because these
ﬁgures do not give any speciﬁcation about who consumed alcohol, when
and in what quantities. This can only be speciﬁed by using representa-
tive surveys of the general population. Thus, for the current exercise,
adult per capita ﬁgures had to be supplemented by survey data and,
where such data were not available, by expert judgements. This proce-
dure may have introduced errors at different points.
• Errors in adult per capita consumption estimates. Because per capita
estimates are derived mainly from production and trade or sale, other
sources (home brewing, cross-border smuggling, illegal production,
etc.) are often ignored. There is a long tradition of trying to estimate
this unrecorded consumption, but mainly in established market
economies where the proportion of unrecorded to recorded is low 
relative to other parts of the world. For example, see the recent 
European Comparative Alcohol Study (ECAS) estimates for Europe
(http://www.fhi.se/pdf/ECAS_2.pdf; Leifman 2001) compared to the
estimates of unrecorded consumption for sub-Saharan Africa given
below. In addition, estimation of unrecorded consumption is particu-
larly difﬁcult in regions where alcohol is prohibited for religious
reasons. In summary, although these sources of error exist, the global
aggregate estimates on adult per capita consumption are among the
best and most reliable sources for global risk factors.
Adult per capita consumption ﬁgures then were used to derive preva-
lence rates for speciﬁc drinking categories for different age–sex groups.
This derivation was based on survey data with the following potential
sources of error.
• Survey measurement error. Alcohol surveys are subject to measure-
ment errors that apply generally to surveys (for an overview see Groves
1989). However, the most important sources of error relating to esti-
mating alcohol consumption include non-probabilistic sampling, sam-
pling schemes that exclude groups with a high alcohol consumption,
and measurement bias. The major problem with survey estimates of
alcohol consumption is that surveys generally account for 66% or less
of alcohol produced or sold (Midanik 1988; Midanik and Harford
1994; Rehm 1998a; de Vries et al. 1999). However, combining survey
and aggregate (i.e. per capita) estimates may ameliorate the problem
of underreporting that is characteristic of survey estimates.
• Errors in combining adult per capita and survey data. Although com-
bining survey and aggregate data can rectify the underreporting of
survey data, other sources of error may be created by this procedure.
This is especially true if the difference in overall adult consumption
between aggregate and survey estimates is large. There are theoreti-
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cally several ways in which the survey estimates could be used to
arrive at the per capita ﬁgures. For example, the prevalence of all
drinking categories could be proportionally increased to cover the 
difference between survey and per capita estimates. This is not possi-
ble, however, as the rate of abstainers would automatically change as
well. Thus, a procedure must be selected to keep the proportion of
abstainers from the survey ﬁxed and proportionally increase the
higher consumption categories at the expense of the middle category.
Even if this procedure is plausible it may introduce error, such as when
survey underreporting differs for different age–sex groups. Neverthe-
less, the overall beneﬁts of combining surveys and adult per capita
data seem to outweigh this disadvantage.
There are other potential sources of error in the exposure estimates.
• Errors in estimating missing survey data. Survey data are available for
only some countries, so that regional ﬁgures had to be estimated from
selected countries where surveys were available. This introduces error,
and overall the lack of data for some countries is probably the most
important source of error for exposure estimates. The more survey
data are lacking, the more severe is this problem. Thus it is least severe
for those who abstain from alcohol, because even when survey data
on the amount of alcohol consumed were not available, many coun-
tries had survey data in which respondents were asked whether or not
they consumed alcohol. The problem of error in estimating missing
survey data was most severe for estimates of drinking patterns, where
expert judgements had to be used to supplement survey results, and
where no production and trade or sale estimates were available for
triangulation.
Overall, this listing of sources for potential errors and biases clearly
indicates that the results of CRA, while based on the best available
sources, are accompanied by large uncertainties, only some of which
could be quantiﬁed.
3. Estimating risk factor–disease
relationships
3.1 Outcomes to be assessed, evidence of causality 
and exclusions
Average volume of alcohol consumption has been related to more than
60 categories of the ninth revision of the ICD (ICD-9). This review
restricts itself to categories that have already been identiﬁed in system-
atic meta-analyses, together with depression, which we describe in more
detail below. Speciﬁcally, the following meta-analytical reviews were
used: Gutjahr et al. 2001; English et al. 1995; Ridolfo and Stevenson
2001; Single et al. 1996, 1999a.
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The categories that have been selected in modelling the impact of pat-
terns of drinking are based on our own literature reviews. The analyses
involving drinking patterns include the two main ICD categories for
which sufﬁcient evidence of a causal link to drinking patterns has been
established: IHD and injuries. In addition, we restricted modelling of the
protective effects of moderate regular drinking on type II diabetes and
stroke to established market economies with the best drinking patterns
(AMR-A, EUR-A and WPR-A), as there is evidence that patterns inﬂu-
ence these diseases as well (for detailed reasoning, see below).
ASSESSMENT OF CAUSALITY
Following the procedure described by English et al. (1995), the evidence
of causality between alcohol consumption and disease outcomes (includ-
ing both harmful and protective effects for particular diseases) is assessed
in accordance with the Australian National Health and Medical
Research Council’s (NHMRC) Guidelines for the development, imple-
mentation and evaluation of clinical practice guidelines, which are the
most used in the alcohol ﬁeld and close to the criteria of Hill (1965).
Sufﬁcient evidence of causality includes outcomes for which the evidence
indicates that an association (positive or negative) exists between alcohol
consumption and the disease or injury and that chance, confounding
variables and other bias can with reasonable conﬁdence be ruled out as
factors in this association. This judgement was made using the usual cri-
teria for establishing causality in epidemiology (Hill 1965; Rothman and
Greenland 1998a), with the most weight placed on the following four
criteria:
• consistency across several studies;
• established experimental biochemical evidence of mediating processes,
or at least physiological plausibility;
• strength of the association (effect size); and
• temporality (i.e. cause before effect).
Two examples of judgements regarding somewhat controversial out-
comes may illustrate this process. For lung cancer, meta-analysis showed
a consistent effect with a relatively large effect size (English et al. 1995;
but see the meta-analysis of Bagnardi et al. 2001, which came to a dif-
ferent conclusion), after adjusting for smoking in at least some studies.
However, evidence for the possible biological mechanisms is not con-
clusive at present (Bandera et al. 2001) and residual confounding from
smoking cannot be excluded as an alternative explanation. Thus, con-
sistent with a recent review of the epidemiological evidence, the evidence
for alcohol causing lung cancer was not judged sufﬁcient to establish
causality according to the criteria listed above (Bandera et al. 2001), and
thus lung cancer was excluded as an alcohol-related disease outcome in
this work.
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On the other hand, although English et al. (1995) concluded that there
was not sufﬁcient evidence linking alcohol consumption and breast
cancer, recent advances both in biological and epidemiological research
have changed this evaluation (especially Smith-Warner et al. 1998; 
Singletary and Gapstur 2001; see below for detailed reasoning), so that
breast cancer now is included in the list of alcohol-related outcomes.
It was concluded that there was limited evidence of causality when an
association (positive or negative) was observed between alcohol con-
sumption and the disease or injury for which a causal interpretation was
considered to be credible, although chance, confounding variables or
other bias cannot be ruled out with reasonable conﬁdence. These dis-
eases were not included in determining either alcohol-related mortality
or burden of disease.
It was concluded that there was inadequate evidence of causality when
the available studies were of insufﬁcient quantity, consistency or statis-
tical power to permit a conclusion regarding the presence or absence of
a causal connection.
It was concluded that there was evidence suggesting lack of causality
when several adequate studies, covering the full range of levels of alcohol
consumption in the population, indicated a lack of a relationship (posi-
tive or negative) between alcohol consumption and the disease or injury.
This conclusion is inevitably limited to diseases and injuries, levels of
consumption and lengths of observations covered by the available
studies, and the possibility of very small risks at the levels of exposure
studied can never be excluded.
EXCLUDED OUTCOMES AND REASONS FOR EXCLUSION
A list of outcomes considered and excluded can be found in English 
et al. (1995). Some of these outcomes had been reconsidered in subse-
quent reviews (Gutjahr et al. 2001; Ridolfo and Stevenson 2001; 
Single et al. 1999a) and we followed Gutjahr et al. (2001) for the ﬁnal
selection of outcomes. Otherwise, the only restriction was one of age.
Outcomes for people under 15 years of age who had been drinking them-
selves and subsequent alcohol-related consequences were excluded for
two reasons:
• there are not enough global data on drinking in these age groups; and
• the epidemiological basis linking drinking to health outcomes is
scarce.
Based on these considerations, the conservative choice was made not
to include these outcomes.
As stated above, this does not mean that no alcohol-related outcomes
are calculated for the age group under 15 years. On the contrary, so-
called second-hand effects of alcohol (somebody else’s drinking causing
alcohol-related harm to a person) are included in the estimation.
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3.2 Overview of methods
META-ANALYSES ON AVERAGE VOLUME OF DRINKING AND DISEASE
Meta-analyses were the bases for estimating the risk relationships
between average volume of alcohol consumption and chronic disease. 
In alcohol epidemiology, there is a tradition of conducting such meta-
analyses as part of social cost studies (English et al. 1995; Gutjahr et al.
2001; Ridolfo and Stevenson 2001; Single et al. 1999a). We used the
results of the most recent existing meta-analyses (Gutjahr et al. 2001)
for most outcomes, and Ridolfo and Stevenson (2001) for breast cancer
and the subtypes of stroke. Details such as inclusion and exclusion of
studies are described below.
MULTILEVEL MODELLING TO DETERMINE PATTERN WEIGHTS
For estimating the contribution of patterns of drinking applied to IHD
and injuries, a new methodology had to be developed. Details of this
method are described and discussed in Rehm and Gmel (2000b) and
Gmel et al. (2001). It consists of combining multilevel12 models with
pooled cross-sectional time series models, and aims at maximizing
methodological rigour and practical feasibility for the data available to
undertake such an analysis. The principal variables for the present study
are time series of adult per capita alcohol consumption and mortality for
different countries, and one value measuring drinking patterns in a
country. One could imagine conducting time series analyses separately
for each country and then relating the patterns measured with the dif-
ferent estimates obtained for the relationship between alcohol con-
sumption and mortality. However, time series data on both mortality and
alcohol consumption for any single country are commonly too short
(Rehm and Gmel 2001a) to perform reliable estimation and hypothesis
testing, and there are no time-speciﬁc data on patterns of drinking within
a country to determine pattern weights in this manner. Even for estab-
lished market economies, there are at most 40 consecutive years of data
from the same source (see e.g. Table 12.12 for the length of time series
on IHD mortality and adult per capita consumption). In many develop-
ing and emerging economies, however, if data are available at all, they
cover less than 10 consecutive years. Similarly, for many countries, owing
to social and political changes (e.g. the countries of the former Soviet
Union), longer time series inherently do not exist.
A common strategy to overcome such data shortcomings for parame-
ter estimation is pooling of data across countries13 to increase overall
sample size, and to set constraints for several parameters (Greene 2000).
Examples of such constraints could be to assume similar (i.e. differences
statistically not signiﬁcant) error variances (homoscedasticity) across
countries, or to estimate the same regression parameters across all coun-
tries, or to assume a distribution for varying parameters (e.g. ﬁxed vs
random).
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The approach adopted for the present study consists of pooling time
series of differing lengths across countries and conducting multilevel
analysis. For this approach, statistical problems arise from three major
sources.
1. Pooling of data may violate the independence assumption in regres-
sion analysis. This concerns at least two aspects. First, the variability
of measurements made in different countries is usually much greater
than the variability of measurements within one country. Thus, data
points are not independent of each other. In addition, within-country
variability itself may differ among countries (heteroscedastic vari-
ances). Second, as countries provide different numbers of disease and
consumption data points, countries with more data points (mainly
established market economies) would have a higher impact on an
overall estimate of the association between alcohol consumption and
mortality than countries for which fewer data points exist (mainly
developing and emerging economies). Such a disproportionate con-
tribution to an overall regression estimate would be aggravated by the
fact that the population sizes of countries would be often inversely
related to the number of data points contributed to the regression
analysis by such countries. For IHD mortality, for example, Switzer-
land (31 data points) and Norway (33 data points) would far out-
weigh the more populous South Africa (3 data points) and the Russian
Federation (8 data points), even though they do not contribute sub-
stantially to the global burden of disease. 
2. The estimation of time series needs further attention as regards to sta-
tionarity (stochastic or deterministic trends in the data) and the cor-
relation of residuals within a country over time (autocorrelation).
3. The use of pooled cross-sectional time series analysis complicates esti-
mation compared to a single time series alone, as errors (or residuals,
both are used synonymously in this chapter) may co-vary across sec-
tions, and the degree of stationarity or autocorrelation may vary
across sections (see below).
It should be noted that it was not possible to estimate all potential
effects simultaneously. Either estimation of parameters failed to converge
(potential explanations will be discussed below), the available standard
software did not include the estimation of more complex models, or esti-
mation of models was not applicable in the present context. To give an
example of the latter, the estimation of cross-sectional correlation of
errors would need time series that are equal in length (so-called balanced
panels), at least with the available software used for estimation (Shazam:
Whistler et al. 2001; STATA: StataCorp 1999; HLM: Bryk et al. 1996;
MLWin: Yang et al. 1999). It was not possible to test models that include
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cross-sectional autocorrelation in the present context, since balanced
panel data are not available.
As not all potential shortcomings and drawbacks of multilevel and
pooled cross-sectional time series models could be considered in one
single model, sensitivity analysis was performed in two phases.
In phase 1, to determine pattern weights, multilevel analyses were 
conducted using a pilot sample of 29 European countries14 for which
data were available for at least three consecutive years in the 1990s on
each of the following variables: adult per capita alcohol consumption, 
standardized mortality and per capita GNP (level-1 variables) and an
estimate of patterns of drinking (level-2 variable assumed to be time-
invariant). Calendar year was used to control for omitted variable bias
and the time structure (Gmel et al. 2001);15 per capita GNP was included
to control for economic strength as a potential confounder. The analy-
ses to elucidate pattern weights for IHD and injuries have, for the present
work, used the same methodology (for details see Gmel et al. 2001). For
the sensitivity analysis and for the ﬁnal pattern weights to calculate
burden of disease in this chapter, data were taken from the following
sources.
• Mortality data (either all-cause mortality in the sensitivity analysis 
or IHD/injury) were obtained from the WHO Mortality Database 
and age-standardized using United Nations population estimates.
Direct standardization of mortality rates was performed using the
latest WHO world standard population (Ahmad et al. 2000). The ref-
erence population is quite “young” with regard to the age distribu-
tions of populations in established market economies, but better
reﬂects developing and emerging economies. On the other hand, the
new WHO standard takes into account the reduced mortality rates in
the older age groups nowadays, which have made the distribution a
little “older” than the formerly widely used SEGI standard (Segi
1960).
• Adult per capita alcohol consumption data were again taken from
WHO Global Alcohol Database described above.
• Per capita GNP data were taken from World Bank statistics, which
used the Atlas method to arrive at standardized, de-inﬂated values in
US dollars for the year 2000.
For all countries in this phase, time series data were collected from
1962 onwards on the four level-1 variables—standardized mortality
(either all-cause mortality in the sensitivity analyses or IHD and injury
in the ﬁnal estimates), calendar year, adult per capita alcohol consump-
tion and per capita GNP.
In phase 2, different models were run to especially take into account
the cross-sectional time series structure, i.e. to assess the impact of even-
tually violating statistical assumption in hierarchical multilevel models.
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For this exercise, data on countries where a long time series exists were
used to try to estimate effects such as heteroscedasticity and error struc-
ture (autocorrelation) with some precision. Per capita consumption and
data on all-cause mortality for 15 countries were obtained from ECAS,
and are extensively described in the February 2001 supplement to Addic-
tion (e.g. Norström 2001). Brieﬂy, per capita alcohol consumption, 
measured in litres of pure alcohol per inhabitant aged ≥15 years, was
obtained from the Brewers Association of Canada (1997). Age-speciﬁc
data on all-cause mortality were obtained from the WHO Mortality
Database and standardized to the WHO 1998 standard population
(Ahmad et al. 2000). For all countries, time series were available for a
time span of at least 40 years. Worldwide, few if any countries exist that
would be able to provide longer time series (say 60 or more years) of
annual data.
Sensitivity analysis, phase 1: multilevel models
The main difference between multilevel models and simple regres-
sion models is that the association between the outcome (mortality) 
and the independent variables (adult per capita consumption; calendar
year as a control variable) is not ﬁxed but varies across cross-sections
(i.e. countries). Therefore, multilevel modelling analytically takes into
account the lack of independence stemming from a potentially lower
variability of data within a country compared to the variability between
countries.
Essentially, this problem is the same as in cluster sampling, where 
variation between clusters is usually also higher than variation within
clusters. Two approaches to account for cluster sampling have been 
suggested (see Lehtonen and Pahkinen 1994). One, the design-based
approach, treats cluster sampling and the effect of it on parameter 
estimates as a nuisance. The information on variation across different
clusters and variation within clusters is not included in the model. The
estimation of CIs for relevant parameters (e.g. slopes and intercepts in
regression analysis) without considering cluster sampling, however, is
usually biased. Commonly, standard errors of parameters are underesti-
mated, i.e. CIs are estimated to be narrower than they really are. The
design-based approach accounts for these effects by adjusting the stan-
dard errors for the impact of the design, e.g. the cluster sampling, but
does not model the effects explicitly. The other approach, the model-
based approach, treats the different variability across clusters as one
parameter of interest in the study and explicitly models this variability.
For this approach, multilevel (random coefﬁcient) models are used. Com-
parison of the two approaches has shown that they yield similar results,
but that the model-based (random coefﬁcient) approach yields additional
information as it is partly able to model the variability of estimates, and
therefore to explain it (Skinner et al. 1989).
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Our modelling is one variant of the model-based random coefﬁcient
approach. The rationale of multilevel models in the present context is
described in detail by Rehm and Gmel (2000b); see also Bryk and 
Raudenbush (1992); Hox (1995); Kreft and de Leeuw (1998). Brieﬂy,
intercept and slopes are assumed to vary randomly16 across sections. 
In a two-level analysis this variation can be predicted by variables at 
the level of the cross-sections (e.g. per subregion). In the present study
the variation in the slopes of adult per capita consumption to predict
mortality will be explained by drinking patterns per country. Thus, 
it is assumed that drinking patterns moderate the association between
adult per capita consumption and mortality. The corresponding model
(without control variables) can be described as follows:
(1)
where t = index of time
c = index of countries
The coefﬁcients b0c and b1c symbolize random variables, which vary
across countries. Therefore, the simplest way to model this random vari-
ation is given by the following equation:
(2)
where g00 = global intercept of mortality rate
m0c = country-speciﬁc variation of intercepts of mortality rates
similarly b1c = g10 + m1c
where g10 = global slope of impact of alcohol (level-2 intercept of 
alcohol)
m1c = country speciﬁc variation of alcohol impact
Inﬂuences of country-speciﬁc drinking patterns on the slopes of per
capita consumption can then be modelled as:
(3)
The impact of one unit of per capita consumption on mortality is thus
assumed constant in time but speciﬁc for each country, and is denoted
by b1c. This impact itself (throughout this chapter called “pattern
weight”) is regarded both as a dependent variable and as a predictor
variable, for which the value not only varies across countries but also
systematically depends on drinking pattern (i.e. pattern value) observed
in the respective country.
The coefﬁcient g10 can be regarded as a baseline measure for the impact
of per capita consumption on mortality.17 The country-speciﬁc deviations
pattern_weight pattern_valuec c c= = + ¥ +b g g m1 10 11 1
b g m0 0 00 c c= +
mortality_rate alcoholtc c c tc tc= + ¥ +b b e0 1
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are introduced by the patterns of drinking in the country and a country
speciﬁc error term m1c.
Note that if we estimated, in a simple one-level analysis, a global coef-
ﬁcient b1 (not varying across countries), this measure would not neces-
sarily be the same as g10 in a random coefﬁcients model including level-2
variables. The coefﬁcient g11 can be regarded as the contribution of drink-
ing patterns to modifying the detrimental effects of per capita con-
sumption on mortality. This modifying effect per unit of drinking
patterns is treated as being the same for all countries. But clearly drink-
ing patterns vary between countries, and therefore the impact on mor-
tality b1c is speciﬁc to each country. There may remain unexplained
variation in these country-speciﬁc impact coefﬁcients. This is expressed
by the level-2 error term m1c. 
Figure 12.2 shows the modiﬁcations in residuals for different models.
Figure 12.2(a) reﬂects a simple regression model in which all countries
were simply pooled into one data set and analysis was performed without
any multilevel modelling (i.e. standard multiple regression; in terms of
multilevel modelling this would be a model with constant intercepts and
constant slopes). Vertical lines in Figure 12.2 separate residuals within a
country from those in other countries. It can be seen that residuals (etc)
are clearly not independent, as for some countries all residuals were
greater than zero whereas for other countries all residuals were below
zero. In addition, residuals within a country clearly exhibit trends over
time, which also violates the independence assumption. In Figure
12.2(b), a random intercept model was used. This means that for each
country a separate intercept was estimated but the association between
alcohol consumption and mortality was constant (i.e. it was estimated
that the global level of mortality differed across countries, but the asso-
ciation between alcohol consumption and mortality was assumed to be
the same across all countries). In this model residuals were more clus-
tered around zero (owing to the random intercept), although there were
still trends in the residuals. In the ﬁnal model also, slopes were allowed
to vary across countries (i.e. the association between alcohol consump-
tion and mortality could vary across countries). In addition, control for
confounding (GNP as constant slope term) and for omitted variable bias
and potential deterministic trend stationarity (calendar year as a random
slope term) was included in the multilevel model. The residuals of such
a model (Figure 12.2[c]) look very much as they should, as they exhibit
neither visible trends nor autocorrelation. Thus, such a model not only
turned out to be feasible but it also seemed to account for most of the
undesirable aspects of residuals in time series analysis, such as nonsta-
tionarity and autocorrelated residuals. Nevertheless, the variability of
errors still seems to be different across countries (heteroscedasticity).
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Figure 12.2 Level-1 residuals of multilevel models: a) constant intercept
and constant alcohol slope; b) random intercept and
constant alcohol slope; c) random intercept and random
slope (including control for confounding, i.e. constant slope
for GNP and random slope for calendar year)
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Unstandardized residuals are the raw residuals as indicated by formula 1 above.
Sensitivity analysis, phase 2: pooled cross-sectional time 
series models
The models discussed above could also be seen as pooled cross-sectional
time series models in so far as data used consisted of time series. The
models discussed here, however, include special features to deal with the
structure of residuals, namely correlations in time. For the models dis-
cussed above, the order of data points in time within a country is not taken
into account and could be randomly rearranged within each country. In
time series analysis, however, it is often assumed that (within each country)
values that are closer in time may be more correlated than values that are
more separated in time. Thus, the time span between two values must be
taken into account. This could not be done by the multilevel modelling,
only indirectly by including calendar year into the models.
The sensitivity analyses of different pooled cross-sectional time series
models used data on 15 countries from the ECAS project. As a starting
point we analysed the data with multilevel models as outlined for Figure
12.2(c), using three different estimation techniques with three different
statistical software packages (2-stage OLS with STATA; iterative GLS
with MLWin; restricted ML with HLM). Parameter estimates across the
three models were comparable and differed less than those from models
discussed below (for details of ﬁndings see Gmel et al. 2001; for details
of differences in estimators see Kreft and de Leeuw 1998).
The simplest model of a pooled time series design, called the “con-
stant coefﬁcient model” (Sayrs 1989) or “population-averaged model
with independent errors” (StataCorp 1999), would stack all observations
across time points and cross-sections into one data ﬁle and analyse the
combined data by standard regression techniques (e.g. OLS regression
for an interval-scaled dependent variable). Such a model would assume
that observations across time and cross-sections are completely inde-
pendent of each other. This model equals a “multilevel” model with a
single ﬁxed intercept and a single ﬁxed slope. This means that neither
the ordering in time nor the grouping within cross-sections (countries)
must be obeyed and, hence, that there is no association between the time
points within a cross-section or between time points over cross-sections,
and that there is no relationship between the cross-sections within a time
point or between time points. The constant coefﬁcient model often serves
as a reference model only. It could be written as follows.
1. Zero expectation of errors for all cross-sections:
E(ect) = 0 for all c, t
2. Constant error variance for all cross-sections:
V(ect) = s2 for all c, t
3. Uncorrelatedness of errors within and across cross-sections:
COV(eit, ejt) = 0 for any i, j, t
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where t = index of time
c, i, j = index of countries, where it ≠ jt
Assumptions 1 and 2 would be violated when, for example, mortal-
ity in a country is always higher than the overall prediction across 
all countries and all time points. For such a country all errors would 
be positive. Similarly, the error variances may vary across countries 
(heteroscedasticity) owing to the fact that, for example, mortality is mea-
sured with different reliability in different countries. Typical for time
series data, errors may be correlated within a country (autocorrelation
within cross-section) but also at the same time point across countries,
which would violate assumption 3. An example of such a pattern may
be seen in the Nordic countries, where there are similar alcohol policies.
Related to the corresponding procedures in STATA (StataCorp 1999)
two sets of models were run. The ﬁrst set uses GEE estimation (Liang
and Zeger 1986) and allows different descriptions of the correlation
matrix within cross-sections, subject to the constraint that the same cor-
relation matrix applies to all cross-sections. The following models were
used, with Rt,s being the t,s element of the correlation matrix, where t
and s describe time points (here, years).
1. The independence structure (i.e. Rt,s = 1 for t = s and 0 otherwise) is
equivalent to a model for which all observations are pooled into 
one ﬁle and analysed as if all data come from the same underlying
population.
2. The autoregressive (AR) structure (i.e. for an autoregressive structure
of order 1, Rt,s = 1 for t = s and r|t – s| otherwise) models an exponen-
tially decaying correlation in time within a cross-section, hence assum-
ing that the less observations are correlated the more they are
separated in time.
3. The stationary structure (i.e. for stationarity of order 1, Rt,s = 1 for
t = s, r for |t – s| = 1, and 0 otherwise) permits a correlation only
between two consecutive time points.
4. The nonstationary structure (i.e. for nonstationarity of order g, Rt,s = 1
for t = s, rts for g ≥|t – s| >0) permits correlations for all observations
separated by up to g time points. The correlation may differ with the
number of time points between two observations, and with the loca-
tion in time (i.e. a different correlation between 1950 and 1951 and
between 1974 and 1975). A completely unconstrained correlation
matrix would be a nonstationary structure with g = n – 1 (number of
time points).
The second set of models uses GLS estimation. Compared with the
GEE models, this method relaxes the restrictions of sameness within
cross-section correlation matrices. Hence, it permits the estimation of
heteroscedastic variances across sections, and the estimation of cross-
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sectional speciﬁc autoregression (i.e. each country is allowed to have its
own error variance and its own magnitude of autocorrelation). The
models are restricted to autoregressive models of order 1.
Thus, the GEE models in STATA permit a greater ﬂexibility in esti-
mating error structures, but assume that these structures are constant for
all countries. On the other hand, the GLS models in STATA allow the
coefﬁcients of autocorrelated residuals and the error variance to vary
across countries, but are restricted to an autocorrelation of order 1 only.
None of these models allows for testing of random coefﬁcient models.
Thus, the association between alcohol consumption and mortality is
assumed to be constant across all countries. The same is true of vari-
ables to adjust for confounding, omitted variable bias and time trends
(GNP and calendar time). Models were used with and without inclusion
of calendar time.
The ﬁndings can be summarized as follows.
• Measurements within countries are highly correlated in such a way
that accounting for correlations only at lags 1 or 2 were not sufﬁcient
(e.g. models with stationary or nonstationary structure up to order
2). Thus, the correlations of higher order remained signiﬁcant. Better
ﬁts were obtained, for example, under the assumption of an auto-
regressive structure, i.e. exponentially decaying correlations with
increasing time span between measurements. In general, point 
estimates of coefﬁcients for the alcohol–mortality association
increased with better control of this autoregressive structure, indicat-
ing that insufﬁcient control would bias estimates of this association
downwards.
• The inclusion of calendar time as a constant coefﬁcient control vari-
able acted in the same direction as controlling for autoregression and
clearly performed better than controlling for nonstationarity alone;
controlling for nonstationarity did not further improve the estimation
of the alcohol coefﬁcient when used in addition to calendar time. As
a conclusion, the use of calendar time as a continuous variable is at
least as good as other methods (e.g. differencing) to account for non-
stationarity in the present context. However, inclusion of autoregres-
sion further improved estimation even when calendar time was
included.
• Whether the autoregressive structure was estimated to be constant
across countries or to be country-speciﬁc resulted in smaller differ-
ences than those between an autoregressive structure and a structure
restricted to low-order lag correlations (nonstationary or stationary).
It should be noted, however, that the estimation of higher order (>2)
nonstationary structures (which allow more ﬂexibility of the correla-
tion matrix) did not converge to a solution. This was probably
because of the number of parameters that needed estimation. For a
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model with an autoregressive structure (e.g. of order 1), although cor-
relations for higher lags can be signiﬁcant, only 1 parameter must be
estimated as it is assumed that correlations of time points with higher
lag orders follow an exponentially decaying function of the correla-
tion at lag 1. In nonstationary models, correlations with a higher lag
order can vary freely and must be estimated separately.
• The inclusion of heteroscedasticity (unequal variances) did not
improve models, or did so only marginally.
As already mentioned, it appeared that the better the error structure
of time series was captured, the higher were the point estimates for the
relationship between alcohol consumption and mortality. In none of
these models, however, could varying coefﬁcients for this relationship
across countries be modelled. The underlying assumption of these pooled
cross-sectional models is that there is a constant relationship and that
pooling is used to increase sample size for efﬁcient estimation, while
adjusting for a more complex error structure than independence.
However, tests for constant coefﬁcients showed that there is signiﬁcant
variation across countries for both the coefﬁcient of alcohol consump-
tion and for calendar year, pointing to geographically differing and not
altogether changing associations. Although the autocorrelated error
structure could not be accounted for, random coefﬁcient models yielded
the highest association for alcohol consumption, pointing to the possi-
bility that the use of random coefﬁcient models better captured the data
and the error structure than constant coefﬁcient models accounting for
autocorrelated residuals, by estimating a constant effect of alcohol con-
sumption and a constant effect of calendar time. Clearly, random co-
efﬁcient models including the autoregressive error structure may further
improve estimation.
There is software that can in principle handle autocorrelation and het-
eroscedasticity in multilevel models (Bryk et al. 1996; Yang et al. 1999).
It should be noted, however, that in the present study the inclusion of
autocorrelated disturbances failed to converge. The possible reason for
the nonconvergence might be that the model was already well speciﬁed
with the inclusion of random coefﬁcient time trends, and the additional
inclusion of further parameters might therefore have resulted in co-
linearity problems. This seems to be a general problem in analysis of
aggregate data in the alcohol ﬁeld, where relatively low variability within
series is coupled with relatively short series. It is, however, not likely that
the omission of autocorrelated disturbances in random coefﬁcient models
may have greatly distorted the ﬁndings. Although including autocorrela-
tion of errors resulted in further improvement, this improvement was rel-
atively minor in pooled cross-sectional time series models with constant
alcohol coefﬁcients that adjusted for a constant coefﬁcient of calendar
time, compared to the improvement from random coefﬁcients models. In
addition, in random coefﬁcient models without including autocorrelation
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the impact of calendar year was not estimated as being constant across
all countries, and might therefore further account for autocorrelation, as
it separately adjusted in each country and therefore better captured the
country-speciﬁc confounding than a country-averaged model.
The advantage of random coefﬁcient models was that not only could
the association between consumption and mortality vary across coun-
tries, but so could the associations with the control variable time. Thus,
the adjustment of time could be analysed in a country-speciﬁc manner.
Finally, none of the pooled cross-sectional time series models could
analyse variations in the relationship between alcohol consumption and
mortality as being moderated by patterns.
In conclusion, all sensitivity analysis performed indicated that multi-
level modelling outperformed pooled cross-sectional time series models,
although the autocorrelated error structure could not be taken into
account directly. As estimation of such a structure was not feasible even
for the longer time series in the ﬁeld, there was no hope that this could
be done when more countries with relatively short series (fewer than 10
data points) were added. On the contrary, adding other countries would
increase the cross-country variability and reduce the impact of auto-
correlation within country, especially as this may have little impact given
the few data points.
3.3 Criteria for identifying relevant studies
The criteria listed in Table 12.8 apply to all meta-analyses used to esti-
mate the relationship between per capita consumption and speciﬁc dis-
eases (English et al. 1995).
Alcohol-related consequences were thus identiﬁed by reviewing and
evaluating large-scale epidemiological studies on alcohol and health,
including epidemiological input into major reviews (Collins and Lapsley
1991; Corrao et al. 1999; Devlin et al. 1997; English et al. 1995; Gurr
1996; Harwood et al. 1998; Klingeman and Gmel 2001; Rice et al. 1991;
Ridolfo and Stevenson 2001; Single et al. 1996, 1999a, 1999b; Stinson
et al. 1993; U.S. Department of Health and Human Services 2000).
Papers were collected primarily from the peer-reviewed international 
literature. As indicated above under the discussion on causality, we 
followed the accepted guidelines established in the ﬁrst major review
(English et al. 1995). All conditions for which evidence of a causal rela-
tionship was conclusive were included in the ﬁnal list. Discussion of
disease conditions where causality was not judged to be sufﬁcient can be
found in section 3.5.
3.4 Description of studies, including 
methodological qualities
More than 6000 studies were included in the different analyses on which
the estimates for this chapter were based. For further descriptions we
refer to the original publications of the meta-analyses (English et al.
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1995; Gutjahr et al. 2001; Ridolfo and Stevenson 2001; Single et al.
1999a). Nevertheless, we provide here a general methodological descrip-
tion of the studies used and their assumptions.
Most studies reviewed used either a cohort or case–control design
(Rothman and Greenland 1998b). For epidemiological studies on alcohol
consumption using these designs, the following limitations generally
apply.
• Alcohol use is mostly measured by only a few questions, either sepa-
rating frequency of drinking and quantity per occasion or combining
them into one modiﬁed frequency question in the tradition of nutri-
tional epidemiology (e.g. Rehm 1998a, 1998b for further descriptions
and a critique). Research has shown that such questions may lead to
underestimates of true consumption. Also, data on the relationship
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Table 12.8 Exclusion criteria for studies used in determining the
relationship between average volume of consumption and
mortality/morbidity in CRA
Reason for exclusion Explanation and/or examples
Restricted study population The study was carried out in a sample that was difﬁcult to 
generalize for the entire population (for example, a cohort
of persons suffering from a particular disorder)
Inappropriate comparison The control group was contaminated by a high exposure to
group the risk factor under consideration or other factors related 
to the condition
No quantitative exposure Exposure was alcohol dependence rather than 
measure alcohol consumption, or alcohol consumption was undeﬁned 
or had poorly deﬁned nominal categories (for example,
“regular” vs “non-regular” drinkers) or was limited to 
frequency of consumption (without considering quantity) or 
was measured in a manner not representative of general 
exposure (for example, with meals or in the last 24 hours)
Duplication of study A study was reported in more than one paper, and was 
already included in the review. A second important way in 
which a study may be duplicated is when it has already been 
included in the earlier review conducted by members of the 
project team. These studies are included in the review but 
not re-examined in detail
Sample size too small There was an insufﬁcient number of cases (n <20 deaths or 
outcomes)
Inadequate control for An important confounding variable was not controlled for in 
confounding variables the study (for example, smoking not controlled for when 
examining impact on heart disease, or only bivariate 
relationships and relative risks presented)
Results not usable Data were presented in a manner that precludes their use 
(for example, data only presented in graphs that are difﬁcult 
to read)
No age- or sex-speciﬁc data This was done where unacceptable (i.e. where the condition 
presented under review is strongly related to age or sex)
between patterns of drinking and health outcomes are limited, as
typical questions in epidemiological surveys cannot be used to
measure drinking patterns (Rehm 2000). Studies with more complete
alcohol assessment are mostly cross-sectional, or the baseline assess-
ment was carried out very recently so that no longitudinal results can
yet be reported.
• The relationships between alcohol consumption and chronic disease
outcomes are often based on outcomes assessed at follow-up,
regressed on several variables from the baseline assessment. These
procedures assume that the baseline variables are stable over time, or
that they are somehow good indicators of the postulated theoretical
relationship (e.g. Rehm et al. 1996). For example, in assessing the rela-
tionship between volume of consumption and liver cirrhosis, it must
be assumed that heavy consumption persists after baseline and is a
good indicator for overall tissue exposure, which is the theoretical
determinant (Lelbach 1975, 1976). Work on the regression dilution
bias has shown that the size of the real effect is often underestimated
by using only the baseline assessment (Clarke et al. 1999) if the expo-
sure is somewhat constant or preserves rank order over time. More-
over, there is evidence from longitudinal studies that individual
drinking patterns are not stable over time (Fillmore 1988; Vaillant and
Hiller-Sturmhofel 1996), which may obscure the apparent relation-
ship even further.
• The relationship between alcohol consumption and outcomes must be
assumed to be fairly constant across settings, in that results of epi-
demiological studies from a few countries are applied to others. While
this may be justiﬁed with biologically based relationships (e.g. alcohol
and breast cancer),18 such an assumption is more problematic with
casualties and injuries as outcomes, since these are much more
context-dependent.
All of these points indicate that the results of the meta-analyses on
which our estimates are based will have limits with regard to precision.
These limits are not captured by the CI for combined relative risks.
3.5 Relative risks and attributable fractions
Some conditions, such as alcoholic psychosis or alcohol dependence 
syndrome, are by deﬁnition causally related and wholly attributable to
alcohol (i.e. they would not exist in the absence of alcohol consumption)
(Table 12.9). For most conditions, however, alcohol is a contributory
rather than a sufﬁcient cause (Rothman and Greenland 1998a). Pooling
of risk estimates for these diseases from individual studies was performed
by means of precision-based weighting (English et al. 1995). Methods
and results of the pooling procedure (meta-analysis) have been described
in more detail elsewhere (Gutjahr and Gmel 2001).
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In contrast, the alcohol-attributable fractions (AAFs) for acute conse-
quences such as injuries are usually directly determined from the blood
alcohol concentration (BAC) at the time of the injury. For example, road
accidents are attributed to alcohol according to whether the driver
responsible for the accident tested positive for alcohol and to what degree
(e.g. BAC ≥0.05%).19 In the case of trafﬁc accidents we have relative risk
estimates, based on case–control studies, for different levels of BAC
(Ridolfo and Stevenson 2001; see also McLeod et al. 1999). But relative
risk estimates are usually rare for acute consequences other than trafﬁc
injuries. Thus, for the purpose of the present study, AAFs from the inter-
national literature were used (English et al. 1995; Gutjahr and Gmel
2001; Ridolfo and Stevenson 2001; Single et al. 1996; Stinson et al.
1993).
To structure the presentation and discussion of results, alcohol-related
health consequences will be categorized as follows.
1. Chronic harmful effects of alcohol consumption, excluding depression
and IHD:
• wholly alcohol-attributable outcomes;
• cancers (neoplasms);
• cardiovascular diseases;
• liver cirrhosis;
• effects of prenatal alcohol exposure;
• neuropsychological conditions; and
• other chronic diseases.
2. Chronic beneﬁcial effects of alcohol consumption, excluding IHD:
• ischaemic stroke; and
• other conditions (type II diabetes, gallstones).
3. IHD as a chronic condition where alcohol has harmful and beneﬁcial
consequences:
• depression; and
• acute adverse effects:
— unintentional injuries (motor vehicle accidents, poisonings,
falls, drownings, other unintentional injuries)
— intentional injuries (self-inﬂicted injuries, homicide, other inten-
tional injuries).
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3.6 Chronic harmful effects of alcohol consumption,
excluding depression and IHD
WHOLLY ALCOHOL-ATTRIBUTABLE DISEASES
A number of diseases are by deﬁnition fully attributable to alcohol
(AAF = 1). These are listed in Table 12.9.
DISEASES WITH A CONTRIBUTORY ROLE
Cancer
Oropharyngeal, oesophageal and liver cancers. Alcohol has consistently
been related to the risk of cancer of the mouth (lip, tongue), pharynx,
larynx, hypopharynx, oesophagus and liver (Corrao et al. 1999; English
et al. 1995; Gurr 1996; Single et al. 1999; U.S. Department of Health
and Human Services 2000; WHO 2000). The relationship between
average volume of alcohol consumed and cancer incidence is usually
characterized as increasing almost monotonically (Bagnardi et al. 2001),
but this may partially be an artefact of the methods used (Single et al.
1999). Evidence for the role of alcohol in these cancers has accumulated
from case–control and cohort studies. Recently, much emphasis has been
placed on investigating biochemical mechanisms in laboratory studies 
to explain the carcinogenic behaviour of alcohol (U.S. Department of
Health and Human Services 2000).20
Female breast cancer. Much research has been conducted over the last
decade on breast cancer. Prior to 1995, it was usually concluded that 
evidence of a causal relationship with alcohol was insufﬁcient (English
et al. 1995; Rosenberg et al. 1993; Schatzkin and Longnecker 1994).
Recent studies and reviews have shown, however, that not only haz-
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Table 12.9 Disease conditions that are by deﬁnition fully alcohol-
attributable (AAF = 1)
ICD-9 code Disease
291 Alcoholic psychoses
303 Alcohol dependence 
305.0 Alcohol abuse
357.5 Alcoholic polyneuropathy
425.5 Alcoholic cardiomyopathy
535.3 Alcoholic gastritis
571.0–571.3 Alcoholic fatty liver, acute alcoholic hepatitis, alcoholic cirrhosis of 
liver, unspeciﬁed alcoholic liver damage
790.3 Elevated blood alcohol level
980.0, 980.1 Toxic effect of ethyl alcohol, toxic 
effect of methyl alcohol
ardous or harmful drinking but also even moderate alcohol consump-
tion can cause female breast cancer (Single et al. 1999a). A meta-analy-
sis by Smith-Warner et al. (1998) found a clear linear relationship over
the whole continuum of consumption. Other original studies supported
this ﬁnding (Bowlin et al. 1997; Corrao et al. 1999; Nasca et al. 1994;
Royo-Bordonada et al. 1997; Swanson et al. 1997; Van den Brandt et
al. 1995; Wingo et al. 1997). In contrast to the weight of evidence, Zhang
et al. (1999) concluded from their investigation that moderate intake did
not increase the risk of breast cancer, and that a low level of drinking
was associated with a protective effect. This ﬁnding, however, appears
to be a notable outlier (Longnecker 1999) and, so far, has not been cor-
roborated. Recent studies have focused on plausible biological mecha-
nisms, including alcohol’s effect on hormones and tissue, its contribution
to the initiation, progression and promotion of breast cancer, and its
interaction with nutritional factors (for an overview see Singletary and
Gapstur 2001; Soler et al. 1998; U.S. Department of Health and Human
Services 2000).
Cancers of the stomach, pancreas, colon, rectum and prostate. Many
recent research projects have investigated whether these cancers are
alcohol-related. Overall, evidence for a causal relationship between
alcohol and cancer of these sites, if any was found, was weak and incon-
clusive (Bode and Bode 1997; Boutron et al. 1995; De Stefani et al. 1998;
Gapstur et al. 1994; Harnack et al. 1997; Ji et al. 1996; Longnecker and
Enger 1996; Lundberg and Passik 1997; Piette et al. 1998; Sarles et al.
1996; Seitz et al. 1998a, 1998b; Singborg 1998; Soler et al. 1998). On
prostate cancer, again most studies did not report observing an increased
risk (Breslow and Weed 1998; Ellison et al. 1998; Hiatt et al. 1994;
Tavani et al. 1994), whereas two cohort studies (Ajani et al. 1998;
Putnam et al. 1998) and one case–control study (Hayes et al. 1996)
reported a small increased risk in men who consume even moderate
amounts of alcohol. In conclusion, evidence for a causal relationship
between alcohol and cancer of the stomach, pancreas, colon, rectum and
prostate has not so far produced consistent results, especially with regard
to physiological pathways. Thus, we did not include these cancers, even
though some of them showed signiﬁcantly elevated risks in a recent meta-
analysis (Bagnardi et al. 2001).
Cancer of salivary glands, ovary, endometrium, bladder. It has been
hypothesized that alcohol might constitute a risk factor for cancer of the
major salivary glands (Horn-Ross et al. 1997; Muscat and Wynder
1998), ovary, endometrium (Bradley et al. 1998; Longnecker and Enger
1996; Newcomb et al. 1997; Parazzini et al. 1995) and bladder (Bruem-
mer et al. 1997; Donato et al. 1997; Longnecker and Enger 1996; Yu et
al. 1997). For each of these sites, results were scarce or conﬂicting, and
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the effects, if any, were not statistically signiﬁcant. Moreover, there is no
knowledge of physiological pathways for these sites.
There is an almost linear dose–response relationship between volume
of drinking and the relative risk of alcohol-related cancers. Although
there have been speculations about the impact of patterns of drinking,
especially for breast cancer (Kohlmeier and Mendez 1997), the current
state of knowledge does not suggest that these play an important role in
the etiology of cancer.21 Thus, the alcohol-attributable burden for cancer
will be modelled exclusively on average volume.
Cardiovascular disease
The role of alcohol, as both a risk and protective factor for cardiovas-
cular disease, has been studied extensively in the past decade. IHD has
been the focus of most research and is discussed separately below. Most
studies suggest that low-level consumption also offers some protection
against ischaemic stroke, and this condition is therefore also discussed
in the section below on the beneﬁcial effects of alcohol.
In contrast, hypertension and other cardiovascular disorders such as
cardiac arrhythmias, heart failure and ill-deﬁned descriptions and com-
plications of heart disease are adversely affected by alcohol (see e.g.
Friedman 1998; Klatsky 1995; Puddey et al. 1999; Rosenqvist 1998; U.S.
Department of Health and Human Services 1997; Wood et al. 1998).
The weight of evidence suggests that daily consumption of more than
30g pure alcohol for men (and presumably lower levels for women)
causes hypertension (Beilin et al. 1996; Curtis et al. 1997; English et al.
1995; Grobbee et al. 1999; Keil et al. 1997; Klatsky 1996). Low-level
intake, however, was not associated with hypertension in men, and may
even confer a small protective effect in women (English et al. 1995).
There are some indications that hypertension may be related to the
pattern of heavy drinking occasions (Murray et al. 2002; Puddey et al.
1999; Wannamethee and Shaper 1991).
For haemorrhagic stroke, the weight of evidence suggests an increase
in risk for males even at low levels of consumption (Berger et al. 1999;
Jackson 1994; Sacco et al. 1999; You et al. 1997). For females, the most
recent meta-analyses of Ridolfo and Stevenson (2001) suggested a pro-
tective effect for drinking categories I and II but an 8-fold increased risk
for drinking the equivalent of more than 40g pure alcohol daily (see
Table 12.10). Patterns of drinking not only play a role in any protective
effects of alcohol on IHD but are also relevant for risk of stroke (Hillbom
et al. 1998) and sudden cardiovascular death or cardiovascular death 
in general (Kauhanen et al. 1997a, 1997b; Kosarevic et al. 1982; 
Poikolainen et al. 1983; Wannamethee and Shaper 1992), with heavy
drinking occasions and intoxication resulting in increased risk. Patterns
of drinking should therefore be included in future estimates of harmful
cardiovascular outcomes.
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Liver cirrhosis
Alcohol consumption has been identiﬁed as the leading cause of liver 
cirrhosis in established market economies (Corrao et al. 1997, 1998;
English et al. 1995). Whereas the association with alcoholic liver cir-
rhosis is clear, with all cases being attributable to alcohol, debate remains
as to whether this equally applies to unspeciﬁed liver cirrhosis. Several
authors contend that, empirically, it is extremely difﬁcult to separate
alcoholic from unspeciﬁed liver cirrhosis, and that the term “unspeciﬁed
liver cirrhosis” is applied when no speciﬁc etiological factor is reported
or identiﬁed (English et al. 1995). Research in the United States and in
Central and South American countries has indicated that an appreciable
proportion of deaths from cirrhosis without mention of alcohol was in
fact attributable to alcohol (Haberman and Weinbaum 1990; Puffer and
Grifﬁth 1967; Room 1972).22
On the other hand, applying AAFs of liver cirrhosis to other countries
can be extremely misleading. In many countries (e.g. China and India),
liver cirrhosis is mainly caused by other factors such as viral infections.
The corresponding AAFs have been shown to vary between less than
10% (China) and 90% (Finland) (WHO 2000).
The relationship between alcohol consumption and liver cirrhosis
seems to depend mainly on volume of drinking and is independent of
pattern of drinking (Lelbach 1975, 1976). However, some research also
indicates a potential effect of occasions of heavy drinking (Rhodés et al.
1993). Moreover, there is some indication that spirits are especially
harmful in causing liver cirrhosis (Gruenewald and Ponicki 1995; 
Kerr et al. 2000; Longnecker et al. 1981; Schmidt 1991). The problem
with this research is that it is almost entirely based on ecological studies
and thus describes only correlations, which may have other causes 
(Morgenstern 1998; Rehm and Gmel 2001a).
Effects of prenatal alcohol exposure
Today, there is ample evidence that alcohol consumption during 
pregnancy is related to various risks to the fetus, which include gross
congenital anomalies and fetal alcohol syndrome (FAS) (Alvear et al.
1998; Church et al. 1997; Faden et al. 1997; Habbick and Snyder 
1997; Larkby and Day 1997; Larroque and Kaminski 1996; Mattson et
al. 1997; Passaro and Little 1997; Passaro et al. 1996; Polygenis et al.
1998; Roebuck et al. 1998; Shu et al. 1995; Windham et al. 1995). FAS
has been characterized as a continuum, with minor physical malforma-
tions at one end and serious neurobiological dysfunctions, including
mental retardation, at the other (Connor and Streissguth 1996). The 
prenatal teratogenic effects of alcohol also include lethal outcomes 
comprising spontaneous abortion, low birth weight, fetal damage, pre-
maturity and intrauterine growth retardation (Abel 1997; Bradley 
et al. 1998; Windham et al. 1997). These can occur even at low average
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volumes of consumption, particularly during the ﬁrst trimester of 
pregnancy.
Mental conditions
The co-morbidity of alcohol dependence with other mental conditions is
high, both in clinical and in general population samples (e.g. Grant and
Harford 1995; Merikangas et al. 1998). The crucial question in this
respect is about causation. We have included depression in this review
only where we believe the evidence to be sufﬁcient to conclude a causal
role for alcohol. Since this relationship is controversial, it is discussed
below in a separate section.
Other chronic conditions
Other risks of alcohol consumption currently discussed in the literature
include epilepsy (see e.g. Jallon et al. 1998; Leone et al. 1997; Martin et
al. 1995), acute and chronic pancreatitis and psoriasis. Whereas for pan-
creatitis the causal role of alcohol seems to be clear, Amman et al. (1996)
and Skinazi et al. (1995) contend that the discrimination between acute
and chronic pancreatitis is not justiﬁable, since the overwhelming major-
ity of patients presenting with acute pancreatitis at the same time have
an underlying chronic pancreatitis (Robles-Diaz and Gorelick 1997;
Thakker 1998). On psoriasis, our search did not yield any recent studies.
English et al. (1995) found that the results of the pooled estimates were
consistent with a moderately strong and statistically signiﬁcant effect of
average volume of consumption.
Table 12.10 summarizes the relative risks at different levels of con-
sumption for alcohol-related chronic consequences.
3.7 Beneﬁcial health effects of alcohol consumption 
on disease
ISCHAEMIC STROKE
Cerebrovascular disease (stroke) consists of several subtypes, the most
common being ischaemic stroke and haemorrhagic stroke, which are
affected differently by alcohol. For ischaemic stroke (the predominant
type) the weight of evidence, including biological mechanisms, suggests
effects similar to those for IHD, namely that low to moderate con-
sumption may offer some protection (Beilin et al. 1996; Hillbom 1998;
Keil et al. 1997; Kitamura et al. 1998; Knuiman and Vu 1996; Sacco et
al. 1999; Thun et al. 1997; Yuan et al. 1997; Wannamethee and Shaper
1996). It seems that this protective effect is more pronounced in females
(Table 12.11).
OTHER BENEFICIAL HEALTH EFFECTS
Alcohol consumption may offer some protection against type II diabetes
and cholelithiasis (gallstones) (see also Ashley et al. 2000 for a recent
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Table 12.10 Relative risks for chronic harmful alcohol-related disease for
different drinking categories (relative to abstainers)
Relative risk
Drinking Drinking Drinking 
category I category II category III
Disease or condition ICD-9 codes Males Females Males Females Males Females
Lip and oropharyngeal 140, 141, 1.45 1.45 1.85 1.85 5.39 5.39
cancer 143–146,
148, 149,
230.0
Oesophageal cancer 150, 230.1 1.80 1.80 2.38 2.38 4.36 4.36
Liver cancer 155, 230.8 1.45 1.45 3.03 3.03 3.60 3.60
Laryngeal cancer 161, 231.0 1.83 1.83 3.90 3.90 4.93 4.93
Female breast cancer, 174, 233.0 NA 1.15 NA 1.41 NA 1.46
<45 years
Female breast cancer, NA 1.14 NA 1.38 NA 1.62
≥45 years 
Epilepsy 345 1.23 1.34 7.52 7.22 6.83 7.52
Hypertensiona 401–405 1.40 1.40 2.00 2.00 4.10 2.00
Cardiac arrhythmias 427.0, 427.2, 1.51 1.51 2.23 2.23 2.23 2.23
427.3
Heart failure and 428, 429
ill-deﬁned complications
of heart diseaseb
Haemorrhagic stroke 430–432 1.27 0.59 2.19 0.65 2.38 7.98
Oesophageal varices 456.0–456.2 1.26 1.26 9.54 9.54 9.54 9.54
Gastro-oesophageal 530.7 NA NA NA NA NA NA
haemorrhagec
Unspeciﬁed liver cirrhosis 571.5–571.9 1.26 1.26 9.54 9.54 13.00 13.00
Acute and chronic 577.0, 577.1 1.30 1.30 1.80 1.80 3.20 1.80
pancreatitisa
Spontaneous abortion 634 NA 1.20 NA 1.76 NA 1.76
Low birth weight 656.5 1.00 1.00 1.40 1.40 1.40 1.40
Psoriasis 696.1 1.58 1.58 1.60 1.60 2.20 2.20
Prematurity 764 0.93 0.93 1.36 1.36 1.36 1.36
Intrauterine growth 765 0.99 0.99 1.68 1.68 1.68 1.68
retardation
NA Not applicable.
a Relative risk estimates taken from Corrao et al. (1999); most major cost studies derived AAFs
for acute and chronic pancreatitis directly (e.g. Australia, for 577.0: 0.24; for 577.1: 0.84 [English
et al. 1995]).
b Heart failure AAF determined indirectly from other circulatory diseases.
c Relative risks not applicable because AAFs were usually obtained directly (e.g. Switzerland, for
530.7: 0.47).
Sources: unless otherwise indicated Gutjahr et al. (2001); Ridolfo and Stevenson (2001).
overview on beneﬁcial effects of alcohol). The Australian meta-analysis
by English et al. (1995) concluded that there was some evidence that
alcohol may protect against the onset of type II diabetes. Since then, the
ﬁndings from a cohort of more than 40000 male health professionals
showed that moderate alcohol consumption may reduce the risk of type
II diabetes, perhaps through the effects of alcohol on insulin sensitivity
(Rimm et al. 1995). In addition, ﬁndings from the British Regional Heart
Study indicated a protective effect (Perry et al. 1995). Further, a follow-
up of men enrolled in the United States Physicians Study revealed a
marked negative association of incident type II diabetes with alcohol con-
sumption (Ajani et al. 1999). In a recent prospective study, a U-shaped
association was found between alcohol and type II diabetes (Wei et al.
2000).
On the other hand, Kao et al. (1998) found evidence (based on small
numbers) of an inverse relationship between alcohol consumption and
the risk of type II diabetes for women. This relationship was not found
in men; indeed, men consuming more than 21 units of alcohol per week
were at increased risk of type II diabetes. A protective effect of moder-
ate alcohol consumption against type II diabetes may be mediated
through the effects of alcohol on glucose tolerance and insulin resistance.
Moderate alcohol drinking has been shown to increase insulin sensitiv-
ity (Facchini et al. 1994; Kiechl et al. 1996) and lower insulin resistance
(Lazarus et al. 1997), even in young adult drinkers (Flanagan et al.
2000). Finally, there is some evidence that inﬂammatory processes may
mediate alcohol-induced diabetes (Imhof et al. 2001; Pradhan et al.
2001). In summary, there is growing evidence from cohort studies that
moderate alcohol consumption reduces the risk of diabetes and a plau-
sible underlying biological mechanism has been identiﬁed. This was the
reason for including this effect as a beneﬁcial effect in subregions with
beneﬁcial drinking patterns (established market economies with best
mortality pattern: AMR-A, EUR-A, WPR-A). For all other subregions,
no effect was modelled for these drinking categories. However, evidence
for the relationship between alcohol consumption and diabetes is far
from conclusive at present.
There is evidence that alcohol consumption may offer some protec-
tion against gallstones (English et al. 1995; Holman et al. 1996). These
ﬁndings have been substantiated by recent large-scale cohort and
case–control studies, which reported an inverse relationship (Attili et al.
1998; Caroli-Bosc et al. 1998; Chen et al. 1999; Leitzmann et al. 1998).
Table 12.11 gives an overview of diseases for which alcohol potentially
has beneﬁcial effects.
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3.8 IHD as a chronic condition for which alcohol has
harmful and beneﬁcial consequences
EPIDEMIOLOGY—AVERAGE VOLUME OF CONSUMPTION
IHD23 is one of the leading causes of death in the world (Murray and
Lopez 1996a). The most important health beneﬁts of alcohol in terms
of IHD have been found at low to moderate levels of average volume of
consumption (Beaglehole and Jackson 1992; Doll 1998; Edwards et al.
1994; Fuchs et al. 1995; Goldberg et al. 1995; Hillbom 1998; Holman
et al. 1996; Jackson 1994; Rehm et al. 1997; Single et al. 1999a; 
Svärdsudd 1998). Only a few individual-level studies have failed to sub-
stantiate this association in men (Hart et al. 1999) or women (Fillmore
et al. 1998; Maskarinec et al. 1998).
While some studies have suggested that alcohol may offer protection
against IHD across the entire continuum of consumption (Camargo et
al. 1997; Doll et al. 1994; Keil et al. 1997; Rehm et al. 1997 [males
only]; Kitamura et al. 1998; Thun et al. 1997), they nevertheless show
that most of the protective effect is gained at low levels of consumption,
such as one drink every other day.
Overall, average volume of drinking and IHD show a J-shape rela-
tionship in the usual medical epidemiological cohort studies in estab-
lished market economies (Corrao et al. 2000). Compared to abstinence,
low to moderate average consumption of alcohol has been found to
confer a lower risk of IHD incidence and mortality. For higher levels of
average volume of consumption, the risk relationship is reversed (e.g.
Corrao et al. 2000; Friedman and Kimball 1986; Rehm et al. 1997), with
heavy average consumption being associated with a risk larger than that
for abstainers. In the most recent meta-analysis Corrao et al. (2000)
demonstrated the described J-shape, and also demonstrated several other
characteristics from the literature on average volume of consumption 
and IHD.
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Table 12.11 Relative risks for chronic beneﬁcial alcohol-related health
effects for different drinking categories (compared to
abstainers)
Relative risk
Drinking Drinking Drinking 
category I category II category III
Disease or condition ICD-9 code Males Females Males Females Males Females 
Type II diabetes 250 0.99 0.92 0.57 0.87 0.73 1.13
Ischaemic stroke 433–435 0.94 0.52 1.33 0.64 1.65 1.06
Cholelithiasis 574 0.82 0.82 0.68 0.68 0.50 0.50
Source: Gutjahr et al. 2001; Ridolfo and Stevenson 2001.
• There was a pronounced sex effect, showing that women were less
protected for a given level of consumption, with an earlier upturn of
the curve.
• The beneﬁcial effect of alcohol was less pronounced for fatal 
outcomes.
• The study results were inconsistent, especially with respect to relative
risk for higher intake, indicating additional inﬂuencing factors not
controlled for.
• The better quality studies placed the maximum beneﬁcial effect at
lower levels of average alcohol intake. The maximum protective effect
was measured at 20g pure alcohol per day; the relative risk = 1 line,
equivalent to abstainers’ risk, was crossed at 72g per day; and there
was a signiﬁcant detrimental effect over 89g per day.
• More speciﬁcally, cohort studies, wholly adjusted studies, studies that
compared drinkers with lifetime abstainers and those that excluded
sick subjects at baseline showed less beneﬁcial effects than
case–control studies, unadjusted or partially adjusted studies, studies
that compared drinkers with current abstainers and those that
included sick subjects.
• Mediterranean countries showed more protective effects for the same
levels of average consumption.
The epidemiological evidence that light to moderate average alcohol
consumption protects against IHD is strengthened by substantial evi-
dence concerning the biological mechanisms by which a protective effect
could be mediated (Rankin 1994; Renaud et al. 1993; Single et al. 1999b;
Svärdsudd 1998). First, moderate alcohol intake has been linked to
favourable lipid proﬁles, especially an increase in high-density lipopro-
teins (HDL) (Baraona and Lieber 1998). It has been estimated that as
much as 40–50% of the protective effect may be attributable to this
mechanism (Criqui et al. 1987; Criqui and Ringel 1994; Suh et al. 1992).
Second, moderate alcohol intake favourably affects coagulation proﬁles,
particularly through its effects on platelet aggregation (McKenzie and
Eisenberg 1996; Rubin 1999) and ﬁbrinolysis (Reeder et al. 1996). Third,
low to moderate consumption of alcohol has been shown to favourably
affect insulin resistance (Kiechl et al. 1996; Lazarus et al. 1997; Rankin
1994). Fourth, it has been postulated that alcohol could protect against
IHD through its effect on hormonal proﬁles, particularly its estrogen
effects (Svärdsudd 1998). Fifth, the alcohol metabolite acetate has been
postulated to protect against IHD by promoting vasodilation (U.S.
Department of Health and Human Services 1997). Sixth, alcohol affects
inﬂammation and, through this pathway, can inﬂuence IHD (Imhof 
et al. 2001; Jacques et al. 2001; Morrow and Ridker 2000; Ridker 2001).
Finally, it is possible that some of the effect is mediated through the anti-
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oxidative constituents of alcohol beverages, especially wine (Reinke and
McCay 1996). Nevertheless, most of the protective effect appears to be
linked to ethanol per se.
The protective effect of light to moderate consumption has been ques-
tioned on several grounds. The role of the comparison group has been
questioned (Shaper 1990a, 1990b; Shaper et al. 1988), it being suggested
that the abstainer group includes people who have stopped drinking
because of health reasons and these are responsible for the elevated
disease risk compared to light and moderate drinkers. Many subsequent
studies controlled for this effect by taking lifetime abstainers as the 
comparison group (Rehm and Sempos 1995). Nevertheless, in most
established market economies, where most of the research on alcohol
and IHD has taken place, abstainers constitute only a minority of the
general population and the possibility that they have other behavioural
characteristics responsible for the elevated IHD risk cannot be excluded.
No alternative explanation has ever been empirically demonstrated,
however. For instance, social isolation has been theoretically claimed 
to confound the alcohol–mortality relationship (Skog 1996), but empir-
ical research has not been able to substantiate this effect (Murray et al.
1999).
In conclusion, the relationship between average volume of drinking
and IHD seems to be J-shaped. Light to moderate drinking is associated
with a lower IHD risk than abstinence or heavy drinking. However, the
results are inconsistent, indicating that factors other than those included
in the study may also determine the relationship. One of the main factors
may be pattern of drinking (i.e. the way in which the same average
amount of alcohol is consumed). In this respect two patterns deserve
mentioning: irregular heavy drinking and drinking with meals.
EPIDEMIOLOGY—PATTERNS OF DRINKING
Heavy drinking occasions
Heavy drinking occasions have been linked to adverse cardiovascular
events for some time (Poikolainen 1983). However, many studies had
used wider endpoints than IHD (Kauhanen et al. 1997b) or samples of
problem drinkers or persons with alcohol-use disorders (Dyer et al. 1977;
Rosengren et al. 1987; Rossow and Amundsen 1997), where heavy
drinking patterns are confounded with volume.
Some of the more recent studies have controlled for (average) volume
of drinking. A case–control study in Australia (McElduff and Dobson
1997) compared 11511 cases of acute myocardial infarction or coronary
death with 6077 randomly selected controls. If people drank in binges
(usually ﬁve or more drinks on an occasion for women, nine or more
drinks on an occasion for men), there were no protective effects for 
coronary events and relative risks were mainly larger than 1 compared
to abstainers (indicating higher risks for major coronary events). This
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elevated risk was present even in groups with low overall volume of
drinking. As expected, the authors also found a protective effect of daily
drinking, which was most pronounced for regular light to moderate
drinkers.
Similarly, Murray et al. (2002) evaluated the cardiovascular conse-
quences of binge drinking (eight or more drinks at a sitting) and usual
(non-binge) drinking of alcohol in a longitudinal, population-based study.
Interview data from 1154 men and women aged 18 to 65 years in Win-
nipeg, Canada were linked to health care utilization and mortality records
in an eight-year follow-up period. Cox proportional hazards regressions
were estimated separately for men and women. The outcomes included
ﬁrst event for physician visits, and hospitalizations and deaths due to
IHD, hypertension, or other cardiovascular disease. Binge drinking
increased the risk of IHD in men (hazard ratio [HR] of 2.3, 95% CI
1.2–4.2) and women (HR of 1.1, 95% CI 1.02–1.2) and increased the
risk of hypertension in men (HR of 1.6, 95% CI 1.04–2.4) but not
women. Binge drinking had no effect on the risk of other cardiovascular
disease. All of these results were controlled for average volume of drink-
ing. Again, the expected cardioprotective effects were conﬁrmed in both
men and women. The harmful effects of heavy drinking occasions on IHD
morbidity and mortality could thus be disaggregated from the effect of
average volume of drinking. Finally, Trevisan et al. (2001a) found in a
case–control design that, after adjustment for average volume of con-
sumption, weekend drinking by men was signiﬁcantly related to risk of
myocardial infarction compared to men drinking less than once a week
(logistic regression: OR 1.9, 95% CI 1.2–3.2).
In addition to the effect on IHD, there appears to be a relationship
between irregular heavy drinking occasions and other forms of cardio-
vascular death, especially sudden cardiac death (Kauhanen et al. 1997b;
Wannamethee and Shaper 1992; Wood et al. 1998). This is consistent
with the physiological mechanisms of increased clotting and reducing the
threshold for ventricular ﬁbrillation after heavy drinking occasions,
which have been reviewed by McKee and Britton (1998). Speciﬁcally,
heavy drinking occasions have been shown to increase the blood level 
of low-density lipoproteins (LDL), which in turn have been linked to
negative cardiovascular outcomes. Contrary to low or moderate steady
drinking, heavy irregular drinking occasions are not associated with an
increase in levels of HDL, which have been linked to favourable cardio-
vascular outcomes. In addition, irregular drinking is associated with
increased risk of thrombosis after cessation of drinking (Renaud and 
Ruf 1996). Finally, irregular heavy drinking seems to predispose to his-
tological changes in the myocardium and conducting systems, as well 
as to a reduction in the threshold for ventricular ﬁbrillation. In con-
clusion, irregular heavy drinking occasions are mainly associated with
physiological mechanisms that increase the risk of sudden cardiac death
and other cardiovascular outcomes, in contrast to the physiological
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mechanisms triggered by regular low to moderate consumption that are
linked to favourable cardiac outcomes. Nevertheless, individual-level
studies are still scarce and some studies show no effects (Murray et al.
1998).
Drinking with meals
Trevisan et al. (2001b) reported on drinking with meals and IHD mor-
tality based on the Risk Factor and Life Expectancy Study, a pooled series
of epidemiological studies conducted in Italy with 8647 males and 6521
females aged 30–59 years at baseline and free of cardiovascular disease.
Subjects were followed up for an average of seven years. Alcohol con-
sumption showed a protective effect on IHD, and drinking wine with
meals was linked to more positive outcomes than drinking wine outside
meals. Compared to drinking with meals, drinking wine outside meals
had a relative risk of 1.8, 95% CI 0.97–3.5 for IHD in males, adjusted
for average volume of drinking and other potential confounders. There
were not enough IHD cases to conduct a similar analysis for females,
but the effects for all-cause mortality for females showed a ﬁve-fold risk
for wine outside meals compared to wine with meals (relative risk of 5.0,
95% CI 1.5–10.9).
Another study (Trevisan et al. 2001a), using a case–control design,
examined 443 male myocardial infarction survivors and 922 healthy
controls aged 35–69 years. Compared to non-drinkers the age, educa-
tion and smoking-adjusted odds ratios for former drinkers and current
drinkers were 0.67, 95% CI 0.32–1.38 and 0.47, 95% CI 0.24–0.95,
respectively, conﬁrming the overall cardioprotective effect of alcohol con-
sumption (see above). Men who reported drinking without food at least
75% of the time had an odds ratio of 1.5, 95% CI 0.96–2.3 compared
to those who drank mainly with meals and snacks, after adjustment for
age, education and volume of alcohol consumed.
The potential mechanisms linking consumption of alcoholic beverages
with meals to a lower IHD risk, compared to consumption between
meals, remain to be fully clariﬁed. However a few mechanisms have been
hypothesized. A study by Trevisan et al. (1987) in a large sample of
Italian men and women found a signiﬁcant association between drink-
ing between meals and higher prevalence of hypertension, compared to
drinking with meals, even after adjustment for differences in alcohol con-
sumption between these drinking pattern categories. These ﬁndings were
recently conﬁrmed in another study using a population-based sample in
the United States (Wu and Trevisan 2001). Finally, Foppa et al. (1999)
found in a controlled randomized trial that moderate consumption of
wine with a meal reduced postprandial blood pressure. Drinking with
meals has also been shown to positively affect ﬁbrinolysis (Hendriks et
al. 1994) and lipid levels (Veenstra et al. 1990).
Other potential physiological links between drinking with meals and
these IHD risk factors include a reduced absorption of alcohol owing to
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the presence of food in the gastrointestinal tract (Gentry 2000). Another
physiological link may be that food increases the alcohol elimination rate
(Ramchandani et al. 2001).
AGGREGATE-LEVEL STUDIES ON PATTERNS AND
AVERAGE CONSUMPTION
Given the described relative scarcity of individual-level studies, it is not
surprising that much of the argumentation is based on aggregate-level
studies, especially on Russian experience with the natural experiment of
the Gorbachev anti-alcohol campaign. The Russian Federation is gener-
ally considered to be one of the countries with the highest rates of irreg-
ular heavy drinking (Bobak et al. 1999; Malyutina et al. 2001). Thus, if
a heavy drinking style has an adverse impact on cardiovascular disease
in general and on IHD in particular, such effects should have become
evident at the population level in the experience of the anti-alcohol cam-
paign during the last years of the Soviet Union. In the period 1984–1987,
when estimated total alcohol consumption in the Russian Federation 
fell by about 25% (Shkolnikov and Nemtsov 1997), age-adjusted male
deaths from circulatory disease fell by 9% (Leon et al. 1997). After the
end of the campaign, the death rate rose again quite dramatically. The
role of alcohol in the recent drastic increases in mortality in the Russian
Federation, however, remains controversial, as many other changes
occurred in the late 1980s and early 1990s (Bobak and Marmot 1999;
Britton and McKee 2000; Leon et al. 1997; McKee et al. 2001; Notzon
et al. 1998; Shkolnikow et al. 2001). There seems to be general agree-
ment, however, that alcohol has played an important role in increasing
mortality rates, although the level of impact is unclear.
There is another indirect line of research on the effect of heavy drink-
ing on IHD. Countries with a tradition of heavier or binge drinking on
weekends show proportionately high IHD or cardiovascular disease mor-
tality on or immediately after the weekend (Germany, IHD: Willich et
al. 1994; Moscow, cardiovascular disease events: Chenet et al. 1998;
Lithuania, IHD events: Chenet et al. 2001; Scotland, IHD events: cf.
Evans et al. 2000). Other aggregate-level research on per capita alcohol
consumption and IHD have failed to ﬁnd effects, even for countries with
the best drinking pattern (i.e. drinking pattern = 1) in a time series analy-
sis with differenced data, controlling for tobacco (Hemström 2001).
Finally, Skog (1983) also found no signiﬁcant effects in a time series
analysis on differenced data for Norway.
SUMMARY OF THE EPIDEMIOLOGICAL EVIDENCE
In conclusion, the relationship between drinking and IHD is complex,
and the epidemiological literature on it is evolving. There seems to be a
clear beneﬁcial effect, supported by biochemical evidence, of regular light
to moderate drinking, but it is unclear how many people actually drink
in a manner that will provide them with these beneﬁts. Also, there are
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indications that irregular bouts of heavy drinking are linked to physio-
logical mechanisms, which are in turn linked to negative IHD outcomes,
as well as to other negative cardiovascular disease outcomes. Better
surveys are needed, including the measurement of biomarkers indicative
of the relationships speciﬁed above. In these surveys, the relevant vari-
ables such as irregular heavy drinking or drinking with meals should also
be included.
Many of the individual-level cohort studies on the relationship between
average volume of drinking and IHD have been carried out on special
populations such as nurses, doctors or other health professionals, mostly
in established market economies, who have relatively regular and poten-
tially beneﬁcial drinking patterns. As a result, the effect of average volume
of alcohol consumption may be overstated in the usual meta-analysis.
Thus, the results of these analyses cannot be applied worldwide, since
more detrimental patterns of drinking prevail in the majority of coun-
tries. Moreover, the impact of pattern of drinking has to be included, in
addition to the effects of average volume of drinking.
Unfortunately, as described above, patterns of drinking cannot be
modelled by meta-analysis owing to the scarcity of data on the rela-
tionship between exposure and outcome. Thus, we used the multilevel
modelling approach described earlier to incorporate patterns of drink-
ing into the estimates.
MEASURING THE EFFECT OF AVERAGE VOLUME OF CONSUMPTION AND
DRINKING PATTERN ON IHD MORTALITY
The details of determining the impact of average volume and pattern of
drinking on IHD are described earlier. The characteristics of the data set
are given in Table 12.12.
Table 12.13 gives an overview of the most important results 
with respect to the differential impact of alcohol consumption on IHD
mortality. As predicted, in countries with consumption pattern 1, alcohol
had beneﬁcial effects on the incidence of IHD. For countries with pattern
2, the impact on IHD varied around zero (i.e. no marked impact of
alcohol). In countries with pattern 3, alcohol showed a detrimental
impact on IHD for males only. For countries with pattern 4, the detri-
mental impact of alcohol was pronounced for both males and females.
Assuming interval scales between the categories of the pattern variable,
the models were estimated as in Table 12.14.
Again, in countries with pattern 1, beneﬁcial effects appeared for both
males (-0.0214) and females (-0.0376). These consumption models indi-
cate that the overall effect of IHD at an average pattern level (2.51 in
the sample used) is detrimental for males and not signiﬁcantly different
from zero for females. In other words, the results from individual-level
studies could be replicated in this aggregate-level study. This means that
for countries such as France and Italy we expect a beneﬁcial effect of
alcohol on IHD mortality; for countries such as Slovenia and the United
1022 Comparative Quantification of Health Risks
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Table 12.13 Average effect of consumption of 1 litre of pure alcohol per
capitaa for different drinking patterns
Pattern of drinking Males Females
1 -0.016227 -0.038174
2 0.004050 -0.014323
3 0.053951 0.001908
4 0.084529 0.035584
a This corresponds to coefﬁcient b3 in the model shown in the footnote.
Level-1 model
Mortality rate = b0 + b1a (YEAR) + b2a
(GNP_PC) + b3a(PC_ALCOHOL) + e
Level-2 model
b0 = g00 + m0
b1 = g10 + m1
b2 = g20
b3 = g30 + g31a (PATB) + g32a (PATC) + g33a (PATD) + m3
where
mortality = age-standardized IHD mortality
YEAR = year of observation
GNP_PC = GNP per capita
PC_ALCOHOL = per capita adult (≥15 years) alcohol consumption
PATB = dummy variable for pattern 2
PATC = dummy variable for pattern 3
PATD = dummy variable for pattern 4.
Table 12.14 Effect of per capita consumption and drinking patterns on
standardized IHD rates, assuming equal intervals between
pattern values
Coefﬁcient SE t-value df P
Males
Effect of per capita consumption 0.033503 0.013417 2.497 72 0.013
at average patterna
Deviations from average patterns 0.036353 0.011622 3.128 72 0.002
Females
Effect of per capita consumption -0.004433 0.008263 -0.537 72 0.591
at average patterna
Deviations from average patterns 0.021969 0.006806 3.228 72 0.002
a Patterns of drinking were entered grand-mean-centred into the equation. Thus, the effect of per capita
consumption displayed here is the effect at the grand mean of pattern, which is 2.51 in this sample.
States there will be no overall effect; for countries such as the Republic
of Korea and Ukraine we expect an overall detrimental effect of alcohol
for males; and for countries such as the Russian Federation we expect a
detrimental effect for both males and females. The results from this
model are consistent with the ﬁnding that the anti-alcohol campaign in
the Gorbachev era had such an impact on IHD mortality in the Russian
Federation.
The model has limitations, however. Most notably, each country has
been assigned one pattern value that is assumed to be stable over time.
Whereas patterns have been found to be stable in the past (Room 1992;
Simpura 2001), clearly this assumption is an oversimpliﬁcation. More-
over, it is clear that in most countries there are people with different
drinking patterns. Thus, future research should be based on distributions
of patterns by sex and age, rather than on one pattern value per country.
The results of this model are not consistent with a recent ecological
analysis by Hemström (2001), using a time series approach with differ-
enced data. Hemström (2001) found a random distribution of insigniﬁ-
cant negative (beneﬁcial) and positive (detrimental) alcohol effect
estimates. He used only per capita data without any control for drink-
ing pattern. However, based on individual-level studies and the results
of the present analysis, beneﬁcial effects would have been expected for
countries with a consumption pattern of 1, such as France, Italy, Portu-
gal and Spain. We can only speculate on the difference in results between
the two analyses. Hemström’s time series were relatively short (45 years
per country), not allowing some of the tests for correct model speciﬁca-
tion (Rehm and Gmel 2001a). There also may have been some overdif-
ferencing problems with co-integration or the joint use of differencing
and taking the logarithm, which may have obscured the effect (Greene
2000; Hatanaka 1996; Yaffee 2000).
On the other hand, the present analysis draws on relatively limited
time series in a wide range of drinking cultures, which increases the
ability to generalize but which also has limitations. Our ﬁndings for the
pattern-1 subgroup have the strong advantage of convergent data from
individual-level studies, supported by biological plausibility. We have
therefore used our ﬁnding of a protective effect at the population level
for the countries with beneﬁcial patterns (pattern 1) as a current best
estimate of effects (for comparison with results using coefﬁcients from
meta-analysis).
Given the limits of ecological analysis, individual-level data should
always be given priority in judgements of causality, although not neces-
sarily in terms of estimates of the overall effect of changes in a risk factor
at the population level (Skog 1996). This applies to our analysis as well.
DETERMINING AAFS FOR IHD, INCLUDING PATTERNS OF DRINKING
To arrive at the AAFs, the results of the dummy regression were taken
and only effects larger than ±0.015 were modelled. However, since the
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multilevel analysis could only control for per capita GNP as a con-
founder, and since there are general limits in controlling for confound-
ing in such analyses (Morgenstern 1998), the effects of alcohol indicators
were halved in order to be conservative and to adjust for any other con-
founding. This approach, though arbitrary in the choice of halving, is
consistent with that taken in risk analysis for other risk factors (e.g.
tobacco) to avoid residual confounding.
Taking into consideration the distribution of patterns in all countries
within the 14 subregions, and standardized mortality rates after 1994,
the AAFs can be derived (Table 12.15).
Table 12.15 shows the effects of alcohol-attributable IHD mortality
based on aggregate-level analysis, halving the effects to adjust for poten-
tial confounding. This can easily be done by using the respective values
in the formulas above.
Alternatively, one may use the relative risks from the individual-level
studies as a basis and apply them to the subregions AMR-A, EUR-A and
WPR-A, as almost all of the studies come from these subregions. Such
an approach leads to higher cardioprotective effects (see Table 12.16)
and may well contain overestimates based on the usual cohort com-
position, where people with more regular drinking styles are over-
represented. However, individual-level studies are usually preferred to
ecological studies both for establishing causality and for making esti-
mates of impact (e.g. Morgenstern 1998). Further, with respect to overall
disease burden attributable to alcohol, this provides a more conservative
approach to estimating.
The resulting AAFs, using individual-level estimates of relative risk 
for AMR-A, EUR-A and WPR-A, would be -0.11, -0.15 and -0.15,
respectively. The cardioprotective effect estimated in this way is larger
than that given above (see Table 12.15). We used these estimates for the
ﬁnal calculations. The numbers for EUR-B are given only for sensitivity
analysis. Overall, the average patterns for this subregion (2.9) are 
much closer to the average pattern for EUR-C (3.6) than that for EUR-
A (1.3). Thus, we did not feel justiﬁed in using the estimates based 
on studies almost exclusively from countries with beneﬁcial patterns (A
subregions).
3.9 Depression
BACKGROUND AND EPIDEMIOLOGY
Alcohol is implicated in a variety of mental disorders that are not
alcohol-speciﬁc. However, no major overview on alcohol-attributable
burden of disease has yet included these disorders (English et al. 1995;
Gutjahr et al. 2001; Rehm et al. 2001a, 2001b; Ridolfo and Stevenson
2001; Single et al. 1999). While the causality of the relation is hard to
deﬁne, sufﬁcient evidence now exists for us to include an estimate of the
causal role of alcohol in depression, a major mental disorder.
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In the general population, alcohol dependence and major depression
co-occur over-proportionally, on both a 12-month and a lifetime basis
(Kessler et al. 1996, 1997; Lynskey 1998). Among alcohol consumers in
the general population, higher volume of consumption is associated with
more symptoms of depression (Graham and Schmid 1999; Mehrabian
2001; Rodgers et al. 2000). Compared to moderate drinkers, both higher
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Table 12.15 AAFs predicted by the multilevel analysis
Age group (years)
Subregion All 15–29 30–44 45–59 60–69 ≥70
Males
AFR-D 0.02 0.03 0.03 0.03 0.03 0.02
AFR-E 0.07 0.07 0.08 0.08 0.07 0.07
AMR-Aa 0.00 0.00 0.00 0.00 0.00 0.00
AMR-B 0.16 0.15 0.15 0.16 0.17 0.15
AMR-D 0.08 0.09 0.10 0.11 0.10 0.08
EMR-B 0.00 0.00 0.00 0.00 0.00 0.00
EMR-D 0.01 0.01 0.01 0.02 0.01 0.00
EUR-Aa -0.04 -0.04 -0.04 -0.04 -0.04 -0.04
EUR-B 0.11 0.12 0.12 0.12 0.12 0.11
EUR-C 0.15 0.14 0.15 0.14 0.14 0.15
SEAR-B 0.01 0.02 0.03 0.04 0.02 0.00
SEAR-D 0.04 0.06 0.12 0.14 0.04 0.00
WPR-Aa -0.07 -0.07 -0.07 -0.08 -0.07 -0.07
WPR-B 0.01 0.01 0.01 0.01 0.01 0.01
Females
AFR-D 0.00 0.00 0.00 0.00 0.00 0.00
AFR-E 0.00 0.00 0.00 0.00 0.00 0.00
AMR-Aa 0.00 0.00 0.00 0.00 0.00 0.00
AMR-B 0.02 0.02 0.02 0.02 0.02 0.02
AMR-D 0.03 0.03 0.03 0.04 0.03 0.03
EMR-B 0.00 0.00 0.00 0.00 0.00 0.00
EMR-D 0.00 0.00 0.00 0.00 0.00 0.00
EUR-Aa -0.10 -0.10 -0.10 -0.10 -0.10 -0.10
EUR-B 0.00 0.00 0.00 0.00 0.00 0.00
EUR-C 0.03 0.03 0.03 0.03 0.03 0.03
SEAR-B 0.00 0.00 0.00 0.00 0.00 0.00
SEAR-D 0.00 0.00 0.00 0.00 0.00 0.00
WPR-Aa -0.10 -0.10 -0.11 -0.11 -0.10 -0.10
WPR-B 0.00 0.00 0.00 0.00 0.00 0.00
a The estimates for AMR-A, EUR-A and WPR-A serve only as sensitivity analysis as the AAFs for these
subregions will be based on individual-level studies (see Table 12.16 below).
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.
(Bjork et al. 1999) and lower (Rodgers et al. 2000) levels of depressive
symptoms have been found among abstainers. Among patients under
treatment for alcohol abuse and dependence, the prevalence of major
depression is higher than in the general population (Lynskey 1998;
Schuckit et al. 1997a). Similarly the prevalence of alcohol abuse and
dependence is higher for patients under treatment for depression (Alpert
et al. 1999; Blixen et al. 1997).
This suggests that alcohol abuse is linked to depressive symptoms, and
that alcohol dependence and depressive disorders co-occur to a larger
degree than expected by chance. However, it is not clear in the individ-
ual case whether depression caused alcohol problems, whether alcohol
consumption or alcohol problems caused depression, or whether both
could be attributed to a third cause (Vaillant 1993). The pathway from
depression to problematic alcohol use and alcohol dependence has long
been discussed under the heading of self-medication (i.e. the use of
alcohol to alleviate depressive symptoms). In addition, a shared third
cause could be certain neurobiological mechanisms (see Markou et al.
1998) or genetic predisposition. Moreover, all three pathways of causa-
tion may co-exist at the same time, with different proportions of the co-
occurring morbidities being attributable to each, and of course some
co-occurrence being simply due to chance.
ESTABLISHING THE CAUSAL LINK BETWEEN ALCOHOL
AND DEPRESSION
Causal relations in epidemiology are usually based on several criteria (Hill
1965; Rothman and Greenland 1998a). Using these criteria, we will
review the evidence that part of the burden of depression is caused by
alcohol. As indicated above, this does not preclude the possibility that part
of the burden of alcohol dependence is also caused by depression, or that
part of the co-occurrence is causally related to some third factor. Follow-
ing the majority of the literature, we base our argumentation mainly on
alcohol dependence rather than alcohol consumption per se. This is done
mostly for reasons of data availability: depression and alcohol dependence
are usually part of the same mental health surveys, and almost all esti-
mates of co-occurrence stem from this kind of survey. It is not usual to
include questions on alcohol consumption per se in this type of survey,
nor is it usual to include a diagnosis of depression in alcohol surveys.
Prevalences of alcohol dependence or alcohol use disorders (i.e.
alcohol dependence and harmful use of alcohol) were thus used as indi-
cator of alcohol consumption drinking categories, assuming a constant
relationship between the two variables. This indicator relationship was
also made possible by the fact that alcohol use disorders by deﬁnition
have an AAF of 1.0—that is, under the counterfactual scenario (Murray
and Lopez 1999) of no alcohol available at all, there would be no burden
due to alcohol dependence. Moreover, in different regions of the world,
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average volume of drinking and prevalence of alcohol dependence are
correlated to a high degree (r = 0.86) (Rehm and Eschmann 2002).
Temporal order
Causal factors must precede consequences. Logically, therefore, only that
fraction of depression in which the onset of alcohol problems preceded
the onset of depression can be caused by alcohol problems. The fraction
in which alcohol problems came ﬁrst is an upper bound for the propor-
tion of depressive disorders caused by alcohol dependence. This upper
bound is summarized in Table 12.17 for different forms of depression in
several countries, based on the International Consortium in Psychiatric
Epidemiology (ICPE) (Merikangas et al. 1998).
Clearly, in all areas (i.e. countries, provinces and cities) mentioned in
Table 12.17, the proportion of depressive disorders preceded by alcohol
dependence is higher for males than for females. This corresponds to the
higher prevalence of alcohol dependence in these areas. In fact, the pro-
portion of rates of depressive disorders and alcohol problems correlate
to 0.80 (major depression) and 0.82 (other depressions) for these areas
(Pearson correlations; alcohol dependence rates from World health
report 2001 and Rehm and Eschmann 2002). This means that at least
64% of the variation in the proportion of depressive disorders in the
various subregions can be statistically “explained” by the variation in
alcohol dependence. Of course, the remarks made above on possible
forms of causal pathway still apply. This relationship provides a basis
for predicting such rates for other subregions where data are lacking (see
below).
Another indicator of the role of alcohol dependence in causing some
depressive disorders is the comparison between onsets for different
mental disorders co-occurring with alcohol disorders. In the US National
Comorbidity Survey (Kessler et al. 1996) the proportion of disorders pre-
ceded by alcohol dependence was higher for depression than for any
other disorder.
Consistency
Epidemiological studies are very consistent, both in the general popula-
tion and in clinical samples, in showing that alcohol dependence and
depressive disorders co-occur to a higher degree than might be expected
by chance. This has been observed in several countries and regions (e.g.
Merikangas et al. 1998; Swendson et al. 1998). In fact, we do not know
of any study where alcohol dependence and depressive disorders did not
co-vary to a larger degree than that expected by chance.
The co-variation between the proportion of people with depressive
disorders with a preceding alcohol dependence and the prevalence of
alcohol dependence is also consistent across countries (see above).
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Table 12.17 Percentages of the population in which the onset of alcohol
problemsa occurred prior to diagnosis of depression, by
country, age and sex
Age
Major depressionb Other depressionsc
group Males Females Total Males Females Total
Country/Area (years) n % n % % n % n % %
USA (NCS) 15–29 119 31.1 241 15.6 20.7 39 28.6 67 11.6 17.8
30–44 168 47.0 286 21.1 30.6 68 51.7 121 22.4 33.0
45–59 59 30.8 117 10.5 17.3 35 32.8 65 13.9 20.6
60–69 — — — — — — — — — —
≥70 — — — — — — — — — —
Total 345 38.7 644 17.1 24.7 142 40.7 253 17.4 25.8
USA 15–29 46 20.8 78 13.7 16.3 25 34.8 32 17.0 24.8
CA 30–44 37 20.9 63 7.5 12.5 40 32.8 23 12.5 25.3
Fresno 45–59 11 1.8 24 21.4 15.1 9 14.3 10 0.0 6.7
60–69 — — — — — — — — — —
≥70 — — — — — — — — — —
Total 94 18.5 165 12.5 14.7 74 31.3 65 12.9 22.7
Mexico 15–29 23 8.2 36 2.9 5.0 14 18.6 7 0.0 12.1
Mexico 30–44 12 30.1 50 2.0 7.3 4 40.4 11 0.0 11.7
City 45–59 6 31.8 14 0.0 9.8 4 20.4 8 0.0 6.3
60–69 — — — — — — — — — —
≥70 — — — — — — — — — —
Total 41 17.9 99 2.0 6.7 22 23.4 26 0.0 10.6
Canada 15–29 56 20.6 123 20.3 20.4 43 26.8 54 19.7 22.8
Ontario 30–44 98 47.0 177 6.1 20.7 47 46.7 62 11.9 26.9
45–59 29 33.6 85 3.0 10.8 9 22.4 36 2.8 6.7
60–69 — — — — — — — — — —
≥70 — — — — — — — — — —
Total 183 36.8 386 10.0 18.6 98 35.8 152 12.5 21.7
Netherlands 15–29 70 26.9 177 10.1 14.9 46 17.4 76 6.4 10.6
30–44 180 35.9 317 13.6 21.7 72 15.8 146 7.8 10.5
45–59 129 31.9 180 7.2 17.5 58 32.2 118 3.7 13.2
60–69 18 33.7 33 4.0 14.4 11 0.0 26 0.0 0.0
≥70 — — — — — — — — — —
Total 397 32.9 707 10.7 18.7 187 20.4 366 5.7 10.6
Brazil 15–29 10 61.0 23 2.5 20.2 4 0.0 6 37.8 23.4
30–44 21 10.0 53 17.0 15.1 7 28.6 22 22.2 23.8
45–59 14 17.6 36 6.5 9.5 15 21.1 15 4.0 12.8
60–69 2 66.7 10 0.0 12.8 2 100.0 6 22.2 38.5
≥70 2 50.0 5 0.0 12.7 1 0.0 5 0.0 0.0
Total 48 26.7 126 9.4 14.2 29 23.9 54 16.9 19.4
Germany 15–29 126 14.6 213 4.8 8.4 39 17.7 84 2.4 7.3
30–44 — — — — — — — — — —
45–59 — — — — — — — — — —
60–69 — — — — — — — — — —
≥70 — — — — — — — — — —
Total 126 14.6 213 4.8 8.4 39 17.7 84 2.4 7.3
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Table 12.17 Percentages of the population in which the onset of alcohol
problemsa occurred prior to diagnosis of depression, by
country, age and sex (continued)
Age
Major depressionb Other depressionsc
group Males Females Total Males Females Total
Country/Area (years) n % n % % n % n % %
Japan 15–29 2 100.0 7 0.0 20.1 0 NA 5 0.0 0.0
30–44 5 23.7 3 0.0 15.1 4 32.2 2 0.0 21.0
45–59 4 0.0 5 0.0 0.0 2 0.0 6 0.0 0.0
60–69 3 0.0 2 0.0 0.0 1 0.0 3 0.0 0.0
≥70 1 100.0 1 0.0 49.8 1 100.0 1 0.0 49.8
Total 14 24.9 17 0.0 11.4 7 27.4 16 0.0 8.3
Chile 15–29 37 28.6 67 11.3 17.4 11 0.0 47 11.4 9.3
30–44 30 27.2 53 2.0 11.1 11 2.2 70 5.7 5.2
45–59 13 44.0 42 6.7 15.4 18 39.3 50 1.7 11.6
60–69 8 21.6 6 0.0 12.0 8 69.1 11 1.0 29.3
≥70 2 7.2 6 0.0 1.9 1 20.4 5 0.0 2.8
Total 89 29.2 173 6.6 14.3 48 26.5 182 5.6 10.0
NCS National Comorbidity Survey.
— No data.
a For NCS, Brazil, Chile and the Netherlands, deﬁned as having an alcohol problem, alcohol
dependence or alcohol abuse. In all other countries/areas, deﬁned as either having alcohol
dependence or alcohol abuse.
b In all countries, major depression is deﬁned with exclusion and without hierarchy.
c In all countries, other depression is deﬁned as having dysthymia or bipolar disorder with
exclusions and without hierarchy.
Source: Table numbers were calculated using the International Consortium for Psychiatric Epidemiology
data (see also Merikangas et al. 1998).
Strength of association
It has been consistently found that alcohol-dependent individuals demon-
strate a two- to three-fold increase in risk of depressive disorders (e.g.
Hilarski and Wodarki 2001; Schuckit 1996; Swendson et al. 1998). This
is an effect comparable in size with many other causal effects (Gutjahr
et al. 2001) (Table 12.19).
Reversibility (remission during abstinence)
Key evidence for a causal effect of alcohol dependence on depressive dis-
orders comes from studies that analyse what happens to rates of depres-
sive disorders when patients with clinical symptoms abstain from
drinking. Most of these studies come to the conclusion that many depres-
sive syndromes markedly improve within days or weeks of abstinence
(Brown and Schuckit 1988; Dackis et al. 1986; Davidson 1995; Gibson
and Becker 1973, Penick et al. 1988; Pettinati et al. 1982; Willenbring
1986). Of course, other things change within therapy, so not all of the
effect is necessarily due to the pharmacological effect of drinking. In addi-
tion, experimental studies have found that more symptoms of depression
are reported during heavy drinking episodes (Isbell et al. 1955; Schuckit
et al. 1997b; Tamarin et al. 1970; Weiner et al. 1971). In conclusion, there
is sufﬁcient evidence that abstinence substantially removes symptoms of
depression in alcohol-dependent persons within a short time.
Family patterns
Several studies have tried to separate alcohol-dependent persons with pri-
mary (sometimes called “independent”) depressive disorders from those
with secondary (sometimes called “induced”) depressive disorders by
examining different family patterns of both alcohol dependence and
depressive disorders. For instance, Hesselbrock et al. (1983) and Schuckit
et al. (1997b) found higher rates of depressive disorders, rather than alco-
holism, in close relatives of alcohol-dependent patients with primary
depression than in patients with secondary depression. Other studies, 
both in clinical samples and in the general population, did not ﬁnd dif-
ferent rates of alcohol dependence or affective disorders based on the
primary–secondary distinction (Grant and Pickering 1997; Hasegawa et
al. 1991). Thus, the studies on genetic vulnerability suggest differences
between primary and secondary transmission, but are not conclusive.
Biological mechanisms
There are several plausible mechanisms by which alcohol dependence
may cause depressive disorders (Markou et al. 1998), but research is not
yet conclusive. It should be noted that there is a biological link via intox-
ication or heavy use rather than via dependence alone.
Dose–response relationship
Merikangas et al. (1998) found that there is a continuum in the magni-
tude of co-morbidity as a function of position on the spectrum of sub-
stance use (use, problems, dependence). While there are relationships at
the level of symptoms in the general population, the relationships are
strongest between alcohol dependence and depressive disorders (see
above).
Potential alternative explanations
There may be other explanations for the co-occurrence of alcohol depen-
dence and depressive disorders, either from genetic disposition or the
environment. For example, Grant and Pickering (1997) suggested that
alcoholism and major depression might be alternative manifestations of
the same underlying disorder. Nevertheless, there is no explanation for
the ﬁnding that depressive symptoms increase markedly during bouts of
heavy drinking and disappear during periods of abstinence, even if no
antidepressant medication is given. This is the strongest indication of a
causal effect.
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Summary of evidence on causality
Overall, we ﬁnd sufﬁcient evidence of causality for the inﬂuence of
alcohol dependence on depressive disorders. The evidence indicates that
a clear and consistent association exists between alcohol dependence and
depressive disorders and that chance, confounding variables and other
bias can be ruled out with reasonable conﬁdence as factors in this asso-
ciation. Consistent with the assessments for other disease and injury cat-
egories, most weight was placed on consistency across several studies,
strength of the association, reversibility, temporal order and the fact that
the effect was at least physiologically plausible.
ESTIMATING AAFS OF DEPRESSIVE DISORDERS
Quantitative estimates of the proportion of depressive disorders attrib-
utable to alcohol can be derived from the high correlation between
alcohol dependence and the proportion of depressive disorders with pre-
ceding alcohol-use disorders (see above), using alcohol dependence rates
in different subregions of the world (Table 12.18, columns 3 and 4).
The empirical data on proportion of depressive disorders with pre-
ceding alcohol-use disorders were regressed on survey results of alcohol
dependence for the same subregions without a constant. The omission
of the constant was due to the fact that in a situation without any alcohol
dependence, the proportion of alcohol-attributable depressive disorders
should also be zero. Thus, the regression line must pass through the
origin. Since the relationship is quite close, the respective regression coef-
ﬁcients became highly signiﬁcant even with few data points.
Clearly, the proportions in columns 3 and 4 of Table 12.18 are the
upper limit of depressive disorders attributable to alcohol. In order to
derive a realistic proportion of alcohol-attributable depressive disorders,
we need to subtract the proportion of co-occurrences due to chance. In
a situation of chance, the occurrence of alcohol-use disorders in de-
pressed persons should be exactly equal to the occurrence of alcohol-use
disorders in non-depressed persons (i.e. the general population). Thus,
the prevalence of alcohol-use disorders was ﬁrst subtracted from the
upper limit to derive AAFs. The prevalence of alcohol dependence was
taken from The world health report 2001, which itself was based on a
pooled analysis of survey results. The relationship between alcohol de-
pendence and alcohol abuse (i.e. harmful use in ICD-10) was derived
from the US National Comorbidity Survey (Kessler 1998) and was as-
sumed to be constant across subregions. This assumption was necessary
as there were fewer data on alcohol abuse than on alcohol dependence,
and as the diagnostic systems used vary considerably for this diagnosis.
To control for possible confounding, the effects were halved as has
been done elsewhere (e.g. IHD analysis above) as well as for other 
risk factors (Peto et al. 1992 for smoking; see also chapter 11). The
resulting estimates for AAFs of depressive disorders can be found in
Table 12.18, columns 5 and 6.
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Table 12.18 Prevalence of alcohol dependence by subregion and sex, and
AAFs (percentage of depressive disorders) in people aged
≥15 years
Prevalence Upper limit Upper limit 
of alcohol for AAF, major for AAF, other AAF, major AAF, other
Subregion dependence (%)a depression depression depression depression
Males
AFR-D 1.37 5.17 5.31 1.68 1.76
AFR-E 2.89 10.93 11.24 3.56 3.71
AMR-A 8.04 30.37 31.22 9.89 10.31
AMR-B 5.72 21.60 22.20 7.04 7.34
AMR-D 5.13 19.39 19.93 6.32 6.59
EMR-B 0.07 0.25 0.26 0.09 0.09
EMR-D 0.07 0.26 0.26 0.09 0.09
EUR-A 5.61 21.21 21.80 6.91 7.20
EUR-B 1.16 4.39 4.52 1.43 1.49
EUR-C 8.22 31.05 31.91 10.11 10.54
SEAR-B 0.77 2.91 2.99 0.95 0.99
SEAR-D 1.58 5.96 6.13 1.94 2.03
WPR-A 3.12 11.77 12.10 3.84 4.00
WPR-B 1.78 6.73 6.91 2.19 2.29
Females
AFR-D 0.10 0.37 0.38 0.12 0.12
AFR-E 0.31 1.17 1.20 0.37 0.38
AMR-A 2.14 8.10 8.33 2.52 2.63
AMR-B 1.18 4.46 4.59 1.39 1.45
AMR-D 1.19 4.50 4.63 1.40 1.46
EMR-B 0.00 0.02 0.02 0.01 0.01
EMR-D 0.01 0.02 0.02 0.01 0.01
EUR-A 1.18 4.46 4.58 1.39 1.45
EUR-B 0.23 0.88 0.91 0.28 0.29
EUR-C 1.39 5.24 5.39 1.63 1.70
SEAR-B 0.07 0.26 0.26 0.08 0.09
SEAR-D 0.05 0.20 0.21 0.07 0.07
WPR-A 1.12 4.22 4.34 1.31 1.37
WPR-B 0.05 0.19 0.19 0.06 0.06
a From World health report 2001, based on survey results (Rehm and Eschmann 2002) and then estimated
consistently with DisMod,24 taking into account case fatality, duration and/or incidence.
These results show that AAFs of depressive disorders vary substan-
tially in different subregions of the world. They reﬂect differences in rates
of heavy alcohol consumption and alcohol dependence. Thus, AAFs are
considerably larger for males than for females. They are highest in the
Russian Federation and its surrounding countries (EUR-C) and in North
America (AMR-A), and almost nonexistent in Muslim-dominated areas
(EMR-B and EMR-D).
CONCLUSIONS ON ALCOHOL AND DEPRESSION
Based on standard criteria of causality, we conclude that there is sufﬁ-
cient evidence for a causal relation between alcohol-use disorders and
depressive disorders. We suspect that careful examination would also
reveal a relationship between heavy drinking and depressive disorders,
although heavy drinking unfortunately is not usually measured as an
endpoint in epidemiological cohort studies. 
The status of alcohol abuse as a causal agent in depression is not as
clear. There are co-occurrences between alcohol abuse and depressive dis-
orders that are larger than chance (Kessler et al. 1996, 1997), but the
relationship is weaker compared to the relationship with alcohol depen-
dence. This may have to do with the less clear conceptual status of
alcohol abuse, which is deﬁned in the current version of the Diagnostic
and statistical manual of mental disorders (DSM) (American Psychiatric
Association 1994) nosology to include social and legal responses to the
patient’s drinking, and which is not a category of disorder in ICD. On
the other hand, many studies found only one factor when analysing cri-
teria of alcohol dependence and alcohol abuse, or a division of factors
that did not correspond to the division between the diagnoses in DSM.
Thus, the relationship between alcohol abuse and depressive disorders
should be clariﬁed in future research. It may have relevance, beyond
burden of disease research, in helping to clarify the status of alcohol
abuse in general.
3.10 Summary of relative risk for chronic diseases, using
CRA disease categories
Relative risk estimates are summarized in Table 12.19.
3.11 Acute adverse health consequences
Alcohol use has been associated with increased risk of injury in a 
wide variety of settings, including road trafﬁc accidents (involving 
vehicles, bicycles and pedestrians), falls, ﬁres, injuries related to sports
and recreational activities, self-inﬂicted injuries and injuries resulting
from interpersonal violence (Cherpitel 1992; Freedland et al. 1993;
Hingson and Howland 1987, 1993; Hurst et al. 1994; Martin 1992;
Martin and Bachman 1997; U.S. Department of Health and Human 
Services 1997, 2000). There is also some evidence that the presence 
of alcohol in the body at the time of injury may be associated with a
greater severity of injury and a less positive outcome (Fuller 1995; Li 
et al. 1997).
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UNINTENTIONAL INJURIES
Alcohol consumption produces effects that are often perceived as 
positive, as evidenced by the widespread popularity of drinking. But 
it also leads to actions that result in unintentional injury and death. 
This section highlights research ﬁndings on causality of alcohol involve-
ment and ﬁndings relevant to establishing dose–response relationships
and drinking patterns. It focuses on trafﬁc injuries, as most of the
research has been conducted in this area, and trafﬁc accidents are 
the most important component of unintentional injuries (Rehm et al.
2003b).
Studies relating average volume of drinking to risk of injury have
found the risk of injury to be positively related to increasing average
intake levels of alcohol, with the risk increasing at relatively low volumes
of intake (Cherpitel et al. 1995). Two studies of injury among older
adults reported a U-shaped relationship between alcohol use and occu-
pational injury (Zwerling et al. 1996) and traumatic deaths (Ross et al.
1990). However, abstinence could be related to existing health problems
or cognitive deﬁcits that are, in turn, related to accident risk (Zwerling
et al. 1996). Hence the higher risk among abstainers is likely to be purely
spurious.
Several patterns of drinking have been related to risk of injury. Fre-
quent heavy drinking and frequent subjective drunkenness are both asso-
ciated with injury, particularly injury resulting from violence (Cherpitel
1996a). Frequency of heavy drinking has also been associated with a
greater likelihood of death due to injury, relative to other causes (Li et
al. 1994). One important line of research in this area has empirically
deﬁned a parameter of usual drinking pattern that is most closely asso-
ciated with the risk of injury and drunk driving behaviour, after adjust-
ing for other drinking pattern variables and characteristics of the drinker
(Gruenewald and Nephew 1994; Gruenewald et al. 1996a, 1996b; Treno
and Holder 1997; Treno et al. 1997). The greatest risk was found in indi-
viduals who consume relatively large amounts on some occasions, and
whose highest amounts are markedly greater than their average amount
per occasion.
Several retrospective studies have compared BAC in individuals who
have experienced a collision or trauma, compared with selected individ-
uals not involved in trauma, using a case–control design (Cherpitel 1992;
Freedland et al. 1993; Fuller 1995; Hurst et al. 1994; Stoduto et al. 1993;
U.S. Department of Health and Human Services 1997). One of the most
inﬂuential case–control series was the Grand Rapids Study of 5985 col-
lisions (Borkenstein et al. 1964; Hurst et al. 1994). Statistically adequate
re-analysis of the Grand Rapids Study indicates that all levels of BAC
are associated with an increased risk of crashes, relative to a BAC of
zero, with an accelerating slope in which the risk of injury increases
markedly with high BACs (Hurst et al. 1994).
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There are clear reasons why alcohol is related to injury. Moderate
doses of alcohol have been demonstrated in controlled experimental
studies to have cognitive and psychomotor effects that are relevant to
the risk of injury, such as reaction time, cognitive processing, coordina-
tion and vigilance (Eckardt et al. 1998; Kruger et al. 1993; Moskowitz
and Robinson 1988; U.S. Department of Health and Human Services
1997). The comprehensive recent review by Eckardt et al. (1998) con-
cluded that the threshold dose for negative effects on psychomotor 
tasks is generally found at around 40–50mg% (equivalent to
0.04–0.05%). The authors also stated, “injury can occur as a result of
alcohol’s disruption of psychomotor function in individuals at BACs of
approximately 10mM”, which is equal to a BAC of little less than
50mg%.
Dose–response curves observed in experimental data are not always
monotonic. For example, a recent experimental study (Lloyd and Rogers
1997) assessed the effects of low doses of alcohol given with a meal, and
found that 8g of absolute alcohol (about 0.25 litre of beer) resulted in
improved performance of complex cognitive tasks relative to no alcohol,
but that 24g of absolute alcohol produced impaired performance. Such
J-shaped or U-shaped effects of low ethanol doses on task-speciﬁc per-
formance are explicable pharmacologically (Eckardt et al. 1998). The
Grand Rapids Study also found that dose–response curves varied some-
what between novices and frequent, experienced drinkers.
In summary, the evidence indicates that the amount consumed per
occasion, and more speciﬁcally the blood alcohol content, is the critical
feature in determining risk of injury. Blood alcohol concentrations as low
as 40–50 mg% may cause psychomotor impairment, leading to increased
risk of injury in circumstances such as driving or operating machinery.
Thus, despite methodological problems, there is evidence of causality
for the most researched injury category (trafﬁc accidents). Table 12.20
gives the AAFs for different kinds of injuries in four recent reviews. The
reviews based their estimates on meta-analyses or other summaries of
the relations found in published studies. It should be recognized that,
while there are many such studies, they are mostly from a relatively small
range of countries. Most of the AAFs were directly derived, for example
from police statistics, although there are case–control studies as well
(McLeod et al. 1999).
Causality, at least for trafﬁc accidents, can be established since:
• alcohol is clearly associated with the outcome;
• there is a dose–response relationship: the higher the BAC, the higher
the chance of injury;
• there is a biochemical explanation for the relationship; and
• with suitable interventions to reduce alcohol consumption, the
outcome is reduced as well. Thus, in a meta-analysis, Shults et al.
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(2001) found random breath-testing programmes or selective breath-
testing checkpoints to be effective in reducing mortality from trafﬁc
accidents by 18% and 20%, respectively.
INTENTIONAL INJURIES
Alcohol is strongly associated with violent crime (Graham and West
2001), although this association varies considerably across settings
(Murdoch et al 1990; Room and Rossow 2001). Studies on violence have
repeatedly shown that alcohol consumption precedes violent events, and
that the amount of drinking is related to the severity of the subsequent
violence. In addition, the experimental literature suggests that alcohol
plays a causally contributing role25 in aggression. Meta-analyses of
experimental studies suggest a small to moderate effect size of about 0.22
(Bushman 1997) in the overall relationship between alcohol consump-
tion and aggression. Some effort has been made to separate pharmaco-
logical effects from expectations,26 but the general conclusion is that
expectations form part of the “psycho-pharmacological” effects of
alcohol (Bushman 1997; Graham et al. 1998), and neither can nor should
be separated in attempting to understand the effects of alcohol. Alcohol
bathes the brain in chemicals and it is likely that a number of different
effects of alcohol contribute to the increased likelihood of aggressive
behaviour. First, alcohol seems to have an effect on the serotonin (5HT)
and GABA brain receptors, similar to that produced by some benzodi-
azepines (Pihl et al. 1993). The subjective experience of this effect may
be a reduced level of fear and anxiety about social, physical or legal con-
sequences of one’s actions. This reduced fear or anxiety may result in
increased risk-taking by some drinkers. This particular causal pathway
has received support from animal research linking alcohol, GABA recep-
tors and aggression (Miczek et al. 1993) and from experimental and
observational research showing higher risk taking associated with
alcohol intoxication (Graham et al. 2000; Pihl and Peterson 1993).
Alcohol also affects cognitive functioning (Peterson et al. 1990), leading
to impaired problem solving in conﬂict situations (Sayette et al. 1993)
and overly emotional responses or emotional lability (Pihl et al. 1993).
Other behavioural and attitudinal effects of alcohol related to aggression
have been identiﬁed, although at this point not necessarily linked to par-
ticular pharmacological effects on the brain. These include a narrow and
tenacious focus on the present (Graham et al. 2000; Washburne 1956),
also described as “alcohol myopia” (Steele and Josephs 1990) and
increased concerns with demonstrating personal power, at least for men
(Graham et al. 2000; McClelland et al. 1972; Tomsen 1997).
Alcohol-related violence involves more complex issues of social inter-
action than would be relevant to drink–driving and other alcohol-related
accidental injuries. In particular, the effects of alcohol are moderated by
both the environment and the characteristics of the drinker (Chermack
and Giancola 1997; Lipsey et al. 1997; Rossow et al. 2001; U.S. Depart-
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ment of Health and Human Services 2000). For example, meta-analysis
of experimental research on alcohol and aggression found that the effects
of environmental manipulation to increase aggression were stronger for
intoxicated than for sober participants. In another meta-analysis, Ito 
et al. (1996) found that the effects of alcohol were greater in situations
characterized by greater anxiety, inhibition conﬂict and frustration, while
differences between sober and intoxicated persons were smaller in 
situations involving high provocation or self-focused attention. Further,
given sufﬁcient disincentives for aggression the effects of alcohol on
aggression can be reduced or even eliminated altogether (Hoaken et al.
1998; Jeavons and Taylor 1985).
As with alcohol-related accidents, some proportion of violence that
occurs after people have been drinking might have occurred anyway,
without the involvement of alcohol. Alcohol-related violence involves an
interaction of the effects of alcohol on one or more people, the envi-
ronment and the personality of the drinker (Graham et al. 1998).
However, the environment for alcohol-related aggression is not inde-
pendent of drinking.27 For example, in environments devoted to drink-
ing (e.g. bars, pubs), it does not make sense to try to determine the
proportion of violence that would have occurred even if the person had
not been drinking, because this particular environment does not exist
without drinking. Although a few incidents that occur in bars involve
interpersonal conﬂict between friends or couples that might have
occurred in another setting, almost all incidents of aggression that occur
in bars are unplanned, emerge from the social interaction in the bar
(Graham and Wells 2001) and often involve strangers. Therefore, it
seems reasonable to assume that close to 100% of incidents of violence
occurring in bars and other environments where drinking is the main
activity should be considered attributable to alcohol, either directly
through the pharmacological effects of alcohol or indirectly through the
social norms related to drinking.
Estimating the proportion of violence in other settings that should be
attributed to alcohol is more problematic. There are pharmacological
effects of alcohol, as described above, that make aggressive interactions
more likely. This is more likely to be the case if all those involved have
been drinking, owing to the interaction of the effects of alcohol on each
person (Leonard 1984). In addition, alcohol is known to increase the
likelihood of the escalation of conﬂict (Martin and Bachman 1997;
Sharps et al. 2001). On the other hand, marital violence, for example,
often occurs when neither party has been drinking. Therefore, the assess-
ment of the exact proportion of alcohol-related violent injuries and death
that should be attributable to alcohol is often difﬁcult, and needs to be
assessed from different sources, such as time series analyses, natural
experiments, case–control studies, emergency-room studies, general 
population surveys and experimental designs (Pernanen 2001).
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DERIVING THE AAFS FOR DIFFERENT SUBREGIONS FOR INJURIES
(BOTH INTENTIONAL AND UNINTENTIONAL)
Injuries are also inﬂuenced by average volume of alcohol consumption
and by patterns of drinking, especially by acute levels of BAC or intox-
ication. To model this relationship, a multilevel analysis identical to the
one on IHD was used (for statistical derivation and speciﬁcation of the
model see section 3.2; for formulas see notes below Table 12.13). Table
12.21 gives an overview of the underlying data. Table 12.22 gives the
main results of the analysis.
The effect of alcohol on injury at pattern 1 is 0.013 for males and
0.010 for females. The effect for pattern 2 populations is the same, as
the coefﬁcients did not signiﬁcantly differ. For pattern 3, the effect is
0.056 for males and 0.014 for females. For pattern 4, the respective
effects are 0.196 for males and 0.027 for females.
The results can be summarized as follows.
• Average volume of drinking has a signiﬁcant detrimental effect on risk
of injury even at consumption pattern 1, independent of sex. The
impact is larger in males.
• The impact of per capita consumption on injury is different between
different countries, as shown by the signiﬁcant variance component.
• No signiﬁcant difference in the effect of drinking on injury risk was
found between patterns 1 and 2.
• Pattern 3 has a signiﬁcantly higher injury risk for both sexes, but the
impact is much stronger in males (about 10 times).
• Pattern 4 has the highest injury risk for both sexes, and again the
impact is much stronger for males.
To estimate AAFs for injuries we used the Australian AAFs, since 
these reﬂected the most up-to-date information (Ridolfo and Stevenson
2001). These were converted into odds ratios,28 which were applied to
estimated exposure prevalence for all subregions, as with other diseases,
multiplicatively adjusted by pattern weights from Table 12.22 and
average volume of alcohol consumption. This procedure must be
regarded as a crude approximation, yet the best attainable at present.
Given the potential variation in the role of alcohol in casualties across
settings, there is an urgent need for empirical studies of the relation-
ship in different world regions, using a variety of methods. The 
WHO Collaborative Study on Alcohol and Injuries (www.who.int/
substance_abuse/topic_alcohol_injuries.htm) constitutes a step forward
on this.
Appendix B gives an overview of the derived AAFs for mortality for
major categories of accidental and intentional injuries, as deﬁned for the
CRA project.
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Table 12.21 Characteristics of data set to calculate the relationship
between per capita consumption, patterns of drinking and
injury mortality
Injury Injury Average 
mortality, mortality, per capita Pattern Year Year 
males per females alcohol of of ﬁrst of last Number
Country 1000 per 1000 consumption drinking data data of years
Albania 0.74 0.21 2.20 3 1992 1998 7
Argentina 0.87 0.28 27.48 2 1966 1996 25
Armenia 0.37 0.10 2.53 2 1992 1998 7
Australia 0.78 0.31 11.19 2 1964 1997 34
Austria 1.07 0.39 14.16 1 1962 1999 38
Azerbaijan 0.68 0.14 2.10 3 1990 1999 9
Bahamas 0.97 0.30 14.30 2 1969 1995 13
Bahrain 0.33 0.09 5.33 2 1985 1988 3
Barbados 0.63 0.17 7.88 2 1964 1995 31
Belarus 1.55 0.35 9.68 4 1989 1998 9
Belgium 0.87 0.41 12.35 1 1964 1994 31
Belize 0.59 0.17 6.01 4 1964 1995 28
Bulgaria 0.89 0.26 11.97 2 1982 1998 17
Canada 0.81 0.31 9.74 2 1964 1997 34
Chile 1.44 0.33 11.58 3 1964 1994 31
Colombia 1.72 0.32 5.49 3 1967 1994 19
Costa Rica 0.94 0.25 4.48 4 1964 1995 32
Croatia 0.93 0.31 13.24 3 1993 1998 6
Czech Republic 0.92 0.40 15.42 2 1986 1999 14
Denmark 0.77 0.40 10.91 2 1964 1996 33
Dominican 0.63 0.20 2.91 2 1965 1985 21
Republic
Ecuador 1.23 0.33 2.30 3 1964 1995 31
El Salvador 1.99 0.36 1.95 4 1964 1993 19
Estonia 2.50 0.58 13.43 3 1992 1999 8
Fiji 0.50 0.26 2.98 3 1978 1978 1
Finland 1.21 0.35 7.42 3 1964 1996 33
France 1.02 0.43 23.15 1 1964 1997 34
Germany 0.54 0.21 13.63 1 1993 1998 6
Greece 0.58 0.23 9.69 2 1964 1998 35
Guatemala 1.49 0.26 2.33 4 1964 1984 14
Guyana 0.90 0.24 9.50 3 1979 1994 4
Honduras 0.62 0.10 2.62 4 1976 1979 4
Hungary 1.39 0.54 15.85 3 1977 1999 23
Iceland 0.85 0.29 5.42 3 1964 1996 33
Ireland 0.60 0.24 10.86 3 1964 1996 33
Israel 0.56 0.29 3.04 2 1975 1996 22
Italy 0.64 0.24 18.48 1 1964 1996 33
Jamaica 0.41 0.10 3.12 2 1964 1985 7
Japan 0.68 0.27 5.78 1 1964 1997 34
continued
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Table 12.21 Characteristics of data set to calculate the relationship
between per capita consumption, patterns of drinking and
injury mortality (continued)
Injury Injury Average 
mortality, mortality, per capita Pattern Year Year 
males per females alcohol of of ﬁrst of last Number
Country 1000 per 1000 consumption drinking data data of years
Kazakhstan 1.65 0.44 7.24 4 1989 1998 10
Kyrgyzstan 0.91 0.25 1.88 3 1995 1999 5
Latvia 2.09 0.52 8.53 3 1989 1998 10
Lithuania 2.26 0.51 5.76 3 1989 1998 5
Luxembourg 0.97 0.37 17.37 1 1967 1997 31
Malta 0.35 0.14 5.27 1 1965 1998 33
Mauritius 0.80 0.26 3.30 3 1964 1998 35
Mexico 1.60 0.33 3.94 4 1962 1995 34
Netherlands 0.51 0.27 9.39 1 1964 1997 34
New Zealand 0.81 0.35 11.36 2 1964 1998 35
Nicaragua 1.25 0.28 3.29 4 1964 1994 17
Norway 0.69 0.27 5.11 3 1964 1996 33
Peru 0.67 0.21 6.13 3 1966 1989 16
Philippines 0.67 0.16 2.59 3 1964 1993 18
Portugal 0.98 0.28 18.85 1 1964 1998 35
Qatar 0.47 0.17 .84 2 1995 1995 1
Republic of 1.09 0.38 8.90 3 1985 1997 13
Korea
Romania 1.11 0.33 10.78 3 1989 1998 10
Russian 2.05 0.50 8.88 4 1991 1998 8
Federation
Singapore 0.64 0.23 2.30 2 1964 1998 35
Slovakia 1.04 0.31 12.54 3 1992 1995 4
Slovenia 1.15 0.38 14.80 2 1994 1998 5
Spain 0.60 0.19 17.20 1 1962 1997 36
Sri Lanka 1.01 0.40 .27 3 1964 1986 13
Suriname 1.05 0.37 6.43 3 1964 1992 21
Sweden 0.72 0.30 7.57 3 1964 1996 33
Switzerland 0.93 0.38 14.99 1 1964 1994 31
Tajikistan 0.58 0.16 2.52 3 1992 1992 1
Thailand 0.92 0.26 3.58 3 1964 1994 25
The former 0.47 0.15 5.76 3 1994 1997 4
Yugoslav Republic
of Macedonia
Trinidad and 0.95 0.27 4.79 2 1962 1994 29
Tobago
Turkmenistan 0.43 0.18 2.13 3 1995 1995 1
Ukraine 1.41 0.32 4.64 3 1990 1999 10
United Kingdom 0.47 0.23 9.49 2 1964 1998 35
United States 0.92 0.32 9.46 2 1964 1997 34
Uruguay 0.84 0.28 8.08 3 1966 1990 24
Uzbekistan 0.46 0.15 1.07 3 1996 1998 3
Venezuela 1.29 0.33 8.31 3 1969 1994 24
Another point concerns the relation of alcohol with type of outcome—
morbidity vs mortality. In general, more severe outcomes are more
related to alcohol than less severe outcomes (Rehm et al. 2003b; Single
et al. 1999b). Consequently, the AAFs for mortality should be higher
than the AAFs for morbidity. Unfortunately, most research to determine
AAFs for injury did not explicitly separate mortality and morbidity (see,
e.g. Table 12.20). Ridolfo and Stevenson (2001) explicitly separated the
AAFs for motor vehicle accidents, and for males found 0.328 for deaths
and 0.247 for hospitalizations; they lacked sufﬁcient data for females.
Based on their work and that of Cherpitel (1994, 1996b), we determined
the ratio of AAF for morbidity as two thirds of the AAF for mortality.
The ratio for other kinds of injury is lower (Cherpitel 1994, 1996b). To
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Table 12.22 Effects of per capita consumption and patterns of drinking
on risk of injury mortality
Variance 
Coefﬁcient SE t-value df P component df c2 P
Males
Average volume = per capita consumption
Not adjusted 0.045 0.013 3.46 79 0.001 0.0106 72 584.1 0.000
Adjusted by GNP, 0.047 0.012 3.90 79 0.000 0.0097 72 620.6 0.000
year
After inclusion of 0.013 0.006 2.05 76 0.040 0.0080 69 532.1 0.000
pattern dummy 
variables on 
second level
Patterns of drinkinga
Pattern 2 –0.009 0.011 <1 76 0.391
Pattern 3 0.043 0.014 3.13 76 0.002
Pattern 4 0.173 0.062 2.77 76 0.006
Females
Average volume = per capita consumption
Not adjusted 0.0097 0.0023 4.19 79 0.000 0.00028 72 398.7 0.000
Adjusted by GNP, 0.0121 0.0021 5.91 79 0.000 0.00021 72 496.2 0.000
year
After inclusion of 0.0096 0.0021 4.46 76 0.000 0.00020 69 412.8 0.000
pattern dummy 
variables on 
second level 
Patterns of drinkinga
Pattern 2 -0.0024 0.0031 <1 76 0.440
Pattern 3 0.0041 0.0030 1.40 76 0.163
Pattern 4 0.0171 0.0077 2.24 76 0.025
a Patterns 2, 3 and 4 are compared to pattern 1.
be conservative, these ratios were set at 0.44 (or two thirds of the ratio
for motor vehicle accidents) (Cherpitel 1994, 1996b).
3.12 Quantitative and qualitative sources of uncertainty
Since most of the chronic disease relationships with alcohol depend on
biochemical processes linked to average volume of consumption over
time, their hazards have been fairly stable across countries (Corrao et al.
2000). On the other hand, injuries are context-dependent to a much
larger degree. A good example is the difference between liver cancer and
trafﬁc accidents. Based on biochemical evidence, there are reasons to
believe that the relationship between average volume of alcohol con-
sumption and liver cancer is relatively stable across different countries
and societies, even though epidemiological work tends to be concen-
trated in established market economies. The most notable exception for
chronic disease has been IHD, where patterns of drinking play a deci-
sive role in determining the impact of average volume of drinking. On
the other hand, the number of accidents (and alcohol-related trafﬁc acci-
dents in particular) depends on many background variables, as illustrated
above. Thus, the risk relations between injuries and alcohol are much
less stable and their transferability is more questionable. Where it has to
be done, it should carry wider CIs.
Based on the above considerations, the following pertain.
• For chronic diseases, estimates of relative risk are usually based on
meta-analyses of more than 20 studies with relatively small CIs. The
uncertainty introduced by cross-population transfer of data is not that
large, as the relationships depend on biochemical mechanisms. It is
therefore suggested that ± 15% of the point estimate be used as the
standard in an uncertainty analysis. This applies to all chronic disease
categories where AAFs are directly derived from prevalence and rela-
tive risk.
• In all cases where AAFs are derived in other ways (e.g. injury), these
fractions are more inﬂuenced by contextual differences from one
region to another and should thus be modelled with more uncertainty.
We suggest ± 30% of the point estimate to account for additional
assumptions.
• IHD is the notable exception. In this case, estimates differ consider-
ably (see the heterogeneity in the meta-analysis of Corrao et al. 2000),
with respect not only to the magnitude but also to the direction of the
relation. To account for this uncertainty and the difference of esti-
mates in different models, we suggest the values set out in Table 12.23.
Table 12.23 is based on the following assumptions.
• For AMR-A, EUR-A and WPR-A, the results from the individual-level
meta-analysis (Corrao et al. 2000) were taken as best estimates. For
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these subregions the results from the aggregate multilevel analysis
were taken as upper limits, and 30% lower than the best estimate as
lower limits.
• For EUR-B, the aggregate multilevel results were taken as best esti-
mates, and the results from the individual-level analysis was taken as
lower limit, and 30% higher than the best estimate as upper limit.
• For all other subregions, the aggregate multilevel analysis results were
taken as best estimates and, based on pattern and volume of the sub-
region, uncertainty intervals were chosen as follows:
— ±0.03 in the case of low-volume drinking (average <3g/day) and
average pattern values lower than 3.5;
— ±0.05 in the case of females for volumes >3g/day and average
pattern values lower than 3.5 (this restriction for females was
intended to account for the higher uncertainty of pattern values
for females); and
— for all other estimates zero was taken as the lower bound, and 
the best estimate plus 30% as the upper bound (except for EUR-
C, the only subregion with an average pattern value greater than
3.5).
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Table 12.23 AAF estimates and uncertainty intervals for IHD by
subregion
Best estimates 
Subregion Males Females
AFR-D 0.02 (-0.05, 0.05) 0.00 (-0.03, 0.03)
AFR-E 0.07 (0.00, 0.09) 0.00 (-0.03, 0.03)
AMR-Aa -0.13 (-0.17, 0.00) -0.08 (-0.12, 0.00)
AMR-B 0.16 (0.00, 0.21) 0.02 (-0.05, 0.05)
AMR-D 0.08 (0.00, 0.12) 0.03 (-0.05, 0.05)
EMR-B 0.00 (-0.03, 0.03) 0.00 (-0.03, 0.03)
EMR-D 0.01 (-0.03, 0.03) 0.00 (0.03, 0.03)
EUR-Aa -0.16 (-0.21, 0.10) -0.13 (-0.17, 0.04)
EUR-B 0.11 (-0.13, 0.15) 0.00 (-0.08, 0.05)
EUR-C 0.15 (0.10, 0.20) 0.03 (0.02, 0.04)
SEAR-B 0.01 (-0.03, 0.03) 0.00 (-0.03, 0.03)
SEAR-D 0.04 (-0.03, 0.03) 0.00 (-0.03, 0.03)
WPR-Aa -0.17 (-0.23, -0.10) -0.13 (-0.17, -0.07)
WPR-B 0.01 (-0.05, 0.05) 0.00 (-0.03, -0.03)
a Best estimates derived from relative risk and not from multilevel estimates.
A number of points need to be emphasized when interpreting these
results. The underlying research for chronic disease is quite heteroge-
neous with respect to quality. In particular, measurement of alcohol pro-
vides limited information on patterns of drinking and for characteristics
of abstainers. Most studies have just one time measurement of exposure.
Often cohorts were selected with respect to minimizing loss to follow-
up, and thus samples with more regular, low-to-moderate drinking styles
were used. This constitutes a problem for estimating the effects of pat-
terns of drinking, as well as for estimating the effects of continuous heavy
drinking.
There is also a problem of measuring exposure with respect to acute
consequences, although slightly different because often the BAC is given
as the only indicator. Such a measure does not allow one to differenti-
ate between the effects of pattern of drinking and average volume of
alcohol consumption, as a heavy drinking occasion may be the excep-
tion or the norm. But for the population level, we need both types of
information, as numbers of injuries will depend on both (see above). 
In addition, the BAC alone does not allow one to determine if alcohol
was a contributing causal factor or not, only in combination with other
information on control conditions, i.e. series of BACs in accident and
non-accident conditions (Borkenstein et al. 1964). Unfortunately, such
control conditions are lacking in most research (Gmel and Rehm 2003).
Thus, with the exception of trafﬁc accidents, the overall quality of the
underlying research for most alcohol-related acute outcomes is of poor
quality and derived AAFs may be subject to considerable error. This is
reﬂected in the wide uncertainty margins suggested above.
3.13 Estimates of risk reversibility
Part of the risk from alcohol is immediately reversible: all acute risks can
be completely reversed if alcohol is removed. Chronic diseases often
depend on lifetime exposure, and thus risk is often reduced but not com-
pletely eliminated by removal of alcohol.
On the other hand, there are indications that a reduction of alcohol
consumption in populations is associated with a fairly rapid decrease in
chronic diseases such as liver cirrhosis. For example, time series analy-
ses showed that decreases in per capita consumption were associated
with considerable concurrent reductions in liver cirrhosis (e.g. Ramstedt
2001; Skog 1980; and especially Cook and Tauchen 1982).
Another example of a chronic condition with rapid, sometimes almost
immediate remission is depression. In fact, most studies come to the con-
clusion that many depressive syndromes markedly improve within days
to weeks of abstinence (Brown and Schuckit 1988; Dackis et al. 1986;
Davidson 1995; Gibson and Becker 1973, Penick et al. 1988; Pettinati
et al. 1982; Willenbring 1986).
It is not clear what effect alcohol removal would have on alcohol use
disorders. Clearly, some criteria of both alcohol dependence and harmful
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use of alcohol would no longer apply (e.g. continued use despite harmful
consequences).
4. Discussion of estimates of alcohol-
attributable burden
4.1 Mortality
Alcohol-related burden of disease is considerable: 3.2% of global mor-
tality and 4.0% of global burden of disease as measured in DALYs. In
terms of alcohol-related mortality, almost half of the global burden
(46%) is related in acute causes, i.e. unintentional and intentional
injuries (see Table 12.24; details in Appendix C). Within this mortality
burden, for acute causes, unintentional injuries are by far the most
important. The next important category is malignant neoplasms with
20% of the overall alcohol-related mortality burden, followed by car-
diovascular diseases (15% of all alcohol-attributable deaths) and other
noncommunicable diseases, a category almost entirely made up of liver
cirrhosis (13%). Cardiovascular deaths are a special case in that differ-
ent patterns of drinking lead to beneﬁcial and detrimental outcomes.
Thus, the net result of 15% does not give a clear picture of the under-
lying structure. Going beyond the net result, alcohol was estimated to
cause a total of almost 600 000 cardiovascular deaths in the year 2000,
exceeding even the alcohol-related burden of unintentional injuries. This
ﬁgure was partly “offset” by the beneﬁcial effects of alcohol on IHD and
stroke. More males than females die of the effects of alcohol, with a ratio
of about 10 :1.
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Table 12.24 Global deaths (000s) attributable to alcohol by major
disease and injury categories, 2000
Percentage of all 
Disease or injury Males Females Total alcohol-attributable deaths
Conditions arising during the 2 1 3 0
perinatal period
Malignant neoplasms 269 86 355 20
Neuro-psychiatric conditions 91 19 111 6
Cardiovascular diseases 392 –124 268 15
Other noncommunicable diseases 193 49 242 13
(type II diabetes, liver cirrhosis)
Unintentional injuries 484 92 577 32
Intentional injuries 206 42 248 14
Alcohol-related mortality (all causes) 1638 166 1804 100
All deaths 29232 26629 55861 In comparison, estimated
Percentage of all deaths that can 5.6 0.6 3.2 total for 1990: 1.5
be attributable to alcohol 
The overall relationship between average volume of alcohol con-
sumption and all-cause mortality is thus J-shaped in established market
economies for age groups under 45 years, where beneﬁts of light to 
moderate consumption on IHD apply (Holman et al. 1996; Rehm et al.
2001c). In countries with a predominant pattern of irregular heavy
drinking, no J-shape can be expected and the shape between alcohol and
all-cause mortality is expected to increase monotonically.
The estimated percentage of alcohol-attributable mortality (3.2%) 
is more than double that estimated in the 1990 GBD study (3.2% vs
1.5%). There are several reasons for this increase. First, alcohol 
consumption has increased overall, especially in the very populous
SEAR-B, SEAR-D and WPR-B subregions, including China and India. 
In addition, in these subregions we do not expect beneﬁts of drinking,
unless the current patterns of drinking change to the positive. Second,
the relative impact of injuries and chronic disease on overall mortality,
both of which are related to alcohol, has increased over the past 10 
years. Third, the methodologies are not comparable between the two
estimates. The 2000 estimate differs in the following three major
respects.
• It is much more disaggregated, with respect both to burden categories
and to regional data. Thus, the present work has included adult per
capita data for almost all countries, and much more survey-related
data than available for the 1990 estimates.
• The present exercise explicitly includes quantiﬁable patterns of drink-
ing for both IHD and injuries, whereas the 1990 estimates were
almost entirely based on volume of consumption. This difference is
most striking with regard to IHD, where the 1990 study considered
only beneﬁcial effects. The current exercise estimates both beneﬁcial
and detrimental effects, depending on patterns of drinking.
• The meta-analyses on average volume of consumption and different
disease outcomes have become much more reﬁned in terms of method-
ology (compare, e.g. Corrao et al. 1999, 2000 with the methodology
of English et al. 1995).
Finally, the estimates in this work are restricted to GBD disease cate-
gories. Several diseases related to alcohol could not be accounted for,
most notably cardiac arrhythmias and heart failure. In the GBD disease
categories, cardiac arrhythmias and heart failure would be part of “other
cardiac conditions”. We had neither epidemiological studies on the
hazards for various diseases in this broad category nor any data on the
relative proportion of cardiac arrhythmias and heart failure among other
cardiac conditions by subregion and sex, in order to separate these dis-
eases. In addition, oesophageal varices, acute and chronic pancreatitis
and several conditions occurring during the perinatal period could not
be included for similar reasons. However, their alcohol-attributable mor-
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tality burden would be likely to be minor compared to the “other cardiac
conditions” mentioned above.
4.2 DALYs
Alcohol-attributable DALYs are summarized in Table 12.25. See Appen-
dix D for details by subregion.
The biggest shift in the relative impact of disease categories compared
to the pattern for alcohol-caused mortality is seen for neuropsychiatric
diseases. Neuropsychiatric diseases are often disabling, but rarely fatal,
and this is reﬂected in the markedly higher proportion of overall disease
burden due to alcohol (38%) in this category compared to alcohol-attrib-
utable mortality (6%). Males have far more (>5-fold) alcohol-related
disease burden than females. The mortality and burden of disease ﬁgures
presented here are net ﬁgures, where the alcohol-related beneﬁcial effects
on disease have been subtracted from its harmful effects. Therefore, the
detrimental effects of alcohol on mortality, and disease burden in general,
far outweigh the beneﬁcial effects.
What are the most striking differences between subregions? Clearly
alcohol-related burden is most detrimental in the developed world. Here
9.2% of the entire disease burden is attributable to alcohol, only
exceeded by the burden attributable to tobacco and blood pressure (see
Table 12.26 and WHO 2002). Here also, the ratio of males to females
is lowest. However, as Table 12.26 indicates, alcohol also places a toll
on health in the developed world, with relatively low mortality 
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Table 12.25 Global burden of disease in 2000 attributable to alcohol
according to major disease categories (DALYs in 000s)
Percentage of all 
Disease or injury Males Females Total alcohol-attributable DALYs
Conditions arising during the 68 55 123 0
perinatal period
Malignant neoplasm 3180 1021 4201 7
Neuro-psychiatric conditions 18090 3814 21904 38
Cardiovascular diseases 4411 -428 3983 7
Other non-communicable diseases 3695 860 4555 8
(type II diabetes, liver cirrhosis)
Unintentional injuries 14008 2487 16495 28
Intentional injuries 5945 1117 7062 12
Alcohol-related disease burden 49397 8926 58323 100
all causes (DALYs)
All DALYs 761562 693911 1455473 In comparison,
estimated total 
Percentage of all DALYs that 6.5 1.3 4.0 for 1990: 3.5
can be attributable to alcohol
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patterns. Here the disease burden attributable to alcohol is the highest
of all 26 risk factors examined in the CRA of the GBD study in 2000
(Ezzati et al. 2002). In high-mortality developing subregions, in Africa
and parts of south-east Asia, alcohol is not yet one of the major risk
factors. Here, the most important risk factors are underweight, unsafe
sex, unsafe water, sanitation and hygiene, and other environmental
factors. However, if past developments can help predict the future, we
can expect that the alcohol-attributable burden will increase in these sub-
regions along with economic development (see also section 5).
4.3 Conclusions
Alcohol causes a considerable burden of disease, in terms both of mor-
tality and disability. While the total elimination of alcohol is not realis-
tic, there are evidence-based policy measures that could substantially
reduce the burden of alcohol. The recent review by Ludbrook et al.
(2001) on measures to reduce alcohol misuse assessed the quality of evi-
dence for four types of intervention aimed at reducing alcohol use and
its consequences. Their ﬁndings coincide with a number of earlier reviews
(e.g. Bruun et al. 1975; Edwards et al. 1994) and with the overview of
Babor et al. (2003). In sum, the following measures were found quite
effective:
• policy and legislative interventions, including taxation on alcohol
sales, drink-driving laws, restricted licensing of outlets and advertis-
ing controls;
• law enforcement, for example random breath-testing of drivers;
• community interventions; and
• brief interventions.
On the other hand, mass media and awareness campaigns were not
found to be very effective, although they seemed to be somewhat more
popular with politicians and policy-makers.
Since these interventions exist and have been empirically shown to
reduce the burden of both chronic and acute disease caused by alcohol,
and also alcohol-attributable social harm, there is no justiﬁcation for
alcohol-related disease to remain at such a high level in many parts of
the world.
5. Projections of the future
Quantitative projections regarding future exposure to alcohol are feasi-
ble only for average volume of drinking, since it is extremely difﬁcult if
not impossible to judge how drinking patterns will alter over time (see
Figures 12.3–12.5).
Adult per capita consumption in EUR-A and EUR-B seems to be
driven by long-term trends (Mäkelä et al. 1981; Simpura 1998). There
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are indications that the current downward trend is levelling off.
However, it is very hard to determine the period of long-term waves with
short-term time series since 1960 or so. Thus, we predict a stable expo-
sure for EUR-A and EUR-B at about the average level of consumption
of the past 10 years. For EUR-C, the curve shows the most change. The
dip at the end of the 1980s is due to the anti-alcohol campaign of the
Gorbachev period in the former Soviet Union (White 1996). At the end
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Figure 12.3 Adult per capita consumption in litres of absolute alcohol
for the AFR, EMR and EUR subregions
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Figure 12.4 Adult per capita consumption in litres of absolute alcohol
for the SEAR and WPR subregions
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of the campaign, alcohol consumption rose again to former levels. Again,
since there is no clear trend after the campaign, we predict about the
same level of consumption as the average of the years after the end of
the Gorbachev campaign. No trends are apparent for EMR-B, EMR-D
and AFR-D. Therefore, the most reasonable projection of future alcohol
consumption would be the level of current consumption. To obtain more
stable estimates, the average of the 1990s has been used.
For the South-East Asia and Western Paciﬁc subregions, the follow-
ing predictions appear justiﬁed based on the trend data shown in Figure
12.4. For WPR-A, there was an upward trend that seems to have stopped
at the end of the 1980s; thus, the average volume of the 1990s was used
as the best projection. For WPR-B and SEAR-B, consumption clearly
increased and we modelled future consumption by a linear upward trend.
The upward trend in SEAR-D was less pronounced, but nonetheless
present, and we therefore again used the linear upward trend.
In the Americas, there has been a long wave of increasing and then
decreasing consumption for North America (AMR-A), almost parallel to
the European consumption. For AMR-B and AMR-D there are slight
downward trends. Since the long-term wave seems to turn upwards
again, and since the downward trends did not reach signiﬁcance, it seems
prudent to model the future for all three subregions at about the same
as the average of the 1990s, as a stable estimate of the status quo.
Trends in drinking patterns have been studied in very special subsets
of populations, such as youth in Europe (Hibell et al. 2000). But at the
global level, for pattern of drinking, there is not even enough reliable
data concerning the current situation, and thus quantitative predictions
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Figure 12.5 Adult per capita consumption in litres of absolute alcohol
for the AMR subregions
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are not possible. Therefore we assumed constant drinking patterns under
a “business-as-usual” scenario. Projections of future adult per capita
alcohol consumption are given in Table 12.27.
In three subregions (SEAR-B, SEAR-D and WPR-B) unrecorded con-
sumption has to be added in order to predict burden, and these data need
to be converted into drinking categories as above, based on surveys. Since
we have neither survey data on the future nor any predictions for survey
or unrecorded consumption, we suggest modelling future consumption
as follows.
• For all subregions except SEAR-B, SEAR-D and WPR-B, predictions
are based on 2000 data on proportions of drinking categories.
• Proportions of drinking categories II and III are increased by 2.1%
over those for 2000 for SEAR-B and WPR-B, and by 0.7% for SEAR-
D (Table 12.28). Of course, there are limits of linear increase, and we
considered the current levels of consumption in the A subregions as
upper limits.
In summary, the best estimates predict global increases in average con-
sumption of alcohol, triggered by increases in developing and emerging
economies in the South-East Asia and Western Paciﬁc regions.
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Table 12.27 Projections of adult per capita consumption by subregion,
in litres of pure alcohol, excluding SEAR-B, SEAR-D and 
WPR-B
Subregion
AFR-D AFR-E AMR-A AMR-B AMR-D
Mean 3.543 4.127 8.276 6.669 3.462
95% CI upper 3.608 4.258 8.428 6.826 3.558
95% CI lower 3.478 3.996 8.125 6.512 3.366
SD 0.085 0.171 0.197 0.204 0.125
Trend No trend No trend Long waves No trend No trend
EMR-B EMR-D EUR-A EUR-B EUR-C WPR-A
Mean 1.248 0.238 12.632 5.372 8.316 7.012
95% CI upper 1.355 0.245 13.008 5.552 8.845 7.127
95% CI lower 1.142 0.231 12.255 5.192 7.787 6.897
SD 0.139 0.009 0.490 0.234 0.688 0.149
Trend No trend No trend Long waves No trend No trend Long waves
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Table 12.28 Projections of adult per capita consumption by subregion, in
litres of pure alcohol, for SEAR-B, SEAR-D and WPR-B
Subregion
SEAR-B SEAR-D WPR-B
Increase per year in litres 0.063 0.014 0.108
of pure alcohol after 2000
95% CI upper 0.068 0.016 0.115
95% CI lower 0.057 0.012 0.102
Increase in adult per capita 2.1 0.7 2.1
consumption 2000 (%)
Trend Linear upward Linear upward Linear upward
Shared variation: year and 1960–1999a 88.0% 93.2% 96.8%
consumption
a The shared variation or “explained variance” denotes a measure of strength of the relationship, i.e. how
much of the variation of adult per capita consumption is explained by the linear trend.
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Notes
1 See preface for an explanation of this term.
2 Social outcomes of alcohol consumption are deﬁned as changes that affect
the social behaviour of individuals, or their interaction with partners and
other family members, or their circumstances (Rehm 2001). Social outcomes
would include family problems, public disorder, or workplace problems 
(for overviews see Gmel and Rehm 2003; Klingeman and Gmel 2001). Social
outcomes or consequences are not addressed in this chapter unless they 
are included in ICD-10. The majority of these problems are not covered 
by ICD-10, even though health is broadly deﬁned by WHO to include 
well-being.
3 Intoxication and dependence are of course also inﬂuenced by biochemistry.
However, since these two intermediate outcomes are central in shaping the
effect of alcohol on many health and social outcomes, they are discussed sep-
arately. The other effects (e.g. on promotion of blood clot dissolution) are
often speciﬁc for one disease or a limited group of diseases. Both intoxica-
tion and dependence are deﬁned as health outcomes in ICD-10.
4 This is not to imply that there is no drinking to intoxication or occasions of
heavy drinking in countries with established market economies; it is simply
to say that this pattern of drinking is more common in countries with devel-
oping or emerging economies.
5 There are other ways of estimating unrecorded consumption, such as those
based on available raw materials (see the estimates for the Russian Federa-
tion by Nemtsov 1998, 2000, 2002).
6 Surveys do not necessarily underestimate the recorded per capita consump-
tion, even though the literature sometimes appears to imply it. For some
countries, e.g. Mexico, adding up the ﬁgures from the survey may lead to
higher estimates than the recorded per capita consumption.
7 This questionnaire can be obtained from the ﬁrst author on request. It was
ﬁnalized at a WHO expert meeting in Geneva, May 2001.
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8 For comparison, a 75-cl bottle of wine contains about 70 g of pure alcohol.
9 As part of the process of developing these ratings, an earlier list of derived
and assigned pattern values as shown in Table 12.3 was made available on
a WHO listserve to a large number of key informants for critical assessment.
This process resulted in the identiﬁcation of local surveys, which helped
improve the estimates.
10 This reasoning was also behind the list of those invited to a WHO workshop
on unrecorded consumption in May 2001, where experts from Brazil, China,
India, Nigeria and the Russian Federation met with other experts on the
methodology of estimating unrecorded consumption to discuss current esti-
mates and develop a methodology to improve data gathering.
11 Ledermann had been the ﬁrst to claim that the distribution of alcohol con-
sumption among drinkers is log-normal. Subsequent research found the exact
shape to be different but still approximately log-normally distributed (e.g.
Duffy 1986 and rejoinders).
12 These analyses are sometimes also called hierarchical linear analyses (Bryk
and Raudenbush 1992). Since the term “hierarchical” is ambivalent (in soci-
ology it has also been used to describe stepwise regression), we exclusively
use the term “multilevel” in this chapter.
13 In the statistical literature units are called sections, hence the method used is
called cross-sectional time series analysis. In our case, countries are sections.
14 Europe was taken as a pilot as data are most available there. The current
analysis included data from 81 countries for injuries and 74 countries for
IHD, most of them outside Europe.
15 Year is only controlling for the linear part of the time structure. However,
sensitivity analyses were carried out to estimate the performance of the
method used.
16 “Random” does not mean that the underlying relationships are completely
random. Effects may be partly deterministic owing, for example, to different
policies. The term “random” here means that effects across sections or coun-
tries cannot be estimated without error, and the errors are assumed to have
a random distribution.
17 If the patterns were estimated as deviations from mean patterns, then 
the value of g10 would reﬂect the average impact of adult per capita 
consumption.
18 Even for biologically based relationships, the relationship could be moder-
ated by other factors such as diet (e.g. alcohol may be related to breast cancer
through hormonal effects, but diet also affects hormonal levels and this may
have an inﬂuence on the alcohol–breast cancer relationship). However, except
for IHD, meta-analyses on alcohol and chronic disease have yielded fairly
similar effects for different populations, so the assumption of applying the
same effect for average volume of drinking is probably justiﬁed.
19 Such “categorical” attribution is quite different from the statistical estima-
tion used in other epidemiological studies. For the usual derivation of
alcohol-attributable fractions see Rothman and Greenland (1998b).
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20 Type of beverage has been excluded so far from our consideration of pat-
terns of drinking. While the evidence is not conclusive on the effect of bev-
erage on all-cause mortality or on cardiovascular disease (e.g. Gruenewald
et al. 2000; Kerr et al. 2000; Rimm et al. 1996), there are some indications
that cancers of the gastrointestinal tract are differentially inﬂuenced by
alcohol in higher concentration.
21 Part of this lack of an inﬂuence on patterns of cancer risk may be due 
to methodological reasons. Most epidemiological studies measure only
volume of consumption and model only monotonically increasing trends, and
thus could not detect any inﬂuence of patterns of drinking even if they were
present.
22 In the Inter-American Investigation of Mortality, which studied 4000 deaths
in each of 12 cities in 1962–1964, the ﬁnal assignment of all deaths from cir-
rhosis “with mention of alcoholism” was 80.4% of all cirrhosis deaths.
About half of these had been “without mention” on the death certiﬁcate.
Only in Santiago and Mexico City was the ﬁnal assignment for “with
mention” less than twice the initial number. The study used searches of
medical records and interviews with decedents’ families and attending physi-
cians to reassign deaths from the initial classiﬁcation (Room 1972, based on
Puffer and Grifﬁth 1967).
23 IHD is used here for denoting all diseases with ICD-9 rubrics 410–414 (ICD-
10: I20–I25). The same categories have also been labelled coronary heart
disease (CHD).
24 DisMod is a software tool that may be used to check the internal consistency
of epidemiological estimates of incidence, prevalence, duration and case 
fatality for diseases. The latest version (DisMod II) is distributed by WHO:
http://www3.who.int/whosis/burden/burden_dismod/burden_dismod_dismo
d2.cfm?path=whosis,burden,burden_dismod,burden_dismod_dismod2&
language=english.
25 The notion of a causal contributing role is at the heart of the epidemiologi-
cal concept of causality (Rothman and Greenland 1998). According to such
standards, as explained in the text, the causal role of alcohol in intentional
injuries is established. According to criteria used in criminology, this may not
be the case.
26 Part of the effect of alcohol on aggression or on other more social outcomes
is due to psychological variables. The term “expectations” denotes the indi-
vidual predictions and expectancies of what will happen after consumption
of alcohol. Experimental research has demonstrated that such psychological
variables play a role in determining outcome.
27 Often trafﬁc accidents are described as if the environment’s effects are 
totally independent of the person’s behaviour. However, tired drunk-drivers
on the road at 03:00 might well not have been there if they had not been
drinking. Intentionality (and alcohol’s effects on it) forms part of what are
called “accidents”.
28 Odds = p/(1 – p).
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Appendix A: “Pattern of drinking” variables and their 
relative weights
HEAVY DRINKING OCCASIONS
(Maximum of 11 points for this component)
Daily drinking
Less than 20% daily drinking for males: 1 point
Less than 10% daily drinking for females: 1 point
Frequency of getting drunk
Most male drinkers usually get drunk when they are drinking: 2 points
Most males drinkers often get drunk: 1 point
Most female drinkers usually or often get drunk: 1 point
Usual quantity per drinking session
Males: more than 60% typically consume four or more drinks per
session: 2 points
Males: between 40% and 60% consume four or more drinks per
session: 1 point
Females: more than 50% consume four or more drinks per session: 2
points
Females: between 35% and 50% consume four or more drinks per
session: 1 point
Fiesta binge drinking
Males: ﬁesta drinking commonly occurs: 1 point
Females: ﬁesta drinking commonly occurs: 1 point
DRINKING WITH MEALS
(Maximum of 4 points for this component)
Males: rarely or never with meals: 2 points
Males: sometimes with meals: 1 point
Females: rarely or never with meals: 2 points
Females: sometimes with meals: 1 point
DRINKING IN PUBLIC PLACES
(Maximum of 2 points for this component)
Males: common and everyday: 1 point
Females: common and everyday: 1 point
SCORING (POSSIBLE RANGE: 0–17 POINTS)
Scoring by summation of individual questions: range 0–17
10–17 points: assign a pattern value of 4
7–9 points: assign a pattern value of 3
4–6 points: assign a pattern value of 2
0–3 points: assign a pattern value of 1
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